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ABSTRACT 
 
Non-invasive methods to investigate brain function have been used in research laboratories 
for many decades, however their popularity has increased in recent years given the ease of 
use and broad application. Such methods have proved valuable in improving our 
knowledge about numerous areas of basic brain function.  
Many non-invasive techniques have also been applied to patient groups to allow further 
identification of pathological mechanisms, but critically a new role has been found for 
some as biomarkers of disease. Neurodegenerative disease is fast becoming one of the 
biggest medical problems in the first world. An aging population has caused the relative 
incidence of many conditions to rise dramatically and studies suggest that this trend will 
continue. Although our knowledge surrounding these conditions has improved 
significantly, most remain notoriously difficult to diagnose and to treat. The recent 
introduction of neuroprotective drugs offers the potential to slow the progression of some 
diseases. However, to take full advantage of these disease-modifying treatments, 
administration must occur early in the disease course which fuels the demand for selective 
and specific diagnostic tests. 
There is currently a great need to enhance the clinical diagnostic repertoire with reliable, 
robust and specific biomarkers of neurodegenerative disease. However, careful, rigorous 
studies are required to validate the use of non-invasive techniques in this role. The same 
level of care should also be applied to techniques used in basic research; without a 
fundamental understanding of the mechanisms underpinning these techniques, their utility 
in the investigation of specific processes or pathways is questionable. This thesis aims to 
address specific cases to evaluate existing techniques and to screen potential new disease 
biomarkers. 
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CHAPTER I: INTRODUCTION 
The last few decades have seen the introduction of a wide range of techniques which 
facilitate the non-invasive investigation of brain function in human subjects. These 
accessible methods have proved invaluable at developing our understanding of motor 
control as well as other neurological processes. 
Many non-invasive techniques have been applied to patient groups to allow further 
identification of pathological mechanisms, but critically a new role has been found for 
some as biomarkers of disease. The ability to detect disease before this can be achieved by 
other clinical scales or investigations is vital at a time when the best treatments we have at 
our disposal can only slow the relentless progression of neurological disease. 
There is currently a great need to enhance the clinical diagnostic repertoire with reliable, 
robust and specific biomarkers of neurodegenerative disease. The incidence and prevalence 
of many neurological conditions is increasing in association with an aging population and 
detailed genetic and pathological investigations have revealed that many diseases are not a 
single entity but actually fall within a complex spectrum of similar pathological processes. 
Despite this huge progress in understanding the nature of neurodegenerative disease, our 
ability to detect it in the earliest stages remains completely inadequate. Patients often have 
to wait many months and sometimes years to receive an accurate diagnosis; often by this 
point substantial irreversible damage has accumulated and there is little which can be done 
in the way of treatment. Although, diagnostic criteria have improved over the past two 
decades, this gap between the onset of pathology and accurate diagnosis is not closing at a 
rate sufficient enough to facilitate useful clinical intervention. This problem needs to be 
addressed if we are to improve patient care and make the most effective use of 
neuroprotective treatments. 
 
Neurodegenerative disease 
Neurodegenerative diseases form a diverse spectrum of chronic neurological disorders 
which are associated with progressive damage to the nervous system. Since neurons are 
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difficult to regenerate or repair in adults, the damage is cumulative and permanent. In all 
conditions, neurodegeneration begins long before symptoms arise, therefore considerable, 
irreversible damage has already accumulated before patients present to a neurology service. 
This feature makes neurodegenerative diseases particularly devastating for patients and 
also incredibly difficult for clinicians to treat.  
Historically, most neurodegenerative diseases were considered to be rare. However, over 
the last half century there has been a colossal improvement in acute phase medical 
treatment for common causes of death such as stroke and myocardial infarction. As a 
result, the population are living much longer with the average life expectancy in the UK 
now 81.5 years for females and 77.2 years for males (Office for National Statistics, 30 Oct 
2008). With an aging population, the relative occurrence of neurodegenerative diseases is 
increasing rapidly (Day et al., 2007; Kondo, 1996; Riggs and Schochet, 1992). This rising 
prevalence represents a huge financial burden on society as well as presenting a significant 
medical challenge for the future.  
In many common neurodegenerative diseases including Parkinson’s disease and motor 
neurone disease, the underlying neuropathological processes are relatively well understood. 
Despite this, there are few specific diagnostic tests, sensitive to the biological hallmarks of 
these diseases. Instead, diagnosis relies largely upon clinical opinion and consensus 
diagnostic criteria. A key feature of these criteria is usually disease progression. Accurate 
diagnoses cannot therefore be applied at a very early stage, limiting the opportunity for 
early intervention.  
Over the past decade, there has been an emerging interest in neuroprotection; developing 
drugs to limit neuronal death and therefore slow progression in chronic neurodegenerative 
disease.  Neuroprotective agents such as Riluzole and Rasagiline have been released onto 
the market with good effect in patients with a disease duration of approximately two years 
(Bensimon et al., 1994; Lacomblez et al., 1996; TEMPO, 2002). It is reasonable to believe 
that these agents would have an even greater neuroprotective effect if administered earlier 
in the disease course, before significant cell loss has occurred. Theoretically this would 
enable progression of the disease to be slowed at a point when there is less damage and 
therefore more residual function, although this has not yet been formally demonstrated. If 
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we are to test and implement this kind of early interventional treatment however, there is 
clearly an urgent need for accurate early biomarkers of disease. 
 
Genetics of neurodegeneration 
Genetic mutations have been shown to play a significant role in the aetiology of many 
neurodegenerative disorders. Consequently, we now have molecular signatures that can 
selectively identify several of these diseases. This is not only useful in symptomatic 
patients; we can also pre-emptively screen populations at a higher risk of developing 
particular conditions. As a result, the onset of some hereditary diseases such as 
spinocerebellar ataxia (SCA) and Huntington’s chorea can be accurately predicted many 
years before the first symptoms appear.  
Pre-symptomatic screening is an incredible achievement of genetic research, however in 
practice it can only be realized in a minority of conditions. In fact, the majority of 
neurodegenerative diseases are by nature genetically complex; they are not usually linked 
to a single gene mutation. Instead, they form a heterogeneous spectrum of disorders which 
can share clinical features and underlying pathology. Moreover, diseases are being sub-
divided and re-classified as there is more understanding of the processes underpinning their 
pathology. Such a complex system undoubtedly makes early, accurate diagnosis a 
significant challenge to clinicians who have few diagnostic tools at their disposal. 
 
Current diagnostic complement 
Traditionally, neurological diseases are identified by their clinical presentation – the signs 
and symptoms that they typically cause. However, this approach is highly subjective and 
largely dependent on clinical experience; in the case of neurodegeneration it is also 
complicated by the fact that many diseases present with similar features. Generally 
speaking, there is a current lack of specific diagnostic tests for almost all of the common 
neurodegenerative diseases. Instead, consensus criteria guide disease classification; these 
usually comprise a specification of clinical features with supporting laboratory data. The 
complexity and often conservative nature of these criteria can delay definitive diagnosis; in 
some cases, clinically definite disease can only be confirmed post mortem. 
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In support of the clinical examination, clinicians have a limited selection of standard
laboratory tests at their disposal. Imaging techniques such as MRI are usually the first port 
of call. These are extremely useful for detecting gross anatomical abnormalities like those 
seen in stroke, although are not always able to reveal subtle changes. In many cases, 
standard brain imaging serves simply to exclude obvious differentials rather than to 
confirm a diagnosis.  
Nerve conduction studies (NCS) are performed as standard for most patients with a 
suspected neuropathy. These involve stimulation of peripheral nerves to evaluate the 
function of motor or sensory nerve fibres. Often, NCS are performed in combination with 
electromyography (EMG) to help localize the source of the abnormality. This test usually 
involves fine needle electrodes inserted superficially into muscles, so can be a little painful. 
EMG and NCS in combination can certainly detect abnormalities associated with 
movement disorders, but they are not always sensitive to discreet differences between 
degenerative diseases. 
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which is available in 
some hospital trusts, although it is usually restricted to research institutes given its expense 
and rather specialist nature. TMS can be helpful in locating lesions in the corticospinal tract 
(CST); indeed it has a supporting role to play in the diagnosis of neurodegenerative 
processes affecting the CST such as MS and MND (Chen et al., 2008; Eisen and Shtybel, 
1990). For some patients however TMS is not appropriate as high stimulus intensities often 
have to be used in the presence of CST damage; this is not always tolerated. 
In addition to the standard tests available, there are some highly specific disease 
biomarkers which can be employed when certain conditions are suspected. For example, 
there are genetic tests for inherited conditions, immunological assays and 
radiopharmaceutical tracers (eg DaTSCAN). Importantly, the availability of these specific 
tests is restricted to a relative minority of diseases; the most common neurodegenerative 
conditions such as Alzheimers disease and MND are still diagnosed largely on the basis of 
consensus clinical criteria. 
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Need for better diagnosis of neurodegenerative diseases 
Many neurodegenerative diseases are not separate nosological entities but instead form part
of a disease spectrum. As such, symptoms often overlap and diseases may also share 
pathologies or genetic mutations. With such a complicated spectrum of disease, a reliable 
method of differentiation becomes critical. The current collection of standard laboratory 
tests (detailed previously) are not sufficiently sensitive to inform diagnosis. In combination 
with clinical examination, current tests are still estimated to result in unacceptably high 
rates of misdiagnosis (Davenport et al., 1996; Rajput et al., 1991). Coupled with the 
increasing prevalence of neurodegenerative disease, the urgent need for better biomarkers 
of neurodegeneration is evident. There are obvious implications for prognosis, treatment, 
and also for future clinical trials. 
It is known that early intervention in neurodegenerative disease is essential. 
Neuroprotective treatment can only be beneficial if it is implemented at a stage where there 
is still sufficient residual neuronal function. In stark contrast to this, it may take years to 
reach an accurate diagnosis for MND or Parkinsonism. By this time, symptoms tend to be 
prominent and often troublesome to the patient who is likely to have acquired some degree 
of disability. Uncertainty surrounding diagnosis can also have huge psychological 
implications for the patient; depression is common in neurodegenerative disease 
(Cummings, 1992; Taylor et al., 2010). 
It is important to note that misdiagnosis or delays induced by consensus criteria will also 
impede experimental trials of novel treatments for neurodegenerative disorders. For 
example, it has been estimated that 20-25% of patients diagnosed with PD actually have an 
atypical form of Parkinsonism (Hughes et al., 1993; Litvan et al., 1997; Rajput et al., 
1991). These diseases tend to be much more aggressive and importantly have very different 
underlying pathology. It is crucial therefore that patients are diagnosed accurately in order 
for the appropriate therapeutic strategy to be put in place. Accurate diagnosis would also 
prevent research being compromised by heterogeneous patient populations. 
All neurodegenerative diseases have a long pre-clinical period during which there is 
considerable cell loss, but no overt clinical symptoms. For example in Parkinson’s disease, 
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symptoms do not appear until  60-80% of dopaminergic neurons are lost (Bernheimer et al., 
1973) and one report suggested that there may be up to 50% loss of motoneurones before 
clinical onset of MND (Aggarwal and Nicholson, 2002). An exciting possibility would be 
the potential for pre-symptomatic diagnosis in these conditions, something which is already 
possible for inherited disorders. This would optimise the therapeutic window for treatment, 
targeting the system before the majority of the damage has been done. Administration of 
disease-modifying therapy in the pre-symptomatic stages of disease may help delay disease 
onset and significantly slow progression. 
 
Disease detection: what are biomarkers? 
Biomarkers accurately measure the status of a particular biological system or process. They 
are objective, quantifiable measures which are independent of opinion. In essence, 
therefore they are a simple measure of a complex process. Consequently, they have a 
significant role to play during many stages of the clinical process.  
Biomarkers can be particularly useful in the initial detection of disease; identifying an 
abnormal physiological measure which is indicative of a pathological process. But this is 
not their only role. Given that they reflect a physiological measure, monitoring a biomarker 
over time can give information about the rate of progression of a disease as well as the 
efficacy of treatment. In addition, initial measures may be able to give some prognostic 
information about the likely clinical course of the condition.  
 
Electrophysiological techniques as biomarkers of neurodegenerative 
disease 
Without sensitive biochemical markers of neurodegenerative disease, we must look for 
indirect evidence of pathology. The term electrophysiology refers to a group of techniques 
classically used to investigate the integrity of the central and peripheral nervous systems. 
As opposed to subjective clinical scoring or consensus criteria, electrophysiology offers a 
precise and objective method of interrogating these pathways. Currently, electrodiagnostic 
tests play a significant role in the diagnosis of peripheral disorders of muscle and nerves, 
but are less frequently utilised in the diagnosis of CNS disease.  
 7 
 
Electrophysiological tests are usually non-invasive (occasionally involving needle 
electrodes) and simple to perform. In a standard clinical neurophysiology department, the 
primary aim is to look for evidence of abnormalities within the nerves and muscles. Here, 
EMG and NCS are particularly useful in helping to distinguish between processes which 
might otherwise look very similar - for example tremor and clonus. The high sensitivity 
and large collection of normative data means that many diseases can be identified early in 
the disease course. 
In the basic science community, there is a rich collection of electrophysiological techniques 
which also have the advantage of interrogating central pathways. There are a diverse range 
of stimulation paradigms which probe particular pathways using techniques such as TMS, 
direct current (tDCS) and electrical stimulation (TES). There are also techniques which are 
known to probe the function of important brain structures such as the cerebellum and 
brainstem. Whilst some of these techniques have already found clinical utility (for 
example, measuring central motor conduction delays in MS with TMS), in most cases they 
have never been considered for diagnostic purposes. However, the simplicity and 
sensitivity of these techniques would make them suitable for this task. 
 
Biomarkers may have a role in monitoring disease progression and drug 
side effects 
Aside from the question of accurate diagnosis, biomarkers could have numerous other roles 
in the clinical setting. For instance, they could be useful in monitoring the course of 
neurodegenerative disease. This could potentially help clinicians with the difficult task of 
predicting disease milestones; ultimately, biomarkers may also provide an accurate 
prognosis as well as yield information on the efficacy of the treatment regimen. This is 
particularly important since we know that neurodegenerative disorders progress at very 
different rates and can be notoriously difficult to treat.  
There may also be an important role for biomarkers in clinical trials. Assessing the efficacy 
of new drugs during phase III clinical trials is currently achieved using clinical measures. 
These are both time-consuming and subjective. A quantifiable biomarker for assessing drug 
efficacy would be much more robust and efficient. Not only would this streamline large 
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multi-centre trials, it could also significantly reduce the length and cost of clinical trials. 
Biomarkers implemented in earlier stages of drug development could also reduce the risks 
assumed by patients during clinical trials by picking up ineffective agents early in the 
process. 
In addition, we know that many drugs can cause unwanted adverse effects in the nervous 
system. It is easy to overlook the importance of this, especially if the drugs are treating the 
primary disease effectively. However, some side effects can be severe and irreversible such 
as the cerebellar atrophy associated with some antiepileptic treatments. In such cases, 
identifying this problem early, before damage accumulates would be very useful. In 
particular a quantitative ratio of drug efficacy versus adverse effects would be an objective 
way of assessing the most appropriate treatment for individuals.  
 
Developing biomarkers 
Many sensitive indicators of nervous system dysfunction have been used in basic science 
for decades. Recently, some of these have become available in the clinical setting for 
diagnostic and therapeutic purposes. TMS, for example, has been used to identify central 
motor conduction delays associated with MS (Eisen and Shtybel, 1990) and excitability 
changes in MND (Vucic and Kiernan, 2006). However there are many more techniques 
which could be exploited successfully in this way.  
Useful biomarkers must fulfil certain criteria. Firstly, they must be able to detect 
objectively a feature or hallmark of a particular disease process. Moreover, they must be 
able to do this with high confidence; that is they must be both sensitive and specific to that 
particular entity. Finally, the results generated using any biomarker must be highly reliable 
and reproducible. Without all of these features, a biomarker simply would not be 
sufficiently efficacious to justify use as a clinical diagnostic test.  
In addition to the criteria above, there are also a number of features which are desirable for 
any clinical test. Ideally, they should be either non-invasive or minimally invasive to 
reduce the impact on patients. There should also be a clear economic justification; to 
warrant routine use, a cost-benefit analysis is often required to take into account the cost of 
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facilities, equipment and the skill base of the staff necessary to conduct and interpret any 
test result.  
 
Thesis objective 
The aim of this thesis is to explore the use of non-invasive techniques both in the 
investigation of normal and pathological brain function. Most of the paradigms discussed 
therefore will not be novel; it is only their application which is novel. I would like to help 
to facilitate the efficient and appropriate use of these techniques in both basic and clinical 
research. To that end, basic studies have been carried out in animals and healthy human 
subjects to help elucidate more information about the underlying mechanisms.  
A major part of this thesis is concerned with improving the diagnosis of neurodegenerative 
disease by verifying the specificity of non-invasive methods and investigating their use as 
biomarkers. In the first instance these techniques have been applied to patients who already 
have an established diagnosis. This gives us the opportunity to test whether the techniques 
have the sensitivity and specificity necessary to be implemented as a biomarker of 
neurodegenerative disease. In the future, the ultimate aim is to extend this research into the 
non-invasive detection of sub-clinical disease by following patients longitudinally. An 
obvious way to test for this would be to use patients with a genetic disposition to a 
particular condition which would allow measures to be taken before and after the onset of 
symptoms. These patients are rare however, so larger scale studies might involve broad 
investigation of all patients presenting to movement disorder specialists with a particular 
range of symptoms. This type of study would enable us to determine at what stage in the 
disease course our techniques are effective and whether they will truly have clinical utility 
as biomarkers. 
All experiments described in this thesis were approved by the Local Research Ethics 
Committee. Those involving patients were also sponsored by the Newcastle-upon-Tyne 
Hospitals NHS Trust. The clinical trial involving use of Levetiracetam required additional 
approval from the Medicines and Healthcare products Regulatory Authority. Animal 
procedures were carried out under UK Home Office personal and project licenses and in 
accordance with the Animals (Scientific procedures) Act 1986. 
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Patients were referred to the studies by the consultants responsible for their care. They 
were identified from specialist clinics within the Royal Victoria Infirmary, Newcastle 
General Hospital and Sunderland Royal Hospital. Age-matched control subjects were 
recruited from members of the Institute of Neuroscience and their friends and families. 
Participating subjects all gave written informed consent. 
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CHAPTER II: ASSESSING THE CORTICOSPINAL TRACT IN 
MOTOR NEURONE DISEASE 
Motor neurone disease (MND) is a sporadic, fatal, neurodegenerative disorder. It is a rare 
condition with an estimated incidence of 1-6 people affected in every 100,000 (Alonso et 
al., 2009; Dean et al., 1994). The MND spectrum comprises four clinically defined 
subtypes between which there is some degree of overlap. These are: amyotrophic lateral 
sclerosis (ALS); progressive bulbar palsy (PBP); progressive muscular atrophy (PMA); and 
primary lateral sclerosis (PLS).  
MND presents most commonly as ALS and is characterised by widespread degeneration of 
neurones within the ventral horn of the spinal cord and the motor cortex. This is typically 
an aggressive and rapidly progressive form of MND; average life expectancy is only 2-3 
years from onset (Forbes et al., 2004; Hudson et al., 1986; Sorenson et al., 2002).  
As with other neurodegenerative conditions, there are some well characterised genetic 
associations with MND. Of these, a mutation in the SOD1 gene on chromosome 21q is the 
most common; this is associated with ALS (Rosen et al., 1993). However, familial MND is 
only reported in an estimated 10% of cases. For the remaining 90% of patients, the disease 
process is considered to be sporadic and there is no known aetiology.  
Early diagnosis is important in a disease in which the primary strategy of treatment is to 
halt, or slow the relentless degeneration of motor neurones. Unfortunately, even at 
symptomatic presentation, when the diagnosis is often uncertain, there is already extensive 
motoneurone degeneration. MND patients could have already lost 10-50% of 
motoneurones before muscles become symptomatically weak (Aggarwal and Nicholson, 
2002). This presents problems for clinical trials of neuroprotective agents; changes in 
endpoints such as strength and disability are likely to be small and difficult to discriminate 
statistically because of the extensive neuronal destruction. Despite this, early trials of the 
neuroprotective agent riluzole demonstrated a small but significant improvement in life 
expectancy in patients with ALS (Bensimon et al., 1994; Lacomblez et al., 1996). This 
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benefit would likely be significantly enhanced if an earlier diagnosis could be achieved to 
open up the therapeutic window. 
 
Current diagnostic criteria for MND 
There are no specific diagnostic tests for any of the conditions on the MND spectrum. 
Instead, diagnosis involves first excluding the possibility of other diseases which can 
mimic MND such as cervical spondylotic myeloradiculopathy, primary progressive 
multiple sclerosis or hereditary spastic paraplegia. Then, doctors turn to clinical 
presentation; patients must fulfil criteria agreed by international committees. It may 
therefore take several months or even years to confirm diagnosis. 
The first and probably still most widely used consensus criteria (El Escorial) were 
introduced by the World Federation of Neurologists (Brooks, 1994) and subsequently 
revised (Brooks et al., 2000) to increase sensitivity. Rapid progression of the condition is 
usually key to diagnosis, except in the case of PLS. Diagnosis is mainly on the basis of 
clinical evidence although neurophysiological tests were incorporated in the revision which 
is important since EMG is able to detect some of the chronic neurogenic changes 
associated with MND. To obtain a label of ‘probable MND’, patients must have a 
progressive history as well as presence of both upper and lower motoneurone signs in at 
least two spinal regions on examination. There must also be an absence of sensory signs 
which cannot be explained by any other differential diagnosis. The El Escorial criteria is 
useful in ALS which has diffuse degeneration across both central and peripheral nerves but 
does not account for the other variants of MND which have a more localized onset. 
Although still in widespread use, the El Escorial criteria have been repeatedly criticized. 
Traynor et al. (2000) demonstrated poor sensitivity in their large cohort of ALS patients. 
Moreover, approximately 10% of their patients died without ever reaching a definite 
diagnosis. Consequently, further standards have been proposed. Specialist criteria were 
created by a subcommittee of the world federation of neurology explicitly to define patients 
appropriate for each phase of clinical trials (World Federation of Neurology Research 
Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease., 1995; Miller 
et al., 1999). These ‘Airlie House’ criteria also evaluated methods of assessment and rating 
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scales in terms of which were preferred tests and which were merely acceptable. The 
‘Awaji criteria’ (de Carvalho et al., 2008) were also proposed which suggested that the 
criteria of denervation in multiple muscles and spinal regions could be fulfilled by a 
combination of findings on clinical examination and EMG studies. This was a minor 
modification to El Escorial which was designed to facilitate earlier diagnosis. A subsequent 
publication has demonstrated this method to be more sensitive than El Escorial in the 
diagnosis of ALS (Carvalho and Swash, 2009).  
EMG studies have long had a central role in the diagnosis of MND and are an important 
feature of consensus criteria. Consequently, there are a number of specific neurogenic 
changes which support a diagnosis of MND. A standard clinical study in the UK consists of 
a 45 minute appointment window during which the clinician must be able to demonstrate 
significant changes in multiple muscles supplied by at least two of the four spinal regions 
(cervical, thoracic, lumbar and sacral). Intramuscular EMG recordings are performed 
which involve insertion of a needle electrode into muscle tissue and recording electrical 
potentials both at rest and during gentle muscle contraction. 
Resting muscles are normally electrically silent in healthy people. However, in MND, 
active denervation gives rise to biphasic fibrillation and fasciculation potentials which 
reflect spontaneous discharge of both individual and groups of nerve fibres respectively. 
Positive sharp waves may also be observed early in the disease course in the absence of 
other electrical abnormalities. These are characterised by a rhythmic discharge in relaxed 
muscles with a sharp positive deflection followed by a slow negative phase which 
gradually returns to baseline. On EMG examination, positive sharp waves can often be 
seen in the presence of fibrillation potentials and although the exact origin is unclear, both 
are thought to arise as a direct consequence of individual muscle fibres losing their 
connection to the corresponding motor axon. 
On voluntary muscle contraction in healthy subjects, there is normally a highly ordered 
recruitment of motor units from small to large as the effort is increased. However, in MND 
this recruitment is usually impaired due to the reduced number of motor units available. In 
addition, the remaining motor units are typically very large and polyphasic as a result of re-
innervation of muscle fibres.  
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A wide range of muscles are usually sampled since a diagnosis of MND by current criteria 
can only be supported if multiple muscles and limb segments are involved. The detection 
of sensory changes or conduction block during NCS are also important findings since they 
do not support a diagnosis of MND.  
There are also further techniques which though not incorporated into diagnostic criteria can 
provide useful information about the state of the system. TMS can be a useful adjunct; it is 
known that patients with MND typically have either absent or small amplitude MEPS 
alongside a prolonged CMCT (Cruz Martinez and Trejo, 1999; Mills and Nithi, 1998; 
Osei-Lah and Mills, 2004). As the disease progresses, MEPs become harder to elicit and 
eventually disappear altogether. A recent report further suggested that MND can be picked 
up before the obvious change in MEPs appear. Vucic and Kiernan (2006) described 
reduced motor threshold which is predictive of MND; this is followed by a significantly 
increased threshold as motoneurones begin to die. 
 
Descending pathways controlling movement 
In mammals, there are a number of descending motor pathways which influence movement 
control (Fig. 2-1A); their relative size is different amongst species, but the general function 
is preserved. The dorsolateral pathways of the corticospinal tract and rubrospinal tracts are 
chiefly associated with fine, dextrous control of distal muscles, in particular the control of 
hand movements. In contrast, the ventromedial pathways of the reticulospinal, 
vestibulospinal and tectospinal tract are predominantly responsible for balance and control 
of posture (Lawrence and Kuypers, 1968b).  
 
The corticospinal tract  
Primates have a unique ability amongst animals to perform very fine, skilled, dexterous 
hand movements. This ability has evolved relatively recently alongside the development of 
the direct corticomotoneuronal projection from the brain to the spinal cord. In humans and 
primates, this projection forms a very specialised component of the corticospinal tract 
(CST) which is the major pathway through which the cortex influences the spinal cord and 
therefore controls movements.  
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Figure 2-1 A: Schematic representation of the major descending motor pathways in 
primates. The corticospinal tract is highlighted in red. Adapted from Brinkman and 
Kuypers (1973). B: Schematic of the descending corticospinal tract showing the central 
connection between cortex and spinal cord and the peripheral projection to the muscle. C: 
Detailed anatomical structure of motor cortex. From www.brainmind.com. 
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The CST is a vast control network constituting approximately 1 million fibres in humans.  
Anatomical studies demonstrate that the CST mainly innervates distal musculature 
facilitating its role in shaping fine fractionated finger movements. It is more developed in 
higher apes (especially humans) than in any other mammal. These abundant direct 
corticomotoneuronal (CM) connections are known to exert powerful monosynaptic effects 
on hand muscles. Moreover digital dexterity is greatest in animals with a higher proportion 
of CM connections (Heffner and Masterton, 1983) indicating the importance of these 
projections in shaping precise movements. 
 
Corticospinal tract anatomy 
The CST originates primarily in the primary motor cortex, although a significant number of 
fibres also arise from the supplementary motor area, arcuate motor area and cingulate gyrus 
(Dum and Strick, 1991; Galea and Darian-Smith, 1994; He et al., 1993; He et al., 1995; 
Nudo and Masterton, 1990). These corticospinal neurones project to all levels of the spinal 
cord, but the majority of fibres terminate in cervical regions which innervate the neck and 
upper limbs (Weil and Lassek, 1929). CST neurones target the ventral horn; here they 
usually synapse onto interneurons but sometimes directly onto motoneurones. The 
corticospinal tract also projects to the medullary region; this is discussed in more detail in 
chapter V. 
The CST is predominantly a crossed pathway; 85-90% of fibres cross the midline at the 
level of the medulla oblongata and descend in the lateral CST via the dorsolateral funiculus 
(Armand and Kuypers, 1980; Rosenzweig et al., 2009). These projections terminate in the 
lateral region of the ventral horn; this area of the spinal cord is particularly rich in 
motoneurones which innervate distal limb muscles. The remaining 10-15% of axons 
descend ipsilaterally in the medial CST, projecting predominantly to the axial musculature. 
Recent work has suggested an added layer of complexity in that there is also a re-crossing 
of a significant number of fibres (Rosenzweig et al., 2009). 
Corticospinal tract fibres are myelinated and therefore fast conducting. The axons of the 
CST are highly collateralised within the brain; branches relay information about 
descending motor commands to other cortical areas. However, compared to other 
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descending pathways, the CST is not highly collateralised within the spinal cord; 
presumably this selective pattern of termination contributes to the facilitation of very fine, 
precisely controlled movements. 
The corticospinal pathway is divided into 2 distinct sections (Fig. 2-1B). Anatomists 
describe the connection between motor cortex and the spinal cord as corticospinal with 
motoneurons projecting from the cord to the muscles. However, clinicians use different 
terminology and it is these that will be used within this chapter. Upper motor neurones 
(UMNs) have cell bodies located in the motor cortex and long axons which project to either 
the brainstem or ventral horn of the spinal cord. Lower motor neurones (LMNs) have axons 
arising from the ventral horn of the spinal cord or the brainstem and project to muscle 
fibres. 
The principle cells of the CST are pyramidal tract neurones, the largest of which are 
commonly known as Betz cells. These are found in layer V of the primary motor cortex 
and were thoroughly described by Ramon y Cajal almost a century ago. The largest Betz 
cells can reach up to 120µm in humans, though the majority are small (<40 µm). The 
cortical layers and their corresponding cytoarchitecture are shown in figure 2-1C. 
Distinct clusters of pyramidal cells are found throughout M1, particularly in caudal parts of 
the precentral gyrus. This pattern of distribution is distinct to M1 but the functional 
significance is unknown. In addition, M1 is not densely packed like other cortical areas and 
in particular layer V is the least densely packed with cells. Unlike the sensory cortices, 
motor cortex has only a very gross somatotopic organisation. The neurologists Penfield and 
Rasmussen (1950) originally revealed the ordered structure of M1 via their microstimation 
mapping studies. However this organisation has since been shown to be less ordered than 
previously thought (Liddell and Phillips, 1950; Schieber and Hibbard, 1993; Schieber, 
2001). Although there are separate areas for large body segments, there is a distributed 
organisation of the smaller parts within these discrete zones. For example, there is overlap 
in cortical representation for the fingers within the area known to contain neurons 
projecting to the upper extremities. A similar level of somatotopy has also been 
demonstrated in premotor areas (Godschalk et al., 1995). 
 18 
 
Motor cortex receives significant input from adjacent somatosensory areas and this sensory 
feedback has a significant role in motor control.  Indeed, lesions of CST cause sensory 
deficits; Hamzei et al (2006; 2008) demonstrated altered activation of somatosensory areas 
in patients with damage to the CST. This was more pronounced in patients with the most 
extensive lesions. Significant corticomuscular coherence has also been identified between 
oscillations in somatosensory areas, motor cortex (Witham et al., 2007) and the periphery 
(Witham et al., 2010) suggesting there is sensorimotor integration in the cortex which 
informs the execution of new movements. Moreover, Riddle and Baker (2005) showed that 
introducing an afferent feedback delay by cooling the periphery could alter this 
corticomuscular coherence.  
 
Corticospinal tract lesions 
Natural, selective lesions of the corticospinal tract are rare (pure motor stroke, caused by a 
lacune selectively affecting the CST). Nevertheless, there have been some cases of 
pyramidal stroke and hemiplegia (Chokroverty et al., 1975; Ropper et al., 1979) which 
have helped us to assess the role of the CST. Such cases report unilateral weakness in 
voluntary movements with deficits most apparent in the distal musculature. Recovery is 
usually weighted towards proximal muscles (Lang et al., 2006) which is in agreement with 
reorganisation of brainstem motor pathways; these have relatively more connections with 
proximal motoneurones.  
Controlled lesion studies in animals have been useful in revealing the functional role of the 
CST in movement control. Lawrence and Kuypers’ (1968) seminal work demonstrated that 
damage to the CST in primates was not as catastrophic as previously thought. Although 
immediately after bilateral pyramidectomy animals were paralysed, they recovered 
relatively quickly. Indeed, after this period of recovery, it seemed that there were very few 
gross deficits in movements; animals could grip, walk and climb surprisingly normally.  
Significant motor deficits were restricted to the fine, fractionated finger movements; 
monkeys struggled to retrieve food from small wells and they had difficulty grooming each 
other. These deficits are thought to be related to the number of corticomotoneuronal fibres 
since they are greater in chimpanzees than macaques (Tower, 1940).  
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Reversible inactivation of motor cortex with muscimol has supported observations in 
lesioned animals. Injections into discrete regions of M1 resulted in weak finger movements 
and an inability to fractionate fingers (Brochier et al., 1999; Schieber and Poliakov, 1998). 
These problems were resolved once the effects of muscimol had worn off. 
 
Current methods of corticospinal tract assessment 
It is considerably easier to assess the integrity of the ‘lower motor neurone’ or the 
peripheral component of the system. Nerve conduction studies (NCS) assess the integrity 
of these pathways and there are hallmark features associated with motor neuron 
degeneration. This represents a simple and reliable test of peripheral nerve function and 
integrity. 
In contrast, we are very poor at assessing the integrity of the ‘upper motor neurone’; this is 
almost always the limiting factor in diagnosis since there are no consistent, robust and 
reliable methods to do this. The standard assessment of CST function for most clinicians is 
limited to assessing the deep tendon reflexes with a tendon hammer. Detection of 
hyperreflexia is a useful sign of a central neurological abnormality but is only a very gross 
test of the stretch reflex loop. It could certainly not be considered a specific test of CST 
integrity since there are many components of this loop which could contribute to the 
abnormalities observed. However, this is often used to infer CST damage given the 
simplicity of the test and its availability in clinic.  
A second useful sign of CST damage is the Babinski reflex which is a primitive reflex 
normally observed in infants before maturation of the CST (Babinski, 1896; Lance, 2002). 
This manifests as a profound dorsiflexion of the toes when the sole of the foot is rubbed 
with a blunt instrument. The response normally disappears in ambulating infants from the 
age of ~12-18 months; thereafter the same stimulus elicits plantar flexion of the toes in 
healthy children and adults. A positive Babinski sign from the age of 2 years is indicative 
of a CST lesion which has unmasked the primitive reflex. Whilst this is a useful sign of 
dysfunction, it is rather non-specific and is abnormal in a number of neurological 
conditions. 
Formal assessment of the integrity of the CST is challenging and can only be performed
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using indirect methods. These techniques are highly specialised and not readily available to 
all clinicians in the UK. Nevertheless the methods are outlined below. 
 
Transcranial Magnetic Stimulation (TMS)  
TMS is a non-invasive method of activating brain structures which can be a useful 
diagnostic indicator of damage to the CST. Weak electric currents are generated in neural 
tissue by the discharge of rapidly changing magnetic fields over the surface of the skull. In 
this way, current is transmitted through the skull (which would normally act as an electrical 
insulator) without causing pain via activation of cutaneous skin receptors. TMS over the 
motor cortex activates the monosynaptic corticomotoneuronal connections which generate 
short-latency MEPs in contralateral muscles. 
Throughout the last two decades, the parameters for TMS of the motor system have been 
well described. There is an enormous amount of data showing the standard limits in the 
normal population. Because of this thorough classification, abnormalities can be identified 
in patients with some neurodegenerative diseases relatively easily using single pulse TMS 
(Eisen and Shtybel, 1990). Indicators of pathology in TMS include delayed conduction 
times, abnormal threshold for evoked responses and abnormal waveform morphology.  
One parameter that is difficult to measure with a standard single pulse TMS protocol is the 
recruitment of upper motor neurons by the stimulus. MEP response amplitude should 
correlate to this but is highly variable from trial to trial, even in healthy subjects, therefore 
reduced conduction as a result of underlying pathology can be difficult to determine. More 
recently, the triple stimulation technique has been developed to improve the sensitivity of 
TMS to loss of UMNs. This comprises a double collision test involving TMS over the 
motor cortex followed by electrical stimulation of the ulnar nerve and Erb’s point. The 
timing is such that almost all of the available UMNs are recruited and respond 
synchronously producing a time-locked MEP in a contracting muscle. The triple 
stimulation technique provides a quantitative measure of the number of upper motor 
neurons that can be activated with TMS and has therefore increased the sensitivity for 
detection of UMN degeneration in conditions such as MND. 
Whilst TMS is certainly a useful diagnostic aid, at high intensities of stimulation, there is 
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profound current spread which can cause discomfort through activation of muscles of the 
face and neck. This is particularly the case when a double cone coil is used to activate 
lower limb muscles. It is also the case with the triple stimulation technique which involves 
3 high intensity stimuli in close succession. Often patients find TMS at these high 
intensities intolerable.  
Unfortunately, TMS equipment is expensive and as a result is only available at limited 
clinical sites throughout the UK. Despite its clear utility in diagnosis, few hospitals have 
the technology; consequently TMS is not usually available as a standard clinical test. Its 
use is typically restricted to research establishments. 
 
Magnetic Resonance Imaging (MRI) 
MRI can be a useful method of revealing CST damage. High signal in motor regions of 
cortex and the pyramidal tracts have been related to diseases such as MND. However, MRI 
is not particularly sensitive to early subtle pathological changes and is usually only useful 
when there is already profound damage to the system. In fact, brain MRI is often normal in 
patients with corticospinal tract dysfunction (Luis et al., 1990; Udaka et al., 1992). 
Furthermore, small areas of signal change are common in the aging brain (Drayer, 1988; 
Hendrie et al., 1989).  
 
MRI tractography 
MRI tractography is a relatively new technique which aims to reveal the underlying 
integrity of brain pathways using non-invasive imaging technology. Diffusion tensor 
imaging, sensitive to diffusion of water in physiological tissue can produce 3-dimensional 
images of structures. Free diffusion occurs in all directions, but barriers such as axons 
cause uneven diffusion. Large axon tracts such as the CST cause diffusion along the 
orientation of the fibres. A number of recent publications have observed early degenerative 
changes in the CST using this method (Ciccarelli et al., 2006; Roccatagliata et al., 2009).  
 
Assessing UMN dysfunction in MND 
To establish a new test of UMN dysfunction in MND, we must first look at the rare cases 
 22 
 
where there is a relatively selective degeneration of the CST. We are not interested in these 
per se since they only make up a very small part of the MND population. However, 
investigating the ‘pure’ UMN and LMN forms of MND enables us to detect whether the 
technique is sensitive to damage within the UMN and more importantly is able to 
differentiate between established cases. If a technique is able to do this effectively, it could 
then be used in ALS to show UMN dysfunction in the presence of LMN disease.    
 
Primary Lateral Sclerosis (PLS) 
PLS is a rare condition which forms part of the MND spectrum and accounts for as few as 
3% of all patients with MND (Gordon et al., 2006). In PLS, there is selective degeneration 
of the layer V pyramidal neurones of the precentral gyrus and corticospinal tract with 
preservation of anterior horn cells (Hudson et al., 1993; Pringle et al., 1992). Patients 
usually present in the fifth or sixth decade with a slowly progressing ascending spastic 
tetraparesis. PLS is characterised by an insidious, slow progression. Unlike other MND 
variants, the disease duration is long which is an important distinction used in the 
diagnostic process. Median disease duration for PLS is 19 years (Pringle et al., 1992); 
consequently this particular form of MND does not significantly reduce life expectancy.  
Anatomically, there is a striking absence of Betz cells from layer V of the motor cortex and 
a reduction in pyramidal cells from other layers (Pringle et al., 1992). Remaining cortical 
cells are often small in size compared to ALS patients or controls (Pringle et al., 1992). 
These fundamental changes within the CST can be detected through non-invasive methods. 
PLS patients have prolonged or absent MEPs (Brown et al., 1992; Zhai et al., 2003) 
(Brown et al., 1992) and localised cortical atrophy on MRI (Pringle et al., 1992).  
There is little evidence for pathology in brain areas other than the corticospinal tract. The 
selective nature of PLS therefore provides the perfect platform to investigate the role of the 
CST in movement and to assess new methods of assessing CST integrity.  Although in PLS 
hand function is impaired and foot movements are slow and weak, there is usually 
sufficient residual function to perform simple repetitive manual and ankle flexion tasks. 
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Progressive Muscular Atrophy (PMA)  
Approximately 10% of MND patients only have lower motor neuron signs at symptom 
onset. In this condition, the degenerative process is initially limited to spinal motoneurones. 
Progressive degeneration of anterior horn cells within the spinal cord is the hallmark 
pathological feature of PMA at autopsy. This is a rapid process and any cells that are 
spared usually contain distinctive inclusion bodies. 
In this ‘pure’ lower motor neuron disorder, there is initially no involvement of the 
corticospinal tract. Consequently, the upper motor neuron signs, spasticity and brisk 
reflexes, are absent. In many cases of PMA however, pathology eventually spreads to both 
upper and lower motoneurones (Ince et al., 2003), therefore this condition is considered to 
be a slowly progressing form of ALS with a significantly longer survival time.  
 
Oscillations and coherence 
Motor cortical cells modulate activity during skilled upper limb movements. Rhythmic 
oscillatory activity can be observed in sensorimotor cortex which typically falls into two 
frequency bands: alpha (8-12Hz) and beta (15-30Hz). The first demonstration of this 
pattern of activity in humans was performed by neurosurgeons using electrocorticogram 
recordings to identify epileptogenic tissue (Jasper and Penfield, 1949; Penfield, 1954). 
Subsequently, oscillations have been demonstrated in motor cortical local field potentials in 
animals (Baker et al., 1997; Donoghue et al., 1998; Murthy and Fetz, 1992) and 
electroencephalograms (EEG) or magnetoencephalograms (MEG) in human subjects 
(Pfurtscheller et al., 1996; Salmelin and Hari, 1994).  
Similar oscillatory activity can also be observed in contralateral forearm and intrinsic hand 
muscles during both isometric and auxotonic contractions. Coupling between oscillations 
in two structures can be measured using coherence analysis. Coherence is a measure of 
correlation of two signals in the frequency domain and is bound between 0 (no correlation) 
and 1 (complete correlation). Coherence in the beta frequency band is present between the 
cortex and the periphery (Baker et al., 1997; Conway et al., 1995; Halliday et al., 1998; 
Kilner et al., 2000; Murthy and Fetz, 1996; Salenius et al., 1997) and has also been shown 
between different muscles. The function and the origin of these synchronous oscillations 
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has been the subject of much debate, however it is clear that they are propagated within the 
corticospinal tract to the periphery. Given this dependence of coherence on the CST, it may 
be a useful indicator of CST dysfunction.  
 
Corticomuscular coherence 
The prevailing view is that the source of corticomuscular coherence (CMC) is the primary 
motor cortex (M1) and that oscillations are propagated to muscle via the corticospinal tract 
(CST). Many groups have found phase lags between cortex and muscle which would 
support this notion (Gross et al., 2000; Mima et al., 2000). In addition, activity generated in 
motor cortex following TMS (Hansen and Nielsen, 2004) and pyramidal tract stimulation 
(Jackson et al., 2002) has been shown to re-set oscillations and modulate corticomuscular 
coherence. 
It has been suggested more recently that coherence is propagated via a loop involving both 
ascending and descending tracts. Coherence between sensory cortices and the periphery 
can be observed (Witham et al., 2010). Moreover, directed coherence is significant both in 
the ascending and descending directions (Witham et al., 2010; Witham et al., 2011). It is 
certainly true that sensory disturbances have a detrimental effect on coherence (Kilner et 
al., 2004; Fisher et al., 2002) so this should be considered in patients who have known 
sensory neuropathies. 
Over the last decade there has been a surge of interest into the functional significance of 
corticomuscular coherence, with only a limited improvement in our understanding. The 
phenomenon has been compared to the visual ‘binding’ process; here, 40Hz oscillations are 
hypothesized to be responsible for the integration of distributed information into a 
complete visual percept. However, this is unlikely to be the case in the motor system for a 
number of reasons, chiefly that 15-30Hz cortical oscillations are abolished upon movement 
execution (Kilner et al., 1999; Pfurtscheller et al., 1996) and therefore are unlikely to have 
a direct role in movement control. This has led some researchers to conclude that they 
simply form an ‘idling rhythm’ within the motor cortex (Pfurtscheller et al., 1996). An 
alternative hypothesis may be that coherent motor oscillations have a role in system 
recalibration following movement. Errors in movements are likely to confuse the system as 
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to where the limbs are in space; evaluation of proprioceptive information would therefore 
be crucial to the accurate planning of new movements. In support of this hypothesis, 
coherence amplitude in the beta frequency range has been shown to vary according to the 
size of the previous movement (Kilner et al., 2003). Moreover, manipulation of afferent 
feedback loops via cooling or ischaemic block reduces CMC (Fisher et al., 2002; Riddle 
and Baker, 2005).  
Whilst beta band coherence is maximal during steady-state isometric tasks, this is not 
reported to be the case during dynamic tasks where there has been shown to be a frequency 
shift to gamma band coherence (Andrykiewicz et al., 2007; Kristeva et al., 2007). This 
increased coherence in the gamma band has been proposed to occur as a result of enhanced 
attention to a more complicated task and reflect the integration of multimodal information 
to optimise the  motor response (Andrykiewicz et al., 2007). This process would therefore 
be analagous to the high frequency oscillations observed in the binding process of the 
visual system (Gray and Singer, 1989).  
Information surrounding the importance of oscillations has also been inferred by observing 
patients with movement disorders. In Parkinson’s disease, untreated patients have excess 
beta band activity in the basal ganglia which normalizes upon administration of dopamine 
or high frequency stimulation of the substantia nigra (Brown et al., 2001). The degree of 
clinical improvement in both cases correlates well to the change in beta band coherence 
(Kuhn et al., 2006; Silberstein et al., 2005). These patients also have increased coherence 
between cortex and the basal ganglia in the beta band (Fogelson et al., 2006; Williams et 
al., 2002). Moreover, beta frequency stimulation of basal ganglia slows movement (Chen et 
al., 2007; Eusebio et al., 2008), however, it must be noted that deficits in movement 
following beta frequency stimulation are very modest. Based on this collection of evidence, 
it has been suggested that the motor deficits found in patients with Parkinson’s disease can 
be largely attributed to the abnormal and synchronous beta band oscillations (Brown, 
2007). This view of excess beta oscillations as pathological is in disagreement with the 
traditional thinking that they subserve a positive state whether that be cortical idling or a 
form of system recalibration.  
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Intermuscular coherence  
Coupling between two EMG signals can also be measured using the coherence method. As 
with CMC, in healthy subjects intermuscular coherence (IMC) is maximal during sustained 
muscle contraction (Norton and Gorassini, 2006). Intermuscular coherence however 
typically shows two distinct frequency bands centred around 10Hz and 15-30Hz (Grosse et 
al., 2002). 
IMC in the 15-30 Hz range is dependent on supraspinal structures, including the CST, 
because it disappears after stroke and complete spinal cord injury (Farmer et al., 1993; 
Hansen et al., 2005). Moreover, in partial spinal cord injury, in which the CST may be 
intact, training in some patients not only increases functional recovery and MEP 
amplitudes, but also increases beta band IMC (Norton & Gorassini, 2006). In contrast, IMC 
in the 8-12 Hz range persists after complete spinal cord lesions (Norton et al., 2003; Norton 
et al., 2004), suggesting that it is largely dependent on segmental or spinal mechanisms.  
Intermuscular coherence has many advantages over corticorticomuscular coherence; the 
most obvious being that an EEG is not required. Scalp EEG, although relatively simple to 
record and in widespread use has many associated difficulties. Signal to noise ratio tends to 
be very low and it can be contaminated by EMG which can make it difficult to use in 
patients with movement disorders. Taking advantage of the fact that the same cortical drive 
which generates CMC is likely to contribute to coherence between muscles, IMC is likely 
to be an easier technique to utilize clinically. It is a quick and easy method which could be 
recorded with the facilities available in a standard hospital neurophysiology department. 
Also, the variability in CMC may be due to scalp projection of cortical signals; with IMC, 
we have more confidence that we are recording from the correct place. 
 
Methods.  
Two assessments were performed on patients recruited to this trial. Firstly, a TMS study 
was carried out to determine motor threshold, MEP latency and amplitude as well as the 
central motor conduction time (CMCT). Since there is a large amount of data on TMS in 
MND in the literature, this enabled comparison of coherence measures to the results of
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previous studies. Corticomuscular and intermuscular coherence was also measured in the 
upper and lower limbs. 
 
Transcranial magnetic stimulation 
Single pulse TMS was performed over motor cortex whilst EMGs were recorded to 
measure motor evoked potentials (MEPs) in the contralateral muscles. Motor threshold 
(MT) is defined as the lowest intensity of stimulation at which an MEP of defined size is 
observed; this is usually the intensity at which there are responses in 50% of stimuli 
(Rossini et al., 1994; Rothwell et al., 1999).  
Active motor threshold (AMT) was identified using a circular coil over vertex whilst 
patients provided a background contraction of either the hand or foot muscles. This was to 
provide the maximum sensitivity for the detection of descending volleys which is 
especially important in patients with degeneration of the corticospinal tract who are known 
to have increased motor threshold (Triggs et al., 1992). The coil was oriented to activate 
the contralateral hemisphere to the limb under investigation (A side up: left; B side up: 
right). Stimulus triggered EMG activity for FDI was viewed on an oscilloscope. Stimulus 
intensity was increased in 5% increments until an approximate threshold was located for 
FDI. From there, intensity was altered in 1% increments accurately to pinpoint AMT. 
MEPs were typically recorded at 10% MSO above the AMT. PLS patients are known to 
have very high thresholds so this stimulus intensity was chosen to allow a consistent 
comparison between patients and controls. Stimuli were delivered at 0.2Hz whilst subjects 
maintained a background contraction of the relevant muscles. At each intensity, 
approximately 10 responses were recorded.  
In some cases, TMS was also performed over the spinal roots to allow measurement of 
peripheral conduction time. This was done at the level of the cervical cord for the upper  
limbs and the lumbar cord for the lower limbs. Subtraction of this peripheral conduction 
time from the MEP latency allowed calculation of central motor conduction time (CMCT). 
 
Coherence task 
Corticomuscular (CMC) and intermuscular coherence (IMC) testing was also performed in
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our patient cohort. Coherence measurement requires only a weak muscle contraction; this 
means that even patients with profound muscle weakness have enough residual muscle 
activity to perform the task. Given the loss of Betz cells in PLS and the resultant loss of 
propagation of oscillations from M1 to muscles, a corresponding loss of coherence in the 
beta frequency band would be expected. 
Subjects were asked to execute a simple repetitive task. They were required to perform an 
auxotonic contraction of the upper and lower limb. For the upper limb, they were required 
to perform a precision grip, guided by a small, compliant piece of plastic tube (Portex, 
external diameter 10mm, internal diameter 8mm, 19cm in length) attached to the finger and 
thumb with micropore tape. Subjects were instructed to oppose the two ends of the tubing, 
a movement which required a minimum force of 1N. The task followed the pattern of a 3 
second hold, followed by a 2 second rest period; a computer generated auditory cues to 
instruct the subject. For lower limb investigations, the task took the same format but with 
dorsiflexion of the ankle.  
Patients were required to perform 100 repetitions of each task. In one case, where a patient 
was particularly weak, this was divided into two smaller, more manageable segments. 
TMS and coherence testing was also carried out in 20 age-matched control subjects. Not all 
subjects underwent both assessments; this is indicated in the figure legends.  
 
Recordings 
Electromyogram (EMG) 
Bipolar surface EMGs were recorded using adhesive electrodes (101600, Bio-logic, 
Biosense Medical) arranged in a standard tendon-belly configuration (or with both 
electrodes on the muscle belly in larger muscles). The electrodes were positioned carefully 
over the muscles of interest since the differential recording is sensitive to populations of 
motor units directly underlying the electrodes. The skin was prepared prior to attachment of 
the electrodes using 100% ethanol solution and then allowed to dry. A ground electrode 
was used, usually placed on the wrist. Signals were amplified (gain:1-5k) and bandpass
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filtered (30Hz-2kHz) via an isolated Digitimer amplifier (NL820). 
The activity in 3 muscles from each limb under investigation was recorded. In the arm, the 
muscles used were first dorsal interrosseus (FDI), flexor digitorum superficialis (FDS) and 
extensor digitorum communis (EDC). During the lower limb task, EMG activity was 
recorded from extensor digitorum brevis (EDB), tibialis anterior (TA) and gastrocnemius 
(GS). 
 
Electroencephalogram (EEG) 
Cortical activity generated by populations of neurons can be measured using non-invasive 
scalp EEG in humans. The EEG signal comprises summated inhibitory and excitatory post-
synaptic potentials from a large number of synchronised pyramidal cells. EEG signals are 
dominated by neuronal activity occurring directly beneath the recording electrodes, but are 
also sensitive to more widespread activity.   
A single channel differential EEG was recorded from sensorimotor cortex, contralateral to 
the muscles under investigation. The scalp was prepared using an abrasive paste (Nuprep, 
Digitimer Ltd) and adhesive electrodes (Ambu Neuroline 720, Biosense Medical) were 
used. During the upper limb task, a montage was used which has previously been identified 
as optimal for recording oscillatory potentials related to hand movements; this involved 
placement of electrodes 3cm lateral to vertex with the non-inverting electrode two 
centimetres anterior and the inverting electrode two centimetres posterior to this point. A 
ground electrode was positioned over the forehead. 
A lower limb montage EEG was also implemented during ankle dorsiflexion. Here, 
electrodes were located more centrally as the leg area of the motor strip is known to be 
located on the bank of the longitudinal fissure. For this, the inverting electrode was 
positioned over vertex with the non-inverting electrode 2cm anterior to this position. The 
ground electrode remained on the forehead. 
In some cases, a conductive paste was used (Ten20) along with a bandage over the 
electrodes to improve contact and minimise the effects of noise. Signals were amplified at 
50k and bandpass filtered (3Hz-2kHz). 
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Recordings were digitized at a sampling rate of 5kHz using a CED Power1401 (Cambridge 
Electronic Design). Data were captured to a PC running Spike 2 software along with event 
markers and where necessary stimulus profiles. 
 
Patients 
Patients were recruited from the specialist MND centre at the Newcastle General Hospital 
by the consultant in charge of their care. Study inclusion was made on the basis of current 
diagnostic criteria for PLS (Pringle et al., 1992) and PMA (evidence of LMN deficits and 
exclusion of other differentials). Only patients with a definite diagnosis and normal sensory 
investigations were included.  
Patient demographics are shown in tables 2-1 and 2-2. Eight patients with PLS and six 
patients with PMA were recruited from the MND service. Data were compared with the 
equivalent recorded from 20 age-matched controls (36-78 years; mean 60 years). 
In addition to the patients recruited to the main trial, one patient was investigated early in 
the clinical process as part of a new prospective trial of intermuscular coherence as a 
diagnostic test for MND.  
 
Primate model of PLS 
Intermuscular coherence was also tested in a primate model of PLS. This involved a female 
macaque monkey (M. Mulatta) with a unilateral lesion of the left pyramidal tract at the 
level of the medulla. The lesion was made using a radiofrequency lesion maker (Model 
RFG 5, Radionics Inc.) whilst the animal was under general anaesthesia. 
The animal had bilaterally implanted EMG patch electrodes over a range of hand and arm 
muscles. These were implanted using a technique developed by Miller & Houk (1993). In 
some cases, EMG recordings were supplemented using surface electrodes. All surgical 
procedures were carried out under aseptic conditions and general anaesthesia (3-5% 
sevofluorane inhalation in 100% O2 with alfentanil infusion).  
Recordings were made 3 months post-lesion. At this stage, the animal had recovered 
normal upper limb function. During the session, the monkey sat in a custom-made
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 Sex 
 
Age at 

(years) 
History  
at 
(years) 
Initial 
presentation 
Past medical  
    history 
Drug history Family 
history 
(HSP) 
Bladder 
function 
Investigations 
Blood tests CSF 
(OCBs) 
EMG/ 
NCS/SEPs 
MRI  MEPs  
Brain c-spine 
1(RC) M 49 4 RUL 
weakness 
Nil Nil Nil NAD Normal B12 
VDRL negative 
NAD 
(absent) 
NAD Rolandic 
atrophy 
NAD UL & LL 
absent 
2(AB) F 66 4 LL and LUL 
spasticity 
LVH Bisoprolol 
Diclofenac 
Fluoxetine 
Baclofen 
Dantrolene 
Oxybutinin 
Quinine 
Riluzole 
Vitamin C & E 
Nil Frequency Normal B12. 
HTLV1, VDRL, 
Borrelia 
burgdorferi 
serology 
negative. 
NAD 
(absent) 
NAD NAD NAD RUL MEP ↓V 
 
LUL & LL MEPs 
absent 
3(PD) M 52 18 LL spasticity 
(R>L) 
HD aged 20 
[Rx DXT+ 
Splenectomy] 
Riluzole 
Vitamin C  
Vitamin E 
Nil NAD Normal VLCFA, 
WBC enzymes 
NAD 
(absent) 
NAD NAD NAD R EDC & R GS 
absent. MEPs 
↓V & ↑CMCT 
4(AM) M 45 3 LL spasticity 
(L>R) 
Pseudo-
bulbar 
Dysarthria 
DM II 
Hypertension 
R Sciatica 
Lisinopril 
Quinine 
Baclofen 
Riluzole 
Vitamin C & E 
Nil NAD Normal B12, 
VLCFA, WBC 
enzymes, VDRL 
negative 
NAD 
(absent) 
NAD (except L 
ulnar 
neuropathy, 
denervation L 
T7 paraspinal) 
NAD NAD R FDS & R LL 
MEPs absent 
R FDI &  
R EDC MEPs ↓V 
& ↑CMCT 
5(GM) M 75 5 LL spasticity 
(L>R) 
L sciatica Bendro-
flumethiazide 
Baclofen 
Riluzole 
Vitamin C  
Vitamin E 
Nil NAD Normal B12, 
VLCFA, WBC 
enzymes 
NAD 
(absent) 
NAD 
(except 
chronic L 
L4/L5 
radiculopathi
c changes) 
NAD NAD R EDC, R EDB & 
R GS MEPs 
absent 
R FDI MEP ↓V 
R TA MEP ↓V & 
↑CMCT 
6 (JH) M 60 5 Pseudobulbar 
dysarthria 
L UL and LL 
spasticity 
IHD 
Colonic 
Carcinoma 
1999 
Hypertension 
Amitriptyline 
Baclofen 
Atorvastatin 
?riluzole 
?VitC/E 
Nil NAD  NAD 
(absent) 
NAD  
(except L L5 
radiculo-
pathy) 
NAD NAD R FDS, R EDC 
absent 
R FDI long 
latency and 
polyphasic 
7(CC) F 42 2 Progressive 
spastic 
paraparesis 
Nil Sertraline 
Femulen 
Nil NAD B12 normal 
Normal VLCFA, 
WBC enzymes 
Protein 
0.54 g/L 
(absent) 
- NAD C5/C6 disc-
osteophyte 
complex (no 
neural 
compression) 
R EDC & R GS 
MEPs absent 
R FDI, FDS, TA & 
EDB MEPs 
↑CMCT & ↓V  
8 (JT) M 74 3.5 Progressive R 
LL weakness 
BPH Nil Nil BOO &  
Urgency 
Copper normal 
Auto-antibodies 
negative 
B12 normal 
 NAD Mild 
involutional 
change. 
Minor small 
vessel CVD 
Multi-level 
degenerative 
changes, no  
neural 
compromise 
Normal UL 
MEPs 
↑CMCT in LL 
MEPs 
Table 2-1: PLS patient demographics 
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 Sex 
 
Age at 

(years) 
History 
at 
(months) 
Initial 
presentation 
Past medical    
    history 
Drug history Family 
history 
(MND) 
Bladder 
function 
Investigations 
Laboratory 
tests 
CSF 
(OCBs) 
EMG/ 
NCS 
Radiology MEPs 
(SEPs) 
1 (LB) F 69 18 Bilateral foot drop 
Progressive LL and 
UL weakness 
Sympromatic 
fasciculations 
IHD 
BP 
Clopidogrel 
Atenolol 
BFMTZ 
ISMN 
Lisinopril 
Nil NAD Anti-GM1 Ab & 
anti-MAG Ab 
negative 
CK 328 
UPEP normal 
NAD 
(absent) 
AHD 
(UL&LL) 
CT head normal NAD 
(-) 
2 (HR) F 67 24 Bilateral foot drop 
Progressive LL and 
UL weakness 
Sympromatic 
fasciculations 
Non-toxic 
goitre 
Ranitidine 
Lofepramine 
Nil NAD Anti-GM1 Ab & 
anti-MAG Ab 
negative 
CK normal 
UPEP normal 
NAD 
(absent) 
AHD 
(UL&LL) 
MRI brain and spine 
normal 
NAD 
(-) 
3 (GH) M 61 10 Progressive LL 
weakness and 
cramps 
Nil - Nil NAD Anti-GM1 Ab & 
anti-MAG Ab 
negative 
CK 372 
UPEP normal 
NAD 
(absent) 
AHD 
(UL&LL) 
MRI lumbar spine 
moderate canal 
stenosis (L3/4 & L4/5) 
without neural 
compression 
NAD 
(-) 
4 (JD) M 73 12 Weakness R UL 
initially, 
progressing to 
bilateral UL & LL 
weakness with 
bulbar 
involvement 
Cervical 
spondylosis 
IHD (MI 2001) 
CD 
Eczema 
Rhinitis 
Appendectomy 
RIH 
Mesalazine 
Aspirin 
Ramipril 
Atenolol 
Nil NAD Anti-GM1 Ab & 
anti-MAG Ab 
negative 
CK normal 
IgG lambda 
paraprotein 
(immuno-
fixation) 
UPEP normal 
NAD 
(absent) 
AHD 
(UL&LL) 
MRI cervical spine 
posterior disc 
osteophytes with 
C3/C4 and C6/C7 
stenosis and 
ligamentous 
hypertrophy but no 
root or cord 
compression 
NAD 
(-)  
5 (PS) M 65 60 Generalized 
cramps (legs, arms 
and abdomen) 
since 2003 and 
left foot drop 
since 2007 
IHD 
BP 
Atenolol 
ISMN 
Aspirin 
Amlodipine 
GTN 
Simvastatin 
Nil NAD Normal B12, 
autoimmune 
screen, SPEP, 
IgG, IgA, IgM 
CK 249 
NAD 
(absent) 
AHD 
(UL&LL) 
Normal MRI spine NAD 
(-) 
6 (KM)  M   Progressive LL 
weakness & mild 
bilateral foot 
drop. Some UL 
weakness on 
examination. 
BP 
Peptic ulcer 
disease 
 
 Nil    AHD 
(UL&LL) 
 Low threshold 
(-) 
              
 
Table 2-2: PMA patient demographics. Abbreviations: ∆= diagnosis; HPC = history of presenting complaint; CSF cerebrospinal fluid; OCBs = 
oligoclonal bands; EMG/NCS = electromyogram/nerve conduction studies; MEPs = motor evoked potentials; LL = lower limb; UL = upper limb; L 
= left; R = right; LVH = left ventricular hypertrophy; HD = Hodgkin’s disease; Rx= treatment; DXT = radiotherapy; DMII = type II diabetes 
mellitus; HTLV1= human T lymphotropic virus; VDRL = venereal disease research laboratory; VLCFA = very long chain fatty acids; V = voltage; 
ISC =intermittent self catheterization; BPH = benign prostatic hyperplasia; BOO = bladder outflow obstruction 
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recording chair and was head restrained via an implanted stainless steel headpiece. She 
wore a loose-fitting neck collar, and a sleeve which restrained the arm on one side. For 
coherence testing, the monkey was required to grip a plastic rod with the hand. The length 
of each trial was variable, however only grips of over 1.64 seconds were included in the 
analysis. 
In addition to measuring coherence, MEPs from bilateral FDI muscles were also recorded 
from this animal. This was done under sedation with ketamine (10mg/kg intramuscular 
injection) with a double small 25mm TMS coil positioned over each motor cortex 
(Magstim Ltd). 
 
Analysis 
EMG recordings were full wave rectified and Fourier analysis was performed to examine 
the frequency characteristics of the data. This was done for each muscle in individual 
subjects and then data were combined to measure the population effect. 
Analysis focused upon the central 1.64 seconds of the 3 second hold period, the phase 
when beta frequency oscillations are greatest. EEG and EMG power spectra, as well as 
CMC and IMC were calculated using two contiguous 0.82s-long sections of data from each 
trial and a 4096-point Fast Fourier Transform (Baker et al., 1997). This yielded a frequency 
resolution of 1.22 Hz.  
The absolute level of power in either EEG or EMG has little meaning, since it will depend 
on such uncontrolled factors as precise electrode placement relative to muscle or cortical 
generators. Accordingly, power was expressed relative to the average total power seen in 
the recording period before task onset. The power spectrum at frequency f was calculated 
using a Fast Fourier Transform (FFT) algorithm as: 
 
     ( )  
 
 
∑   ( )  
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where n is the number of disjoint sections, * denotes complex conjugates and Xi(f) is the 
fourier transform for each segment of data within the signal. 
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Coherence was then calculated to measure the extent of the correlation between two signals 
in the frequency domain. This is defined as the normalised cross-spectrum and was 
calculated by: 
   ( )  
|
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 ( )    |
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where X(f) and Y(f) are the Fourier transforms of the two signals. 
Significance levels were calculated using formulae from Rosenberg et al (1989) based on 
the number of disjoint sections used. Coherence is significantly different from zero if it is 
larger than Z, at P<0.05 where 
          (   ) 
 
Averages were calculated for subject groups to allow comparison of coherence across the 
population. This was achieved simply by calculating the mean coherence over the full 
spectrum. Data from muscles in the upper limb and the lower limb were pooled to increase 
sensitivity. 
To compare coherence within the beta frequency band between patient groups, the relevant 
data was first extracted. The window of interest was set between 15-30Hz and the mean 
coherence within this range was calculated for each subject. These values were used to 
populate cumulative distribution plots for each group. 
Unpaired t-tests allowed statistical testing between patient and control groups each of 
which consisted of different sample sizes.  
There are intrinsic problems associated with the measurement of coherence. Averaging 
coherence across different datasets is difficult since there are inherent properties of the data 
which will affect the outcome. Firstly, the two datasets are collected under different 
conditions even when we control for as many variables as possible. Moreover, altering the
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size of disjoint sections used in the FFT affects the frequency resolution. This did not affect 
the results reported here since all subjects and patients (with the exception of one PLS 
patient) performed the same number of trials and the number of data segments used in the 
analysis was uniform throughout. 
Coherence estimates are positively biased (overestimated) and this bias depends on the 
sample size. Sampling bias is defined as the difference between the actual coherence value 
and the estimated coherence for a given subset of data. Working with physiological data, 
we only ever have a finite subset of data available to estimate coherence. In addition, the 
coherence magnitude probably changes with time. Using a larger number of trials within 
analysis reduces variability and gives an estimate with lower bias but it is difficult to 
eliminate this problem. It is also difficult to know exactly how much data is needed to get 
an accurate result where coherence values are small as these values are subject to more bias 
and are therefore less accurate.  
To reduce the effect of bias on the results presented here, the number of trials (~100) and 
therefore disjoint sections (~200) used for analysis in every individual were kept within a 
strict range. This could have been increased further by asking subjects to complete more 
trials but for patients with muscle weakness it would be difficult to maintain the same level 
of effort for a longer period of time. 
Coherence bias was calculated using equation (2) from Benignus (1969).  
 
     
 
 
(     ) 115(115)(115) 
 
Bias-correction was then applied to the intermuscular coherence data by subtracting Bcoh 
from the initial coherence values. In almost all cases, the bias was approximately 0.005. 
This obviously has a bigger effect on the smaller values of the patients.  
IMC analysis was also performed on the data collected from the upper and lower limb tasks 
described previously. The analysis itself was also the same except that it was limited to the 
EMG channels recorded. The base channel for the coherence analysis was either FDI or
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EDB. 
To test the application of intermuscular coherence as a biomarker, an odds analysis 
approach was taken. This allowed us to determine the relative likelihood of having MND 
given a particular coherence value. This is a useful method for the present application since 
it could be applied cumulatively; combination of information from all muscles in this study 
could give a more accurate prediction than one alone. However, it is acknowledged that the 
present dataset is not yet sufficiently comprehensive to provide definitive values; the 
method described here simply demonstrates the type of simple but effective approach 
which could be used.  
Firstly, curves were fitted to the log-transformed cumulative probability data based on a 
Gaussian distribution. The odds ratio was then calculated by dividing the probability of 
each coherence value being from a PLS patient by the probability of the same value being a 
control. This calculation was done across the coherence spectrum for each muscle 
investigated.  
 
Results 
Figure 2-2 shows the results of investigations in a single patient with PLS (patient AB) 
followed longitudinally over a two year period. AB presented aged 64 with a two year 
history of progressive bilateral weakness. This began in the lower limbs and gradually 
ascended; the left arm and leg were more severely affected than the right and the 
investigations were thus limited to the left side only. AB had no lower motor neurone signs 
and normal nerve conduction studies. During the initial investigation, MEPs were small, 
delayed and poorly formed (Fig. 2-2A). Corticomuscular and intermuscular coherence in 
the beta band was present (Fig. 2.2D). The patient was re-assessed 22 months later during 
which time the disease had gradually progressed. There was particular deterioration in 
mobility as a result of lower limb weakness and the arms were notably weaker. At this 
point, there were no MEPs present, even when the stimulator output was maximal (Fig. 2-
2E). Patient AB had no significant corticomuscular or intermuscular coherence in any of 
the muscles tested (Fig. 2.2H). As such, it appears that both TMS and coherence are
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Figure 2-2 A-D: Results obtained from patient AB on her first assessment in the 
laboratory. A: MEPs are shown from 3 muscles in patient AB (red) and an age-matched 
control subject (black). B: Raw EMG records show modulation with the task; arrows 
indicate trial onset. C: Example power spectra for left FDI muscle and contralateral EEG. 
D: Corticomuscular and intermuscular coherence spectra. Significance levels are 
represented by dashed lines. Note the higher significance level for AB who completed 
fewer trials (this data was not used in the average in order to reduce coherence bias). E-G: 
As in A-D; data from the patient’s second visit to the lab.  
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Figure 2-3 A: Transverse section through the pyramids at the level of the medulla showing 
the extent of the PT lesion in monkey M. B: MEPs evoked from stimulation of right (black) 
and left (red) motor cortex 3 months post lesion to the left pyramidal tract. C: 
Intermuscular coherence plots calculated from EMG data collected during a steady hold 
task. Dashed line indicates significance level. 
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measures which reflect the degeneration of the CST. 
Figure 2-3 shows data recorded from a monkey with a lesion of the pyramidal tract. A 
transverse section through the pyramids at the level of the medulla shows the extent of the 
lesion and that it was confined to the pyramidal tract (Fig. 2-3A). Similar to the patient 
shown in figure 2-2, MEPs and significant intermuscular coherence could only be observed 
when the corticospinal tract was intact (Fig. 2-3B, C).  
Active motor thresholds for TMS are shown in figure 2-4. There was a significant 
difference between PLS patients and both PMA patients and controls for the upper limb 
(P<0.05). However, for the lower limb, although the difference between PLS patients and 
controls was significant (P<0.05), thresholds for the PMA group failed to be significantly 
different to PLS patients (P=0.053). Interestingly, some of the PMA patients within the 
cohort exhibited particularly low AMTs; this measure of cortical hyperexcitability has 
previously been observed in the early stages of MND and may reflect a compensatory 
cortical adaptation (Mills and Nithi, 1997; Vucic and Kiernan, 2006).  
There are very few systematic studies of active motor threshold in the literature so it is 
difficult to get normal values for a large cohort. However, mean threshold for upper limbs 
in control subjects was found to be the same as those previously shown in older subjects 
(Oliviero et al., 2006). In fact, most studies utilise resting motor thresholds. Whilst easier to 
determine than active threshold, this is less useful in patients with CST disease. Active 
muscles produce tonic motoneurone firing which increases the sensitivity for detection of a 
CST volley. This becomes critical in patients who have degeneration of pyramidal cells and 
motoneurones since they may have insufficient residual connections for TMS to activate 
muscles at rest.  
MEP latencies (Fig. 2-5A) and central motor conduction times (CMCT; Fig. 2-5B) are 
presented for FDI and EDB. These parameters are largely outside normal limits for both 
PLS and PMA patients. On the basis of this data it would be difficult to separate patients 
with pure upper motor neurone and lower motor neurone degeneration using TMS.  
Averaged corticomuscular coherence spectra are shown for the patient subgroups and
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Figure 2-4: Scatter plots of active motor thresholds versus age for the upper limb (A) and 
lower limb (C). Dotted lines denote the upper and lower boundaries of control means +/- 
2SD. Control subjects here were aged between 49-68 years. Corresponding cumulative 
probability plots show the population spread of active motor thresholds for the upper limb 
(B) and lower limb (D). 
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Figure 2-5: Scatter plots of MEP (A,C) and CMCT (B,D) latencies. Dashed lines in A and 
B denote normal values +/- 2SD obtained from Eisen and Shtybel (1990); subjects aged 20-
83 years old. Dashed lines in C and D show control means +/- 2SD since normative data 
was not available for the distal foot muscles in the literature (subject ages: 36-68 years). 
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healthy controls in figures 2-6 and 2-7. There is a striking reduction in beta band power in 
the EEG of PLS patients. This probably reflects the loss of Betz cells in the motor cortex. 
There was also a notable absence of significant beta band corticomuscular coherence across 
the PLS population (Fig. 2-6). In fact, taking the bias into account, PLS patients have 
almost zero coherence. In contrast, beta range EEG power and CMC is relatively preserved 
in PMA patients, particularly in the upper limb (Fig. 2-7). 
Intermuscular coherence between different muscle pairs are shown for our patient 
subgroups and healthy controls in figures 2-8 and 2-9. Population analysis reveals that on 
average PLS patients do not have significant beta band IMC (Fig. 2-8), but that it remains 
in patients with PMA (Fig. 2-9). This is less evident in the lower limb but importantly some 
IMC is still present in patients with PMA whereas it is completely absent in PLS. 
Cumulative distribution plots for corticomuscular coherence are shown in figure 2-10. 
Significant differences between groups (P=<0.05) were only found between PLS patients 
and controls in FDI, and between PLS and PMA patients in EDB. A better separation of 
groups was found with intermuscular coherence (Fig. 2-11). Significant differences were 
found between PLS and PMA patients (P=<0.05; FDI-FDS, FDI-EDC, EDB-TA) and 
between PLS patients and controls (P=<0.05; FDI-FDS, EDB-TA, EDB-GS).  In contrast, 
there were no significant differences in intermuscular coherence between PMA patients 
and control subjects. 
Below each cumulative distribution plot in figure 2-10 are the fitted cumulative probability 
curves and the associated plots of the odds ratio for each muscle pair. This displays the 
odds of a person being normal or having MND given a particular value of coherence for 
that muscle pair. Odds of being diagnosed with MND are significantly higher with lower 
coherence values. Combination of the odds from different muscle pairs could increase the 
power of the prediction. 
Figure 2-12 shows the results obtained from a patient studied prospectively. Patient AP is 
30 year old male with a two year history of progressive weakness and muscle wasting in 
the lower limbs. He initially presented with a unilateral foot drop; symptoms then 
progressed in an ascending and asymmetric manner predominantly affecting the left leg. 
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Figure 2-6: Population averages are shown for the PLS patients (green) and age-matched 
controls (black). Upper limb results are shown in A-C (8 patients & 16 controls) and lower 
limb results are shown in D-F (6 patients & 13 controls). A, D: EMG power across all 
muscles investigated. B, E: EEG power. C, F: Corticomuscular coherence combined across 
all muscles.  
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Figure 2-7: Population averages are shown for the PMA patients (green) and age-matched 
controls (black). Upper limb results are shown in A-C (6 patients & 16 controls) and lower 
limb results are shown in D-F (6 patients & 13 controls). A, D: EMG power across all 
muscles investigated. B, E: EEG power. C, F: Corticomuscular coherence. 
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Figure 2-8: Population averages are shown for intermuscular coherence in PLS patients 
(green) and age-matched controls (black). Upper limb results are shown in A-B (8 patients 
(15muscles) & 16 controls (32 muscles)) and lower limb results are shown in C-D (6 
patients (12 muscles) & 13 controls (24 muscles)).  
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Figure 2-9: Population averages are shown for intermuscular coherence in PMA patients 
(green) and age-matched controls (black). Upper limb results are shown in A-B (6 patients 
(10 muscles) & 16 controls (32 muscles)) and lower limb results are shown in C-D (6 
patients & 13 controls (24 muscles)).  
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There was no upper limb involvement and no upper motor motor neurone signs at this 
stage. Initial EMG studies revealed some neurogenic changes which were confined to the 
lower limbs. This was felt to be consistent with a lumbo-sacral polyradiculopathy. A follow 
up study was completed 10 months later since there was a clear progression in symptoms; 
the lower limb muscles became progressively more wasted and the patient became aware 
of fasciculations in both upper and lower limbs. The second neurophysiological 
examination revealed severe neurogenic changes in the lower limbs combined with mild 
changes in the upper limbs. These were thought to be indicative of diffuse anterior horn 
cell disease but criteria for ALS were not fulfilled since there was no evidence of upper 
motor neurone involvement. No significant IMC was found in patient AP between 15-30Hz 
in either leg or in the upper limb. Subsequently, genetic tests revealed this patient had a 
point mutation at c341T>C in the SOD1 gene on chromosome 21q; this has been shown to 
be linked to familial ALS (Rosen et al., 1993). The combined odds for patient AP as having 
MND (vs having no CST disease) across all muscle pairs was calculated as 280.5:1 (FDI-
FDS: 8:1; FDI-EDC: 5.9:1; EDB-TA: 0.5:1; EDB-GS: 11:1). Detection of abnormal 
intermuscular coherence was completed 6 months prior to the positive genetic test. 
Moreover, 21 months later this patient still does not fulfil criteria for definite MND on any 
of the commonly used clinical scales (excluding the results of the coherence analysis and 
genetic tests which would not normally form part of the diagnostic process). 
 
Discussion 
Increased MEP latencies & relationship to disease duration 
Prolonged MEP latencies and CMCTs can be observed in both PLS and PMA. These 
findings support previous observations showing that these TMS parameters are often 
abnormal in MND (Brown et al., 1992; Cruz Martinez and Trejo, 1999; Mills and Nithi, 
1998). This study has also shown in one patient that MEPs disappear with progression of 
disease (Fig. 2-2). However, despite the clear abnormalities detected, these do not appear to 
be uniform. This likely reflects the subtle mix of upper and lower motor neuron signs 
exhibited by patients over the course of a long disease. Furthermore, some patients have 
MEP latencies and CMCTs within the normal range. The variable findings in TMS
 48 
 
 
 
Figure 2-10: Cumulative distribution plots for corticomuscular coherence between FDI-
EEG (A), FDS-EEG (B), EDC-EEG (C), EDB-EEG (D), TA-EEG (E) and GS-EEG (F). 
Coherence is plotted on a logarithmic scale. 
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Figure 2-11: Cumulative distribution plots are shown for intermuscular coherence between 
FDI-FDS (A), FDI-EDC (B), EDB-TA (C) and EDB-GS (D). Coherence is plotted on a 
logarithmic scale. In each case, the individual histograms of coherence values are shown 
for PLS patients (blue) and controls (green) with the Gaussian curve fit (dotted line) 
superimposed. The odds ratio curve is also displayed for each muscle pair. 
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Figure 2-12: Prospective patient data from a 30 year old male patient with suspected 
anterior horn cell disease. A: Gantt chart showing timeline of diagnosis according to 
available consensus criteria (not considering coherence or genetic tests) and clinical tests. 
B: Odds ratio plots from figure 11. Dashed line shows log coherence values found in the 
left upper and lower limbs for patient AP. C: Intermuscular coherence plots for the lower 
limb muscles. 
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parameters are not sufficient to differentiate the conditions from each other, or from normal 
controls in many cases. Moreover, abnormalities within these parameters do not correlate 
to disease severity in MND (Mills and Nithi, 1998). 
 
CST and 15-30 Hz corticomuscular coherence 
In a group of 8 patients with PLS, this study has shown that significant 15-30 Hz 
corticomuscular coherence is absent and is associated with reduced beta band oscillations 
in the motor cortex. However, the study has also demonstrated that corticomuscular 
coherence is highly variable in healthy individuals. In fact, it was difficult to separate 
patients from control subjects using these values. There are many reasons why this was the 
case. Firstly, there may have been  variability in the EEG recordings. This could have been 
due to a number of factors such as high electrode impedence or inaccurate electrode 
positioning. However this is not likely to introduce such high variability since the 
sensorimotor potential measured is large and easily recorded over a wide area of scalp. 
Moreover, EEG power was observed in the beta frequency band in all subjects. 
Recent evidence from our laboratory suggests that the variability in coherence might not be 
as straightforward as previously thought (Witham et al., 2011). Using a Granger Causality 
method, they have shown that there is significant directed coherence both in the ascending 
and descending direction between EEG and EMG in humans. This suggests that 
oscillations are part of a sensorimotor loop, being propagated out to the periphery on a 
motor arm and returning information about the state of the system on a sensory arm. 
Corticomuscular coherence would therefore be a relative measure of both of these 
interactions. Significant coherence would be observed if the oscillations propagated in one 
direction were bigger than in the other. Importantly however, if oscillatory propogation 
were equal in both directions, cancellation could occur and the result would be no net 
corticomuscular coherence.  
Since CMC could not be reliably and robustly obtained in healthy control subjects, it is 
probably not useful as a test of CST dysfunction. 
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15-30Hz intermuscular coherence 
Beta band oscillations in the muscles are thought to occur as a result of a common cortical 
drive from the CST. These oscillations and the coupling between them disappear after 
stroke and complete spinal cord injury (Farmer et al., 1993; Hansen et al., 2005; Norton et 
al., 2003; Norton et al., 2004). Moreover, in partial spinal cord injury, in which the CST 
may be intact, training in some patients not only increases functional recovery and MEP 
amplitudes, but also increases beta band IMC (Norton and Gorassini, 2006). On the basis 
of this evidence from the literature and our findings, it seems to be that intermuscular 
coherence reflects the integrity of the corticospinal tract. The results presented here show a 
clear and significant separation of PLS patients from PMA patients and control subjects 
using this parameter. In the monkey, there is also a distinct absence of IMC following 
pyramidal tract lesion. Moreover, intermuscular coherence was absent in a patient with 
anterior horn cell disease before they met clinical criteria for MND (Fig. 2-12). IMC would 
therefore appear to be a simple, non-invasive method of assessing upper motoneurone 
function without the difficulty associated with EEG recording. 
 
15-30 Hz EEG and EMG oscillations in PLS 
The findings from this study provide evidence that the CST couples 15-30 Hz oscillations 
in motor cortex and EMG. Histological evidence from post mortem studies has confirmed 
that neuronal attrition is limited to the Betz cells of primary motor cortex in PLS (Pringle et 
al., 1992). This would suggest that it is specifically the large diameter, fastest conducting 
CST axons that are fundamental to 15-30 Hz corticomuscular coherence in man. Previous 
reports have shown that beta oscillations can originate in the motor cortex and be 
propagated via a descending tract to the periphery. Roopun et al (2006) showed evidence of 
beta oscillations (20-30Hz) generated in layer V pyramidal cells in cortical slices. These 
oscillations were not dependent on synaptic input, but were abolished by reducing gap 
junction conductance. Furthermore, Jackson et al (2002) demonstrated that the phase of 
beta oscillations could be reset by stimulation of the pyramidal tract in monkeys. This 
supports the suggestion that pyramidal tract neurones are involved in the generation of beta 
oscillations which are then propagated to the periphery.     
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The reduction of beta band EEG oscillations in the 15-30Hz range and the corresponding 
absence of significant corticomuscular coherence in PLS patients could support the 
hierarchical model of corticomuscular coherence; here, there would be a corticofugal 
propagation of 15-30Hz oscillations. In line with this thinking, it may be that in PLS 
oscillations are not propagated faithfully from the motor cortex to the muscles. However, 
recent evidence suggests that oscillations may be travelling in a loop with both an 
ascending and descending arm (Witham et al., 2007; Witham et al., 2010; Witham et al., 
2011). Given that the sensory arm of the loop may be important in mediating coherence, 
the technique should only be used in patients who have normal sensory nerve conduction 
studies and sensory evoked potentials.  
 
Patient medication 
Five PLS patients who participated in this study were taking the neuroprotective agent 
riluzole (see table 2-1), which has a number of potentially confounding pharmacological 
actions. Riluzole blocks non-inactivating persistent inward sodium currents (Urbani and 
Belluzzi, 2000), activates  potassium conductances (Duprat et al., 2000) and blocks protein 
kinase C (Noh et al., 2000), thereby reducing glutamate release (Wang et al., 2004), 
increasing glutamate re-uptake (Fumagalli et al., 2008) and enhancing the post-synaptic 
effects of GABAA mediated inhibition (He et al., 2004). Reduced extracellular glutamate 
concentrations are unlikely to affect beta-frequency oscillations in frontal cortex (Roopun 
et al., 2006), whereas enhanced GABAA transmission will increase oscillations in 8-12 and 
15-30 Hz ranges (Baker and Baker, 2003). Although by blocking protein kinase C, riluzole 
could theoretically inhibit intracellular calcium oscillations (Kim et al., 2005), there is no 
evidence linking low frequency intracellular calcium oscillations and 8-30 Hz cortical 
oscillations. Reassuringly, in this study there were no significant difference between the 
results obtained from the five PLS patients who were taking riluzole and the three PLS 
patients who were not. Moreover, PMA patients, who were all taking riluzole, appeared to 
have normal corticomuscular and intermuscular coherence. 
 
Clinical application of intermuscular coherence  
MND is a clinical diagnosis, dependent on the presence of lower and upper motoneurone
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disease in multiple regions, after excluding other, potentially treatable causes. The El 
Escorial criteria were revised in 1998 to include preclinical evidence on EMG of lower 
motor neuron disease outside regions identified clinically. This requires documentation of 
EMG changes indicative of denervation in at least two muscles innervated by different 
roots and nerves, in two different limbs. As a consequence, the revised criteria have 
permitted earlier and more accurate diagnosis of MND, particularly the ALS and PMA 
variants.  
Despite the improvement brought about by consensus criteria, the diagnosis of MND is still 
not satisfactory. Mean time to diagnosis is 16 months from symptom onset (Donaghy et al., 
2008; Househam and Swash, 2000). Many of these patients will have ALS which has a 
mean life expectancy of only a further 16 months post diagnosis (O'Toole et al., 2008). 
This is a very small time window in which to see any benefit of neuroprotective drugs. 
Moreover, by this stage, much of the cumulative damage to motoneurones has already 
taken place. The key to optimise the effects of neuroprotection is early detection of upper 
motoneurone dysfunction. 
From this small study, we can conclude that 15-30Hz intermuscular coherence might be 
used as a simple, inexpensive and accessible test for assessing CST integrity. All that is 
required are facilities for EMG recording, a computer and analysis software. Most of this is 
readily available in standard neurophysiology departments, therefore the data required for 
coherence analysis could be collected routinely during an EMG or nerve conduction study. 
Intermuscular coherence appears to be a robust measure of CST function, however this 
should be confirmed in a larger patient sample (including other conditions presenting with 
progressive CST dysfunction).  
It is important to note however that sensory afferents are likely to play an important role in 
both 15-30 Hz corticomuscular coherence (Baker et al., 2006; Riddle and Baker, 2005) and 
intermuscular coherence (Kilner et al., 2004). Therefore any diagnostic inference regarding 
CST function using coherence can only be made in the presence of normal somatosensory 
evoked potentials and sensory nerve action potentials. 
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Future plans 
This is a small scale study which was designed to provide some clarification of the origin 
of coherence and its potential value as a diagnostic indicator. The results presented herein 
demonstrate that intermuscular coherence is a reasonable measure of CST integrity but a 
larger study is required which involves more patients and a larger control cohort with 
specific age-matched divisions. In addition to this, the specificity and selectivity of 
coherence for MND needs to be tested. Therefore we would also like to investigate this 
technique in some other neurological conditions which can mimic MND for example spinal 
muscular atrophy, multifocal motor neuropathy and hereditary spastic paraplegia.  
We know that the technique works in a group of patients with established disease. But the 
aim is to use it to detect changes early on in the disease course; to be able categorically to 
diagnose MND before this can be done by consensus criteria. The next step therefore is to 
carry out a prospective study in a large group of patients who are referred to the MND 
clinic for investigation. This would enable us to test the sensitivity and specificity of 
coherence as a diagnostic test and to determine at what disease stage changes in coherence 
become apparent. Only then would coherence be useful as a diagnostic test, promoting 
early disease detection and facilitating earlier introduction of neuroprotective agents. 
Recent work suggests that directed coherence may be a more useful indicator of CST 
integrity than intermuscular coherence. We may see little or no net coherence if ascending 
and descending synchronous oscillations are sufficient to cancel each other out. Perhaps 
therefore, descending directed coherence (EEG→EMG) would be abnormal in patients with 
CST degeneration whilst ascending directed coherence (EMG→EEG) remained unaffected. 
This should be further investigated in patients with both CST and sensory deficits. 
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CHAPTER III: CORTICOSPINAL ACTIVATION CONFOUNDS 
CEREBELLAR EFFECTS OF POSTERIOR FOSSA STIMULI 
 
Since the ablation studies of the nineteenth century, it has been known that the cerebellum 
plays a critical role in movement control. It receives a vast number of inputs from all over 
the brain leading it to be well placed to co-ordinate complex multi-joint movements.  
Given the importance of the cerebellum in movement control, disruption or dysfunction of 
this structure can be highly disabling. An objective way of assessing cerebellar function 
would therefore be invaluable for early diagnosis of degenerative processes and in 
monitoring disease progression.  
Non-invasive electrophysiological study of the cerebellum is difficult because of its deep 
location within the skull. Current tests are indirect and rudimentary; most importantly, they 
are only applied when obvious cerebellar signs are evident. This is often too late for 
patients to begin neuroprotective treatment. 
A sensitive test of cerebellar function would be useful to help diagnosis of severe 
degenerative disorders. This would in turn feed into recruitment of appropriate patients for 
clinical trials and help monitor disease progression. In addition, there are potential 
applications for clinical monitoring of drugs with known cerebellar side effects such as 
antiepileptics.  
 
The cerebellum 
Despite our extensive knowledge of cerebellar anatomy, we still do not fully understand the 
role of the cerebellum in motor control. At first glance, the structure has an extremely 
regular and simple organisation, but modelling the function of the cerebellum has proved 
surprisingly difficult. To date no one model of cerebellar function has been able to explain 
all of the phenomena observed in behavioural studies.  
Much of our knowledge relating to cerebellar function has arisen from studying the effects 
of damage to it. Flourens (1824) observed the motor deficits arising from lesions of the 
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cerebellum in animals. He suggested that the role of the cerebellum is to co-ordinate 
movements; his pioneering experiments demonstrated that the cerebellum is not necessary 
for movement, but that without it, movements are inaccurate, dysmetric and poorly co-
ordinated.  
The first detailed description of the effects of cerebellar damage in humans was recorded 
by the eminent British Neurologist Gordon Holmes. During his time serving with the 
British Expeditionary Forces in the first world war, he observed soldiers with gunshot 
wounds to the cerebellum and described a characteristic ‘decomposition of movement’. 
Following cerebellar damage, complex multi-joint movements were broken down into a 
series of separate, fractionated movements. Patients exhibited impaired movement timing, 
movement onset, and showed inappropriate movement acceleration. These problems were 
often most pronounced in movements which required sensory guidance. Holmes proposed 
therefore that the cerebellum ‘tunes up the cerebral motor apparatus…so that they respond 
promptly to volitional stimuli…’.  
Whilst the theory of cerebellar function is complex and contested, the general view is that 
the role of the cerebellum is not to initiate movement, but to regulate the precise timing and 
co-ordination of movements. It achieves this via a vast network of connections between the 
motor and sensory areas of the brain and spinal cord.  
 
Anatomy of the cerebellum 
The majority of the cerebellum is composed of a highly folded, convoluted layer of gray 
matter; this comprises the cerebellar cortex. Underneath is a layer of white matter, the 
arbor vitae, which contains all of the myelinated afferent and efferent fibres which relay 
information to and from other areas of the brain. Embedded within the white matter are the 
cerebellar output relays of the deep cerebellar nuclei (DCN). 
The cytoarchitecture of the cerebellar cortex is very well documented. This is largely 
thanks to the detailed histological studies perfomed by Ramόn y Cajal in the late nineteenth 
century. These remarkable descriptions and drawings of the cerebellar cytoarchitecture 
revealed the simplicity and uniformity of the cerebellar structure. Cerebellar cortex is 
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organized into three well defined layers: the molecular layer, Purkinje cell layer and deep 
granular layer (see Fig. 3-1). Highly localized within these layers are the cells of the 
cerebellar circuit.  
Purkinje cells are the focus of activity within the cerebellar cortex. They are large and 
distinctive cells, characterized by their extensive dendritic tree. Their cell bodies reside in 
the narrow, single cell thick, Purkinje cell layer whilst long dendrites project into the 
molecular layer. Purkinje cells receive inputs from two main sources. Climbing fibres wrap 
around Purkinje cell dendrites as they wind their way up through the molecular layer from 
the white matter. The elaborate twisting structure of the climbing fibres around Purkinje 
cell dendrites means that many hundreds of synapses are present; climbing fibres therefore 
provide a very strong input. Parallel fibres course perpendicular to the Purkinje cell 
dendritic trees, running through them at a right-angle and making synapses on to multiple 
cells.  
The granular layer is packed densely with small granule cells. As a result of this dense 
packing, the cerebellum contains 50% of all neurons in the brain despite only being 10% of 
the total brain volume. Granule cell axons project from their source through the Purkinje 
cell layer and into the molecular layer where they split into two and traverse the molecular 
layer as parallel fibres. Golgi cells are inhibitory interneurons in the granular layer which 
synapse onto granule cells. Input is received from mossy fibres and parallel fibres allowing 
for feedforward and feedback inhibition of granule cells. 
The molecular layer is the outermost layer of cerebellar cortex and contains the Purkinje 
cell dendritic tree; here, the different input fibres converge. Stellate and basket cells are 
also distributed throughout the molecular layer; these are inhibitory interneurons which 
synapse directly onto Purkinje cells. 
Purkinje cells are the sole output of the cerebellar cortex, providing inhibitory input to the 
deep cerebellar nuclei. The majority of output fibres from the cerebellum originate in the 
DCN. This symmetrical and bilateral group of nuclei consists of the lateral dentate nucleus, 
intermediate interpositus nucleus and medial fastigial nucleus. DCN receive a combination 
of inhibitory input from Purkinje cells and excitatory collateral input from mossy fibres and 
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Figure 3-1: Schematic diagram showing the structure of the cerebellar cortex. From 
Movements of the eyes (Carpenter, 1988). 
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climbing fibres.  
 
Inputs to the cerebellum 
Mossy fibres deliver inputs to the cerebellum from a variety of sources, however a large 
proportion arise from cortical areas via the corticopontocerebellar tract. This delivers an 
efference copy of motor commands to Purkinje cells and the DCN via the pontine nuclei,  
including information about the visual, motor and sensory aspects of intended movements. 
Mossy fibres are carried in the largest of the cerebellar peduncles, the middle cerebellar 
peduncle. The substantial volume of these inputs demonstrates the importance of the 
cerebellum in co-ordinating movements.  
Mossy fibres synapse onto granule cells which are located within the cerebellar cortex; 
their axons are parallel fibres which project onto Purkinje cells. Parallel fibres have a very 
weak effect on Purkinje cells, therefore many mossy fibres must fire simultaneously and 
rapidly in order to excite them. When Purkinje cells are activated by this pathway, they 
produce characteristic  simple spikes which typically have a very fast discharge rate.  
Mossy fibres can also arise from the spinocerebellar tract. The dorsal aspect of this 
ipsilateral ascending pathway carries information about proprioception from golgi tendon 
organs and muscle spindles in the periphery. In contrast, the ventral spinocerebellar tract 
transmits an efference copy of the motor program to the cerebellum (Arshavsky et al., 
1978).  
Climbing fibres originating in the inferior olive have a much more direct and powerful 
effect on cerebellar Purkinje cells. These projections arrive into the cerebellar cortex via 
the inferior cerebellar peduncle. Each climbing fibre targets up to 10-15 Purkinje cells, 
however each Purkinje cell receives input from only one climbing fibre (Eccles et al., 
1966). Activation of this pathway causes discharge of distinctive slow frequency complex 
spikes. This powerful input can suppress simple spike activity via mossy fibre input 
(Ekerot and Kano, 1985; Ito et al., 1982). Climbing fibres relay information from 
sensorimotor cortex, spinal cord, reticular formation, red nucleus, superior colliculus and 
the vestibular system. 
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Outputs from the cerebellum 
There is a highly ordered, topographical pattern of projections from DCN (Hoover and 
Strick, 1999). These cerebellar efferent fibres are carried via the superior and inferior 
cerebellar peduncles crossing the midline in the caudal midbrain. The main target is the 
contralateral ventrolateral and ventroanterior regions of the thalamus. It was initially 
thought that the pathway beyond thalamus projected exclusively to primary motor cortex. 
In fact, central to the cerebellothalamocortical pathway is a very strong projection from 
dentate nucleus to motor and premotor cortices (Orioli and Strick, 1989; Sasaki, 1976). 
However, alongside these projections,  anatomical studies have repeatedly shown that there 
are a wide range of non-motor cortical targets (Barbas et al., 1991; Dum and Strick, 2003; 
Goldman-Rakic and Porrino, 1985; Middleton and Strick, 2001; Miyata and Sasaki, 1983; 
Sasaki et al., 1979). These projections include red nucleus, superior colliculus, vestibular 
nuclei and prefrontal cortex. This suggests that the cerebellum has a more global role in the 
control of movement than previously thought. 
Information gathered from cortical areas is relayed back to the cerebellum via reciprocal 
connections to the pontine nuclei (Glickstein et al., 1985) and inferior olive (Andersson and 
Nyquist, 1983; Baker et al., 2001) thereby forming a complete motor loop. The strongest 
cortico-pontine and cortico-olivary connections are from areas 4 and 6 but there are a wide 
range of cortical sources (Allen et al., 1978; Glickstein et al., 1985; Tsukahara, 1974). 
The cerebellum also projects to both the reticular formation (Bantli and Bloedel, 1975; 
Cohen et al., 1958) and the red nucleus (Dekker, 1981); these are the origin of two major 
descending pathways from the brainstem. Stimulation of DCN in macaques produces short 
latency bilateral responses in forelimb muscles which are postulated to be mediated via 
either the reticulospinal or rubrospinal tracts (Soteropoulos and Baker, 2008). In monkeys, 
these pathways have been shown to have monosynaptic connections with motoneurones or 
spinal interneurons (Fujito et al., 1991; Riddle et al., 2009). 
 
Measuring Cerebellar Dysfunction  
Current measures of cerebellar function are by nature very crude. They lack sensitivity and 
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rely largely on either subjective assessment or indirect measures of movements. Clinically
there are three main measures of cerebellar function. Firstly, MRI is available to detect any 
gross abnormalities although it is not able to identify subtle morphological changes. 
Pegboard tests are often used to probe motor co-ordination; the time to complete a series of 
movements is related to the degree of dysfunction. However this is a very crude and 
inaccurate way of measuring cerebellar function. Ataxia scales are used primarily for 
monitoring progression of conditions affecting the cerebellum. These are really the 
mainstay of assessing the cerebellum in clinic. However these scales are often highly 
subjective, being susceptible to both intra- and inter-rater variability.  
In the research laboratory, there are many more tests which have been designed to 
investigate the role of the cerebellum in motor function. Often these are very robust and 
reliable techniques, for example motor learning and eyeblink conditioning, yet the 
transition between research investigation and clinical application has never been made.  
There is an evident gap for a specific marker of cerebellar dysfunction - not necessarily for 
those with overt cerebellar disease but for detection of subclinical cerebellar disorders. We 
currently lack the ability to diagnose conditions early and also to detect cerebellar disease 
within a complex motor disorder. An example of this lies with the complicated tree of 
Parkinsonian disorders. An estimated 20-25% of patients with Parkinsonism are thought to 
have conditions other than Parkinson’s disease (Hughes et al., 1993; Litvan et al., 1997; 
Rajput et al., 1991). One of these conditions, multiple system atrophy (MSA), critically 
involves degeneration of the cerebellum yet it is difficult to differentiate from PD in the 
early stages. The ability to detect subclinical cerebellar disease in these instances is crucial 
not only for patients but also for effective early recruitment to therapeutic clinical trials. 
 
Non-invasive stimulation of the cerebellum 
Non-invasive electrical stimulation of the cerebellum was first demonstrated by Ugawa and 
colleagues (1991). High voltage electrical stimuli were applied across the back of the skull; 
electrodes were positioned over the two mastoid processes. This did not have direct motor 
effects but was capable of suppressing MEPs elicited by non-invasive stimulation over 
motor cortex (Ugawa et al., 1991; Ugawa et al., 1994a). As with all forms of percutaneous 
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electrical stimulation, there is unavoidable local activation of cutaneous receptors. 
Consequently the method is very painful and therefore often not tolerated by subjects.  
To overcome the problem of painful stimulation, magnetic stimulation of the cerebellum 
was subsequently implemented (Ugawa et al., 1994b; Ugawa et al., 1995; Ugawa et al., 
1997; Werhahn et al., 1993). The introduction of a double cone coil which could activate 
deeper structures than conventional coils facilitated this move. Optimal coil position was 
investigated; this was found to be mid-way between the occiput and the mastoid and was 
proposed to be due to specific activation of the cerebellum. The effects observed at this 
stimulation site were the same as those reported from electrical stimulation over the 
occiput. Ugawa and colleagues (Ugawa et al., 1994a; 1995) suggested that the effects may 
result from inhibition of the DCN as a result of activation of Purkinje cells. This hypothesis 
is consistent with reports that MEP suppression was not present in patients with specific 
degeneration of cerebellar cortex (Ugawa et al., 1994b).  
When cerebellar TMS was first introduced, the specificity of the technique was 
investigated. Ugawa and colleagues first considered activation of descending motor 
pathways; they demonstrated that stimulation over the occiput could produce a single 
descending volley in the spinal cord which could be collided out by stimulation of the 
peripheral nerves (Ugawa et al., 1994c). Moreover, collision of an antidromic spike elicited 
by stimulation over the occiput with descending volleys from motor cortex showed that this 
was likely to occur via the corticospinal tract (CST); (Ugawa et al., 1994c). The optimal 
site for direct activation of CST was found to be over the midline (Ugawa et al., 1994c) 
rather than the lateral site proposed for specific cerebellar stimulation.  
Ascending sensory afferents could also be activated using this method. High intensity TMS 
causes contraction of neck and proximal muscles; this would activate a multitude of 
cutaneous afferents and muscle spindles. Appropriately timed sensory volleys could 
therefore influence motor output. Despite consideration of activation of these other 
structures, it was concluded that at the intensities used and given the specificity of 
stimulation site and polarity that the effects observed must be due to cerebellar stimulation. 
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Since the first descriptions of cerebellar stimulation, there have been many reports in the 
literature using this technique. Recently, there has been a surge of interest in low frequency 
repetitive TMS (rTMS). With this technique, it is possible to create ‘virtual lesions’, 
reversibly inactivating regions of cerebral cortex to investigate their normal function. A 
range of reports have emerged investigating cerebellar function using rTMS over the 
posterior fossa (Del Olmo et al., 2007; Jancke et al., 2004; Miall and Christensen, 2004; 
Theoret et al., 2001). 
 
‘Cerebellar inhibition’ of MEPs 
Electrical (Ugawa et al., 1991) or magnetic (Ugawa et al., 1995) stimulation over the 
posterior fossa (PF) has been shown to suppress MEPs elicited by motor cortical 
stimulation 5-7ms later. Evidence from patients with focal cerebellar lesions suggests that 
this is likely to occur via a cerebellothalamocortical pathway (Matsunaga et al., 2001; 
Ugawa et al., 1994b; Ugawa et al., 1995; Ugawa et al., 1997); reduced MEP suppression is 
seen in patients with lesions of the cerebellum or one of the inflow/outflow pathways, but 
is normal in ataxia of non-cerebellar origin. As a result, Ugawa et al (Ugawa et al., 1994b; 
Ugawa et al., 1997) suggested that cerebellar stimulation could be a useful tool to 
distinguish disease of cerebellar outflow (yielding impaired suppression) from that of 
cerebellar afferent pathways (suppression normal).  
This paired stimulation technique is a promising technique for detecting sub-clinical 
cerebellar dysfunction. It could have potential applications in the early diagnosis of 
degenerative processes like MSA at a stage at when neuroprotective treatment could be 
implemented. However, reports have shown preserved MEP suppression in patients with 
cerebellar agenesis (Meyer et al., 1993; Meyer et al., 1994; Ugawa et al., 1994b; Ugawa et 
al., 1997). In addition, concerns remain over the specificity of the technique. It is known 
that stimulation over the posterior fossa region can directly activate descending motor 
structures such as the pyramidal tract. Collaterals of these CST neurons could potentially 
exhibit an inhibitory effect on motor cortical cells via recurrent inhibition (Renaud and 
Kelly, 1974).  
 
 65 
 
Methods 
Eleven healthy volunteers (age 23-54 years, 10 male and 1 female) consented to participate 
in this study. Subjects sat resting their head on a custom-made frame, modelled on an 
ophthalmic slit lamp (Fig. 3-2A, B). Straps immobilised the head with the neck flexed. 
Magnetic stimulation coils were clamped rigidly to the frame.  
 
EMG recordings 
Surface electromyogram (EMG) recordings were made from two intrinsic hand muscles 
(first dorsal interosseus, FDI; abductor pollicis brevis, AbPb) and two forearm muscles 
(flexor digitorum superficialis, FDS; extensor digitorum communis, EDC). EMG signals 
were amplified (gain 1-5K, bandpass 30 Hz-2 kHz) and digitised at a 5 kHz sampling rate 
by a Power1401 interface (CED Ltd, Cambridge, UK) running Spike2 software, together 
with signals indicating the time of trial onset and occurrence of auditory cues. 
 
Transcranial Magnetic Stimulation 
Stimulation over motor cortex was performed using a 13cm outside diameter round coil 
(Magstim 200 stimulator). This was oriented A side up for left hemisphere activation. 
Stimulus intensity was set to generate an MEP from FDI/AbPB at approximately 0.5 mV at 
rest (MEP sizes: FDI, 0.53±0.09mV; AbPB, 0.27±0.07mV; EDC, 0.17±0.03mV; FDS, 
0.21±0.04mV, mean ± SEM across subjects). PF stimulation used a double cone coil and 
another Magstim 200 stimulator.  
The threshold intensity for direct activation of CST fibres was first identified with the coil 
centred over the inion, oriented to produce a downward current in the brain. This was 
termed the direct motor threshold (DMT). Subjects produced a gentle background 
contraction, and stimulus-triggered EMG from FDI and AbPB were viewed on an 
oscilloscope. Stimulus intensity was increased in 1% increments until a response above 
background was observed. Threshold was defined as the intensity of stimulation which 
produced an MEP in 50% of stimuli. MEP latencies were a few milliseconds shorter than 
responses to motor cortical stimuli, consistent with brainstem CST activation. Mean 
threshold intensity was 75% MSO (% maximum stimulator output; range 60-100%). The 
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Figure 3-2: Photographs showing experimental set-up. A: Subject seated with forehead 
resting on the frame. A round TMS coil is mounted on a fixation bar to hold it in place over 
the M1 hotspot and a second coil (double cone) is held over the occiput. B: Rear view 
showing the position of the two coils relative to the head. C: Example MEP traces showing 
the relative timings of the conditioning (PF) and test (Ctx) stimuli. A test MEP is shown in 
the dashed example with a conditioned MEP denoted by the black line. 
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coil was then repositioned midway between the inion and the right mastoid incisura. 
Intensities used during the experiment ranged from DMT-20% to DMT, in 5% steps. 
 
Motor threshold identification 
Subjects made a background contraction and PF stimuli (0.2Hz) were given at a randomly 
chosen intensity. The coil remained oriented to produce a downward brain current since we 
found this to be the most sensitive method of detecting CST activation in our subjects. This 
experiment was performed with the muscle active to produce tonic motoneurone firing, 
providing the greatest sensitivity to detect a CST volley via its evoked EMG activity. 
Subjects were required to squeeze the levers of an auxotonic precision grip manipulandum
 
(Riddle and Baker, 2005) between finger and thumb. Lever displacement had to exceed 
17mm; below this, a tone sounded until the criterion displacement was achieved. It is 
reasonable to expect that CST activation will also occur at the same intensity when the 
subject is at rest, since stimulation is distant to the axon initial segment and hence 
insensitive to the level of cortical excitability. This is so, even though the weak CST volley 
produced by a near threshold PF stimulus is unlikely to generate a measurable MEP in 
resting motoneurons. 
 
Paired pulse paradigm 
Subjects were at rest. Motor cortex was stimulated either alone, or preceded by PF 
stimulation (3, 5 or 7ms intervals; intensities as before). Here, the coil was inverted to 
generate an upward brain current, previously found to be optimal for MEP suppression 
(Ugawa et al., 1995). Around 20 stimuli at each intensity were delivered.  
 
Analysis  
Off-line analysis in the MATLAB environment separated responses according to condition 
and compiled averages of rectified EMG. Single sweep responses were measured as the 
area between the MEP onset and offset, judged from the averaged response. Responses to 
PF stimulation alone were normalised as a percentage of the mean background level over 
the 20ms prior to the stimulus. Significance was assessed by comparing single trial 
responses with a similar duration of the pre-stimulus background (paired t-test). 
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Conditioned responses to motor cortical stimulation were expressed as a percentage of the 
unconditioned response; significant suppression was assessed with unpaired t-tests. 
 
Results 
Single subject results 
Figures 3-3A-E show the results from an individual subject, in whom the initial estimate of 
the threshold for a direct response to PF stimulation was 70% MSO. Figure 3-3A shows a 
clear averaged EMG response at this intensity. No significant direct responses were present 
at lower PF intensities (Fig. 3-3C). Conditioned MEPs (7ms ISI) are illustrated for this 
subject in Fig. 3-3B. Suppression was elicited consistently at all intensities of PF 
stimulation. Therefore, for this individual, stimulating at intensities of DMT-5% and below 
seems to generate MEP suppression in the absence of direct CST activation.  
Figures 3-3F-J show data from a subject whose PF threshold was initially estimated as 80% 
MSO. Significant suppression was seen as low as 65% MSO (Fig. 3-3I), however there was 
also a significant direct response to PF stimulation at this intensity (Fig. 3-3H). The 
observed suppression cannot therefore be unambiguously assigned to a cerebellar pathway. 
Moreover, although the response was not significant at 60%, the response region was 
above baseline, and the characteristic bifid peak produced by an MEP in rectified EMG 
was clearly visible (Fig. 3-3F, 60%). It would be unsafe to conclude that there was no CST 
activation at an intensity of 60% MSO in this subject. 
ISI timecourses for individual subjects (Fig. 3-3E,J) confirmed that MEPs were suppressed 
at 5 and 7ms intervals, but not at 3ms, consistent with previous reports (Matsunaga et al., 
2001; Ugawa et al., 1995). Previous work has used PF stimulus intensity 5-10% MSO 
below the threshold estimated with the coil in the midline (Matsunaga et al., 2001; Ugawa 
et al., 1994b; Ugawa et al., 1995). At this intensity, we found 9/11 subjects had 
significantly suppressed MEPs. However, all nine also had a direct response in at least one 
muscle.  
 
Redefining threshold for accurate threshold identification 
Working from the direct response threshold subjectively estimated with the coil at the
 69 
 
 
Figure 3-3: Single subject results. A: Averaged rectified EMG (FDI) following PF stimulation at different intensities. Vertical dashed 
lines show response region. Grey shading shows mean baseline ± 2 standard errors. B: MEPs following motor cortical stimulation 
(intensity 44% MSO). Dotted lines are unconditioned responses; solid lines show responses conditioned by PF stimulation. C: 
Response magnitude (expressed as a % of mean background EMG) versus intensity. D: Conditioned response magnitude as a 
percentage of unconditioned responses. E: Average time course of MEP suppression at DMT-10%. In (C, D and E), error bars show 
standard errors; horizontal dotted lines in (D and E) show standard error of unconditioned response. Filled circles indicate significant 
points (P < 0.05). F–I: As in (A)–(D) for a different subject. Motor cortical stimulation in this subject was performed at 36% MSO. J: 
Average time course of MEP suppression at DMT-5% for this subject. 
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midline is clearly unsound. Stimuli weaker than this with the coil placed more lateral do 
produce CST activation, confounding the interpretation of MEP suppression. It is unlikely 
that this was due to a lower threshold in the lateral position, as a previous study 
demonstrated that the midline was the optimal position for CST activation (Ugawa et al., 
1994c). Alternatively, weak responses following near-threshold stimuli may be missed in 
single sweeps, causing threshold to be assigned higher than it actually is. Some previous 
reports determined threshold from averaged MEPs (Daskalakis et al., 2004), but many 
authors do not clearly describe the method used. Choosing the intensity of PF stimulation 
more carefully might therefore allow selectivity for cerebellar pathways. In order to test 
this, responses to PF stimuli were rectified and averaged; threshold was then redefined 
according to the presence of significant MEPs in these averages. This is a sensitive means 
of determining threshold and was designated the objective direct response threshold 
(ODRT). 
 
Population data 
Averaged data are presented as a function of intensity relative to ODRT in figure 3-4. For 
the 3ms interval (Fig. 3-4A), MEP suppression (circles) was not evident at any intensity. 
By comparison, a clear effect on motor cortical output was observed with the longer 
intervals. For 5ms, significant MEP suppression was generated at 15% MSO below ODRT 
(Fig. 3-4B), whilst suppression at the 7ms ISI was significant at all intensities tested (Fig. 
3-4C). Overlain on the plots of figure 3-4 is the averaged direct response (squares). When 
data was averaged across subjects, small but significant responses were seen even 10% 
below ODRT. This suggests that even when we determined threshold using a highly 
objective, sensitive method in single subjects, weak responses were still present at lower 
intensities. These could only be revealed by the increased statistical power of pooling data 
across subjects. 
 
The effect of current direction on PF stimulation 
One important parameter of PF stimulation is the orientation of the TMS coil. It has 
previously been shown that an orientation yielding an upwards brain current (as used here) 
generates the greatest MEP suppression. In a subset of 7 subjects, the direct motor
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Figure 3-4: Average direct response and MEP suppression for each ISI is plotted versus 
stimulus intensity (expressed relative to ODRT). Solid lines plot average MEP suppression 
at ISI’s of 3 ms (A), 5 ms (B) and 7 ms (C). Filled circles indicate significant points 
(P < 0.05). Dashed lines show average direct response size (expressed as a % of mean 
background EMG) following PF stimulation for comparison. Filled squares indicate 
significant points (P < 0.05). All curves are averaged over the 11 subjects who participated 
in this study. Error bars show standard errors. 
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responses were tested when the coil was oriented either to produce this current direction, or 
the opposite. Figure 3-5A plots the response amplitude averaged across subjects versus 
intensity relative to ODRT. The two plots indicate responses generated with a brain current 
oriented downwards (solid line) and upwards (dashed line). Significant responses were 
generated at 10% below ODRT with the downward brain current, but only at 20% above 
ODRT with the upward brain current. Figure 3-5B illustrates the response seen in one 
subject at 74% of maximal stimulator output with a downward brain current; by contrast 
there was no response at this level (Fig. 3-5C) or at a higher intensity (84%; Fig. 3-5D) 
with the coil inverted. 
In a subset of subjects (2/11), we also conducted the conditioning-test experiment with both 
PF coil orientations (upward and downward brain current). Stimulation intensities were the 
same for both recordings though we identified the motor threshold in both orientations. 
Contrary to previous reports (Ugawa et al., 1995) an equal degree of MEP suppression was 
observed with both current directions (Fig. 3-5E).  
 
Discussion 
Magnetic stimulation of the PF probably has complex actions, and a variety of peripheral 
and central pathways could contribute to its effects (Meyer et al., 1993). Antidromic action 
potentials in the CST could plausibly produce MEP suppression, as corticospinal neurones 
are known to make recurrent collaterals to inhibitory interneurones in the cortex (Renaud 
and Kelly, 1974). Other brainstem pathways, such as the spinothalamic tract or dorsal 
columns, could also produce MEP suppression.  
To be certain that MEP suppression is mediated by cerebellar pathways, we must exclude 
all other possibilities. This requires a particularly stringent standard of evidence: to exclude 
a CST contribution, for example, it is necessary to show with high confidence that there is 
no activation of corticospinal fibres. It is critical therefore accurately to measure the 
threshold for a direct response to corticospinal stimulation. When this was done using 
online observation of single sweep responses, threshold was generally overestimated. 
Subsequent observation of averaged traces revealed significant averaged responses at 
intensities below our initial threshold estimate. However, even correcting the threshold
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Figure 3-5: Effect of coil orientation on direct responses. A: Direct response size as a 
function of stimulus intensity relative to ODRT, averaged across seven subjects. Solid line 
indicates measurements with brain current downwards; dashed line indicates brain current 
upwards. Solid circles indicate responses significantly different from zero (P < 0.05). Error 
bars show standard errors. B-C: Example response from one subject (FDI muscle) with an 
intensity of 74%, brain current downwards (B) and upwards (C). (D) Same subject, 
intensity 84%, brain current upwards. E: Average MEP suppression in 2 subjects across all 
muscles recorded with both an upward and downward brain current. Filled circles denote 
datapoints which are significantly different from baseline.  
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measure using these averages (ODRT) did not give the required level of confidence that no 
response was present. When data was averaged across subjects, small but significant 
responses at intensities below ODRT could be revealed. 
Antidromic activation of corticospinal axons has the greatest potential to generate MEP 
suppression following PF stimulation (via intra-cortical recurrent collaterals). Such 
activation cannot be assessed directly; we can only measure the generation of responses in 
muscle, which results from orthodromic activation of corticospinal axons and subsequent 
synaptic action on motoneurons. This study revealed a marked difference in the efficacy of 
upward versus downward orientations of stimulating current in generating muscle 
responses. The most plausible explanation for this difference is the presence of anode block 
with the upward current. Stimulation over the brainstem, where the tracts are small, may be 
sufficient to concentrate current and generate a focal hyperpolarisation. This would prevent 
transmission of MEPs, but suppression via antidromic activation and recurrent inhibition 
would remain unaffected. This notion is supported by the fact that MEP suppression was 
observed using either an upward or downward current for stimulation over the PF (Fig. 3-
5E). Despite anode block affecting the orthodromic transmission of activity for the upward 
brain current, the observation of suppression suggests a role for recurrent inhibition in the 
phenomenon. Therefore, only if no direct response can be seen following PF stimulation 
with a downward brain current is it safe to assign MEP suppression seen with an upward 
brain current to non-CST pathways. 
 
The future of PF stimulation 
The deep location of the cerebellum beneath the skull means that high stimulus intensities 
are routinely used in TMS studies (mean threshold here was 75%). Due to current spread at 
high intensities, a stimulus of this size over the PF is likely to activate many structures, 
including part/all of the cerebellum. However, it is difficult to identify exactly how much 
each structure contributes to the effects on MEPs.  
Preserved MEP suppression has been demonstrated in some patients with degenerative 
ataxia or cerebellar agenesis (Meyer et al., 1993; Meyer et al., 1994; Ugawa et al., 1994b; 
Ugawa et al., 1997).  Disruption of the cerebellar outflow via thalamus to cerebral cortex is
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likely to produce associated changes in cerebral cortical function, which could plausibly 
include the networks underlying recurrent inhibition from CST activation. Abnormal 
suppression would then be seen in patients with cerebellar dysfunction, but the test would 
not directly measure the cerebellar pathology. This distinction becomes of key importance 
when PF suppression of MEPs is used to investigate an unknown disease. In that case, the 
confounded cerebellar and CST responses to PF stimulation demonstrated in this study will 
make unambiguous interpretation of results impossible. 
Unpublished data from our laboratory has failed to demonstrate conditioning of MEPs with 
cerebellar stimulation in an anaesthetised marmoset monkey (personal communication with 
Dr Demetris Soteropoulos and Prof. Stuart Baker). Epidural stimulation over motor cortex 
was performed in order to elicit a volley in the spinal cord. This was preceded with 
epidural stimulation of cerebellar cortex with ISIs between 1-10ms. No conditioning effects 
were observed at any of the intervals tested. 
Given the non-selective nature of TMS over the PF, its utility as an experimental tool will 
depend on the purpose to which it is put. If all that is desired is to activate the cerebellum, 
this can probably be achieved. However, if coactivation of other structures would confound 
the results obtained, the method must be used with considerable caution. To conclude 
therefore, although some of the effects are likely to be mediated by cerebellar pathways, it 
is difficult to justify PF stimulation as a specific diagnostic test for subclinical cerebellar 
disease. In addition, the technique can be uncomfortable which would preclude use in frail 
or elderly patients.  
 
Impact on other research 
Data from this study has shown that CST activation occurs at intensities routinely used to 
stimulate over the PF. Although it remains possible that the cerebellum contributes to the 
observed suppression at this level, the confounding activation of other structures are likely 
to generate ambiguous results. Therefore, a highly conservative approach must be taken if 
this method is to be used as a specific assessment of cerebellar function. Intensities 15-20% 
below threshold should be used and suitable controls undertaken in order to verify the 
absence of activity in other motor pathways. The results presented here agree with reports 
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that demonstrate some patients with cerebellar defects continue to show motor cortical 
suppression following PF stimulation (Meyer et al., 1993; Meyer et al., 1994; Ugawa et al., 
1994b; Ugawa et al., 1997).  
The surge of interest into ‘cerebellar’ TMS is a concern. The latest wave of studies merely 
reproduce the standard methods without any consideration for the wider effects of TMS 
over this region. It may be that some of the consequences of PF rTMS do indeed result 
from disruption of cerebellar pathways. However, the profound recurrent inhibition from 
repetitive antidromic CST activation would also severely impair motor performance, 
limiting the conclusions which can be drawn from these studies.  
 
Recent developments 
A recent study has demonstrated that for two thirds of a large cohort of healthy subjects, 
the optimal site for CST activation is lateral to midline (Shirota et al., 2010a). The finding 
of heterogeneity within a large population supports the findings reported here; most 
subjects reported had MEP suppression with corresponding direct responses following 
TMS in a lateral position. This highlights the difficulty in finding a site for selective and 
specific activation of the cerebellum; especially one which is consistent across subjects. 
Despite the potential for confounding activation of descending motor pathways, the interest 
in ‘cerebellar’ TMS remains strong. In particular, the potential role of this paired pulse 
paradigm as a diagnostic test is still under investigation. One Japanese group recently 
found MEP suppression to be abnormal in patients with PSP but normal in PD patients who 
were on medication (Shirota et al., 2010b). In addition, Ni et al (2010) showed motor 
cortical inhibition was reduced in PD patients off medication. These two studies in 
combination support the original hypothesis – that this technique could be used for the 
detection of subclinical cerebellar disease. However care should be taken when interpreting 
their results in terms of whether the effects described are mediated by the cerebellum. Both 
used a stimulus intensity which was only 5% below threshold and the coil was in the lateral 
position. Moreover, this particular group of patients have complicated movement disorders 
which are likely to affect a variety of brain systems. 
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CHAPTER IV: THE ROLE OF LEVETIRACETAM IN THE 
TREATMENT OF CEREBELLAR TREMOR 
 
Multiple Sclerosis (MS) is the most common and disabling neurological disorder affecting 
young adults in the UK and as a result costs the NHS millions of pounds a year (Kobelt et 
al., 2006). It is a chronic and complicated disease with no cure. Onset is early, usually 
between the ages of 20 and 50; and disease duration is long, with patients on average living 
40 years beyond diagnosis (Kesselring and Beer, 2005). A multitude of symptoms and 
progressive disablement means that there is a high prevalence of social and psychological 
problems, and that MS is therefore a complex disease to treat effectively.  
The underlying pathophysiology of MS describes an autoimmune disease which primarily 
attacks oligodendrocytes within the central nervous system. This is characterized by 
multiple focal lesions to the white matter of the brain and spinal cord. The lesions are 
plaques of demyelination, mediated by B and T cells which appear to be sensitized to 
myelin antigens. As a result, histological analysis of lesions shows a selective loss of 
myelin and oligodendrocytes, with the preservation of nerve cells and axons. This feature 
distinguishes MS from other autoimmune disorders. Patients are responsive to 
immunosuppressive therapy, confirming the underlying pathology of this disease. 
In over 85% of cases, multiple sclerosis follows the pattern of relapse and remission 
(Weinshenker et al., 1989a; Weinshenker et al., 1989b). Relapses develop acutely and are 
typically followed by several weeks or months of recovery. Sometimes this recovery is 
complete but often patients retain residual symptoms which become more troublesome as 
the disease progresses. Patients are usually neurologically stable between relapses. Disease 
modifying treatments such as beta interferon, natalizumab and campath can reduce the 
number and severity of relapses and slow the progression of disability (Coles et al., 2006; 
Miller et al., 2003; Paty and Li, 1993).  
Many patients with relapsing-remitting MS go on to develop a progressive form of the 
disease; this is no longer characterised by discrete autoimmune attacks. Instead, the disease 
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follows a steady course characterized by a slowly progressing disablement; 50% of patients 
are reported to require a walking aid 15 years after diagnosis (Runmarker and Andersen, 
1993; Weinshenker et al., 1989b) and 50-80% of patients also become unable to work 
during the first 10 years of disease onset (Rao et al., 1991). This combination of factors and 
a general loss of independence means that depression and anxiety (sometimes present in 
even the most benign cases) feature highly amongst MS patients. Pharmacological 
management is therefore desirable in order to help the patient to lead a relatively ‘normal’ 
lifestyle. 
Current MS therapy has two aims; short term symptomatic relief and long term slowing of 
disease progression. Immunomodulatory treatments are disease-modifying and aim to 
reduce the severity and frequency of relapses. These are taken over long periods to help 
alter the time course of the disease. Drugs such as interferon-beta and natalizumab are very 
effective in many patients, however the long term effects have yet to be fully investigated 
since these drugs have only been widely available for less than twenty years.  
Symptomatic drugs do not alter disease progression, but are used for the day-to-day 
management of an individual’s specific symptoms. Given that some patients do not qualify 
for immunomodulatory therapy, especially those who have the progressive form of the 
disease (Rieckmann et al., 2004), symptomatic treatments are essential for most patients 
(Samkoff and Goodman, 2011). 
In severe cases, more radical treatments have been attempted such as thalamotomy and 
thalamic deep brain stimulation. However, so far these therapies haven’t shown evidence of 
any sustained long term benefit. In fact, results are highly unpredictable, often depending 
on careful patient selection and dedicated post-operative care. On average MS patients 
have a life expectancy only seven years shorter than normal (Stevenson and Thompson, 
1998), so that specific symptomatic treatments remain highly desirable.  
 
Tremor 
Tremor is classified as a rhythmic, involuntary oscillatory movement. It is a common 
manifestation of multiple sclerosis (MS), estimated to affect between 26-58% of patients 
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(Alusi et al., 2001; Pittock et al., 2004). Typically tremor is not an isolated feature in MS, 
but is often coupled with other cerebellar symptoms which together form a complex motor 
disorder. Consequently MS tremor is usually associated with a poor prognosis (Pittock et 
al., 2004). 
Traditionally, Holmes’ (rubral) tremor was considered to be the characteristic severe 
tremor found in MS patients. This constitutes both a rest, postural and action tremor of low 
frequency and irregular pattern. However, Alusi et al (2001) found no patients out of a 
large cohort with true rubral or resting tremor. Instead, 58% exhibited an action tremor of 
either a postural, intention or kinetic type. Interestingly, 20 of these were asymptomatic 
despite exhibiting something similar to physiological tremor. Of the symptomatic patients, 
most described the tremor as originating in the arms before spreading to the other limbs 
(often bilaterally) and progressing in severity.  
The origin of MS tremor is difficult to pinpoint due to the nature of the disease. Multiple 
diffuse white matter lesions are spread throughout the brain and spinal cord which means 
that tremor is rarely an isolated symptom. However, damage to the cerebellum or one of 
the cerebellar afferent/efferent pathways is generally considered to be the primary cause 
(Feys et al., 2005). Experimental inactivation of the cerebellar nuclei in animals reversibly 
generates tremor with similar properties to that seen in MS (Vilis and Hore, 1980). 
Moreover, Alusi et al (2001) found a strong positive correlation between tremor and the 
severity of other cerebellar signs such as dysmetria and dysdiadochokinesia, which 
supports this theory.  
Similar tremor is also seen in many other neurological conditions such as essential tremor 
and stroke. There is hypothesised to be an overlap in the pathophysiology in that the 
cerebellum is implicated in most cases. For the purposes of this chapter, the tremor 
observed in this patient cohort will be referred to as either MS or cerebellar tremor. 
 
MS (cerebellar) Tremor 
Cerebellar tremor is usually associated with movement; patients present with 
discontinuities in their movements, which are more obvious when the movement is slow 
 80 
 
and are amplified towards the end of the movement (intention tremor). In general, this type 
of tremor becomes worse as more precision is required for a movement, for example 
pointing to a target. Intention tremor in particular can be highly disabling; it is associated 
with severely impaired quality of life measures and is regarded as one of the most difficult 
symptoms of MS to treat. Postural tremor can also be a manifestation of cerebellar disease 
although this is much less common and can often be the result of combined cerebellar and 
brainstem lesions in MS. 
Cerebellar tremor tends to occur at approximately 3-6Hz, but is highly irregular in 
frequency and amplitude. The underlying mechanism driving these rhythmic oscillatory 
movements is unclear. Figure 4-1 shows the extensive network of cortical areas that 
contribute to the preparation and co-ordination of movements. For each movement elicited, 
an efference copy is relayed to the cerebellar nuclei via olivary and pontine pathways. This 
carries information regarding the sensory, visual and motor aspects of the intended 
movement. In addition, interpositus receives peripheral feedback via spinocerebellar 
pathways to update the system as the movement progresses. Clearly therefore, this is a 
complex network with multiple feedback loops contributing to online error correction. 
Therefore, alteration of any part of this system could potentially give rise to tremor. 
Many groups have attempted ablation studies to try and determine the particular region 
which is critical to the generation of cerebellar tremor. The crucial area is thought to be one 
of the deep cerebellar nuclei given that this type of intention tremor does not arise with 
lesions of the cerebellar cortex. However, there has been no firm conclusion with some 
groups stressing a role for dentate (Cooke and Thomas, 1976; Vilis and Hore, 1977),
 
some 
for interpositus and others suggesting that both are implicated (Gemba et al., 1980). Such 
conflicting results are likely to arise because these two cerebellar nuclei are in such close 
proximity and the techniques used (cryoprobes, muscimol inactivation and electrolytic 
lesions) are not selective enough to inactivate one in isolation.  
Despite the focus on identifying a central mechanism responsible for the generation of 
cerebellar tremor, many authors have proposed a role for peripheral factors. Vilis and Hore 
have shown that tremor amplitude and frequency depend on mechanical factors associated 
with movements. In a series of experiments, they cooled dentate and interpositus cerebellar 
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Figure 4-1: Schematic diagram showing the complex network of neural pathways 
associated with movement control and co-ordination. Theoretically, tremor could arise 
from a disturbance in the normal function of any of these loops. Reproduced from Tremor: 
Elble and Koller (1990).  
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nuclei in monkeys as a model of cerebellar tremor (Vilis and Hore, 1977; Vilis and Hore, 
1980).
 
Cooling generated ipsilateral discontinuities in acceleration traces which appeared as 
rhythmic oscillations. During performance of a flexion-extension tracking task, addition of 
a spring load to the forearm muscle increased the tremor frequency whilst adding an 
inertial load reduced tremor frequency. Additionally, tremor was resynchronised with a 
limb perturbation. In this way, tremor was influenced by mechanical conditions, which 
implies a possible role for the proprioceptive feedback reflex in its pathophysiology. A 
limb weighting study in humans has also shown that damping of the mechanical 
component of movement can reduce action tremor (Aisen et al., 1993).  
A further theory for the generation of tremor implicates altered muscle spindle sensitivity. 
Cooling of peripheral muscles has been found to reduce cerebellar intention tremor (Feys et 
al., 2005). This is thought to be because temperature sensitive muscle spindles fire less 
frequently at lower temperatures, therefore decreasing the afferent feedback contribution to 
the stretch reflex. In addition, following cerebellectomy or cerebellar lesioning, reduced 
drive to motoneurones and reduced afferent feedback activity causes both static and 
dynamic spindle sensitivity to decrease (Gilman, 1969a; Gilman, 1969b). This could 
therefore account for the delayed movement onset latencies described by Vilis and Hore 
(1980). However, Vallbo (1971) demonstrated the onset of Ia firing to begin up to 50ms 
after initial EMG activity which does not fit with this theory. Moreover, muscle spindle 
sensitivity is restored with time (Van der Meulen and Gilman, 1965), and so although 
muscle spindles may contribute to tremor production, there are likely to also be other 
mechanisms involved. For instance, the increased motor unit twitch times observed by 
Riddle & Baker (2005) in peripheral cooling could be responsible for the EMG onset delay 
described by Vilis and Hore (1980). 
As already described, many theories concerning the origin of cerebellar tremor implicate 
peripheral factors. However, it has been shown that cerebellectomized primates still exhibit 
tremor despite the removal of peripheral afferent feedback (Gilman et al., 1976). In 
addition, cerebellar tremor and discontinuities occur in the absence of visual feedback, 
therefore error recognition and correction by the cerebellum do not depend upon the visual 
system (Flament et al., 1984). Although it is likely that there is a peripheral
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contribution, this is probably only by way of modulating activity from a central rhythm 
generator.  
 
Treatment of MS tremor    
Tremor is regarded as one of the most difficult symptoms of MS to treat and also one of the 
most frustrating for the patient. Severity varies according to time of day, and is worsened 
by high temperature (Uhthoff’s phenomenon), excitement, physical exertion and fatigue.  
Aside from pharmacological treatment, compensation techniques can be used to help 
patients manage tremor. Movements can be stabilised by bracing the reaching hand, or 
limbs can be fixed in a ‘position of function’ to allow necessary daily tasks such as eating. 
Occupational therapy can also help train patients to learn basic movement patterns with the 
aim that eventually they will become more automatic and controlled. In addition, studies 
have shown that weighting a limb can help reduce tremor (Aisen et al., 1993). This works 
by lowering the mechanical resonant frequency and therefore damping the oscillations. 
However, this may promote weakness and fatigue in some patients. Physiotherapy can help 
reduce tremor in some patients, although effects are usually temporary.  
Surgeons have attempted to alleviate MS tremor through stereotactic techniques for over 40 
years; initially, by way of thalamotomy, but more recently by thalamic stimulation. The 
optimal target site for such procedures is controversial, with some teams aiming for the 
nucleus ventralis intermedius (cerebellar input nucleus) (Hirai et al., 1983) and others, the 
nucleus ventralis oralis posterior (basal ganglia output) (Alusi et al., 1998; Nguyen and 
Degos, 1993). In fact, the target site may vary according to the particular tremor subtype 
exhibited by the patient and indeed some surgical studies have shown thalamic stimulation 
to be more beneficial for patients with postural rather than kinetic tremor (Montgomery et 
al., 1999; Waubant et al., 2001).  
There are concerns over the long-term effects of surgery; tremor reappears in 20% of 
patients after 12 months (Alusi et al., 2001). There is also a substantial risk of 
complications, including hemiparesis and seizure. As a result, surgery is usually only 
considered for the most severely affected; a careful selection process identifies those most 
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likely to benefit. The selection criteria usually distinguishes those with a stable disease 
history and minimal disability. Recent studies have explored possible tests which could 
help to select these patients (Alusi et al., 2003; Liu et al., 2000). 
Pharmacological therapy is the mainstay of treatment for MS tremor. Clinical trials have 
explored the use of drugs such as glutethimide (Aisen et al., 1991), izoniazid (Hallett, 
1985; Koller, 1984), carbamazepine (Sechi et al., 1989), primidone (Henkin and Herishanu, 
1989), propranolol (Koller, 1984) and cannabis (Fox et al., 2004). Although these agents 
can prove beneficial for some patients, results are not consistent. Moreover, patients often 
experience intolerable side effects, notably hepatotoxicity with high doses and many drugs 
exacerbate common MS symptoms such as fatigue.  
All current techniques to treat MS tremor show only limited success. Drug therapy is 
certainly a useful tool, but efficacy is subjective. Occupational therapy is not effective in all 
patients and limb weighting promotes weakness and fatigue (Hewer et al., 1972), two 
common MS symptoms. In addition, surgical therapy has shown limited success, 
principally due to the relatively small numbers of patients investigated, but also as long-
term effects are largely unexplored. A combinatory approach to treatment is therefore 
desirable until further progress is achieved in this area. 
 
Leviteracetam  
Recent studies have suggested that Levetiracetam (LEV) could be effective in the treatment 
of MS tremor (Feys et al., 2009; Mandler, 2003; Solaro et al., 2008; Striano et al., 2006). 
LEV was licensed by the FDA in 1999 for use as an adjunctive anticonvulsant therapy. 
Since then, it has been found to have a unique mode of action amongst anti-epileptic 
agents. This has led to a multitude of off-label trials of LEV for indications ranging from 
psychiatric disorders (Grunze et al., 2003) to migraine (Brighina et al., 2006) and chronic 
pain management (Rossi et al., 2009b).  
Antiepileptics in general have a wide range of pharmacological actions. Some are known to 
inhibit GABA uptake and breakdown such as vigabatrin, thereby increasing inhibitory 
neurotransmission. Others alter ionic conductances such as the calcium and sodium 
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currents associated with action potentials. In fact, most antiepileptic drugs have multiple 
actions upon the central nervous system which are not fully understood. Indeed, the 
antiepileptic mechanism of action of LEV is yet to be fully elucidated. Preclinical studies 
suggested that Leviteracetam has no effect on sodium, calcium or potassium channels, and 
does not alter the neurotransmission of GABA or glutamate (Sills et al., 1997; Zona et al., 
2001). 
More recently, an in vitro study demonstrated that LEV is involved in the partial inhibition 
of N-type calcium currents (Lukyanetz et al., 2002). These ionic conductances are present 
predominantly on presynaptic cell membranes, and their modulation affects the level of 
intraneuronal calcium and consequently overall cell excitability. In vitro studies have also 
demonstrated that LEV binds to a specific site on synaptic vesicle protein 2A which is 
found predominantly in cerebral cortex, hippocampus and the cerebellum (Lynch et al., 
2004; Noyer et al., 1995). This molecule is involved in the process of neurotransmitter 
vesicle fusion and exocytosis.  
It is unlikely however that these are the only effects mediated by LEV. Poulain and 
Margineanu (2002) suggested that the drug may affect postsynaptic GABA function and 
modulate GABA-gated currents by acting indirectly on GABAA receptors. Further 
biochemical testing is required to confirm whether this is the case. 
The specific localisation of the LEV binding site to the cerebellum has raised interest in the 
prospect of treating cerebellar disorders. An anecdotal report by Mandler et al (2003) 
showed reduction of severe cerebellar tremor in one patient following treatment with LEV. 
Subsequently, several clinical trials have investigated the effect of LEV on cerebellar 
tremor in MS. Striano et al (2006) found a significant reduction in outcome measures 
following a 5-6 week titration.  Contrary to this, neither Feys et al (2009) nor Solaro et al 
(2008) reported any reduction in tremor severity or improvement in motor function during 
their respective trials. The conflicting results may be a consequence of differing dosing 
regimen; LEV dose was much higher in the Striano study group (3-4000mg/day), as 
opposed to 1-2000mg/day administered by Feys et al (2009) and a maximum of 
1500mg/day used by Solaro et al (2008).  
 86 
 
Aims/outline 
The aim of this study was to evaluate and quantify the efficacy of LEV in the treatment of 
upper limb cerebellar tremor. Previous studies have used a range of clinical outcomes 
including tremor/ataxia scores, quality of life assessments and some quantification of 
reaching movements. This study utilised accelerometry and 3-dimensional motion tracking 
to facilitate quantification of tremor amplitude within the cerebellar tremor frequency band.  
 
Methods  
Patients & study design 
Twenty patients with a diagnosis of multiple sclerosis (McDonald et al., 2001) and clinical 
evidence of cerebellar tremor were initially recruited to the study. All patients provided 
informed consent prior to the start of the trial. The study was approved by the local 
research ethics committee and the MHRA. 
Patients were not asked to withdraw any regular medication as we intended to investigate 
the use of LEV as an adjunctive therapy. Clinical data from patients completing the study is 
shown in table 4-1. Mean patient age was 40.7 years and disease duration 7.3 years. 
The study design is illustrated in Fig 4-2; we chose a double blind, placebo controlled, 
crossover approach. Following recruitment, patients were randomized to one of two 
treatment groups.   
Each patient received a six week course of both LEV and placebo tablets, separated by a 
washout phase of 2 weeks. Dose was titrated up from 250mg BD to 1500mg BD or the 
maximum tolerated dose. Of the 10 patients who completed this schedule, only one (patient 
10) reported side effects, principally dizziness, limb weakness and exacerbation of fatigue. 
This resolved after a few days and the patient elected to continue with the trial. 
Consequently, all patients reported here achieved the full dose of 3000mg/day.  
A total of 10 patients were withdrawn from the trial (4 x adverse effects, 2 x inadequate 3-
8Hz tremor on first assessment, 2 x non compliance, 1 x infection, 1 x rapid progression of 
MS).  This is consistent with previous findings showing that patients with MS are more
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Patient   Age   Sex  MS type  Yrs since    Tremor type                                Medication 
                                       Δ 
1                 41          F           RR              13                Postural & Intention                  Rebif 22, Gabapentin     
2                 50          F           SP               13                Intention           Baclofen, Amantidine 
3                 33          F           RR              1                   Postural          Copaxone 
4                 41          M         SP                3                  Intention           Avonex 
5                 24          F           PP                9                 Postural & Intention        Mitoxantrone, Solifenacin,                 
                                                       Gabapentin, Tizanidine 
                                                                                                                          Co-codamol, Warfarin  
6                 26          F           RR              2                  Postural & Intention                  Gabapentin, Amitriptyline 
7                 60          M         PP               0.5              Postural & Intention                   Etoricoxib, Amlodipine,  
                                                                                                                           Fluoxetine 
8                 38          F           RR             11               Postural, Intention                       Natalizumab, Gabapentin,   
             & Orthostatic                              Baclofen, Citalopram   
 9                45          F           PP              1.5              Intention                                      Baclofen, Citalopram,    
                                                                                                                           Codeine, Gabapentin 
10              49          M           SP             19               Postural & Intention                    None 
 
RR, Relapsing Remitting; PP, Primary Progressive; SP, Secondary Progressive 
 
Table 4-1: Patient demographics are shown for the participants who completed the study. 
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Figure 4-2: Flow chart showing crossover trial design. 
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likely to experience adverse effects with antiepileptic medication (Solaro et al., 2005). 
Since the study design was placebo-controlled, there was no need to perform a balanced 
randomisation process; consequently following dropouts, data was analysed from 7 patients 
who initially received LEV and the remaining 3 commenced the trial with placebo 
treatment.  
 
Motion recordings 
Tremor is usually measured using an accelerometer; this measures the magnitude and 
direction of acceleration of an object which is particularly useful in the assessment of 
movement disorders since it is an objective measurement rather than the traditional 
subjective clinical scoring methods. Advancement in technology has led to very small and 
sensitive accelerometers that lend themselves well to measurement of human movements 
such as tremor and myoclonus. Triaxial piezoelectric accelerometers (Model 35A Isotron® 
accelerometer, Endevco) were attached to the finger and elbow of the limb under 
observation. Signals were amplified using an Endevco Isotron signal conditioner (Model 
2792B) to produce an overall sensitivity of 5mV/ms
-2
 and digitised using a Power1401 
(CED Ltd, Cambridge, UK) before being stored on a PC using Spike 2 software (sampling 
rate 1kHz). 
Arm movements were recorded using a 3D motion tracking system (Liberty, Polhemus 
Inc); four sensors were positioned on the arm to record movements. A teardrop sensor was 
placed on the index finger and three standard sensors were attached to the wrist, elbow and 
shoulder. The source was located in a fixed position on the task board; all experiments 
were performed within a 1 metre locus of this point. A custom written software interface 
(programmed in Borland Delphi 7) was used to collect data from the Polhemus system 
which was sampled at 240Hz. 
Surface EMGs were also recorded from an intrinsic hand muscle (FDI), 2 forearm muscles 
(FDS and EDC) and 2 upper arm muscles (triceps and biceps). 
 
Behavioural tasks 
To investigate postural tremor, patients were asked to hold a specific posture for a total of a 
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minute. This required arm extension in front of the body with the arm held at 90 degrees to 
the trunk. Patients were also required to perform whole arm reaching movements to assess 
kinetic tremor. Two small posts were mounted on a table at a distance of 30cm apart in the 
sagittal plane. On the top of each post was a light emitting diode (LED, 3mm diameter); 
these were illuminated alternately every 3 seconds. Patients were required to point at the lit 
LED. They were instructed not to touch the posts, support the limb with their other arm or 
rest their arm between trials. Approximately 30 trials (defined as a movement from the 
closest LED to the furthest, and back again) were completed at each assessment. Patient 5 
was not able to complete this task due to the severity of her kinetic tremor. 
 
Clinical assessments 
As a standard clinical assessment of tremor, patients were asked to complete a 9-hole peg 
test. Two of these pegboard tasks were used, one with small 6mm diameter pegs and one 
with larger 12mm pegs. The time taken for completion of the task was measured. 
Population data was averaged to test for significant changes in performance. 
A video recording was also taken during each session; this included footage of finger to 
nose pointing, rapidly alternating movements, walking and the pegboard tests. From these 
videos, an independent clinician scored the various elements of cerebellar tremor using a 
previously published 10 point visual analogue scale (Bain et al., 1993). Patients were also 
required to perform a self-assessment of their tremor using the same scale. 
 
Analysis 
Data analysis was performed using custom written programs in the MATLAB environment 
(Mathworks Inc). For postural tremor, the power spectrum was calculated from each axis 
of the elbow accelerometer recording. Spectral estimation used the whole 60 s recording, 
divided into 29 non-overlapping 2-second windows for Fourier analysis; this provided a 
frequency resolution of 0.5 Hz. The three spectra were summed, providing an estimate of 
the total acceleration power. Confidence limits on the spectral estimates were determined 
as in Press et al (1989).  
The tremor band of interest was selected as 2.5-10Hz, encompassing the known
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frequencies of cerebellar tremor (Elble and Koller, 1990). The area under the curve for 
each subject and visit was measured for this region; values were normalised as a percentage 
of the baseline assessment.  
The therapeutic effect of LEV, or the efficacy, was calculated across the population using 
the mean area under curve values from the data as: 
         
           ⁄
           ⁄
 
An efficacy value less than 1 would therefore indicate that LEV tended to reduce MS 
tremor. The significance of this difference between the effect of LEV and placebo was 
determined using a Monte Carlo method, involving randomly shuffling the data between 
drug and placebo classes and recomputing the difference. The rank of the experimentally 
observed difference amongst a large number of shuffles (10,000) was used to assign an 
approximate significance level.  
To determine whether there was a significant effect of LEV on MS tremor within 
individual subjects, Z-scores were calculated according to: 
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where AUC is the area under curve for the tremor frequency band and SD are the 
corresponding standard deviations. Z-scores less than -1.96 lie outside the 95% prediction 
interval and are therefore considered to reflect a significant effect of LEV on MS tremor.  
Deficits during movement were assessed using 3D motion tracking data from the wrist 
during pointing movements. The recording was first divided into individual pointing 
movements, using the times of illumination of each LED target as the onset and offset time 
of the movement segment. The three axes of finger position were low-pass filtered (20Hz 
cut-off), to remove measurement noise. The path length of the trajectory taken by the finger 
in travelling from the initial to final movement was then measured as: 
  ∑|  ⃗      ⃗ |
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where  ⃗  represents the three-dimensional vector of position measured at sample point i 
(i=1..N), and |  ⃗      ⃗ | represents the distance between positions measured at sample 
points i and i+1. The total distance moved by the finger was calculated as: 
  |  ⃗    ⃗ | 
The values of T and D were averaged across the approximately 60 pointing movements 
available, yielding average values  ̅ and  ̅. An index of movement impairment was 
calculated as    ̅  ̅   . If the finger trajectory followed a perfect straight line between 
the start and end points of each movement, T would equal D, and hence the index I would 
equal 0. Larger values of I indicate increasing deviation from a straight line path.  
The index I is affected by increases in finger path length due both to tremor, and also to 
hypermetria. Therefore the analysis was repeated, with the initial low-pass filter configured 
to remove all frequencies above 2 Hz. This smoothed out tremulous movements; the value 
of I was then sensitive mainly to dysmetria (Idys). The difference between this measurement 
and that made with the low-pass filter set to 20 Hz (Iall) was taken as an assessment of the 
impact of action tremor (Itremor). For each patient, measurements were normalised to those 
made during the baseline visit. 
LEV efficacy for MS action tremor was calculated as described previously. Again, 
significance was assigned using a Monte Carlo method. 
 
Results 
To determine which patients had significant postural tremor, clinical tremor scores were 
plotted against the sum tremor power between 3-7Hz (Fig. 4-3A). Patients who fell below 
the dotted line were considered not to have postural tremor and were therefore removed 
from the population analysis. This left 6 remaining patients. Figure 4-3B shows 
representative power spectra for one patient with severe MS tremor. In each plot, the dark 
grey line represents represents baseline data and the light grey corresponds to maximum 
treatment dose; 95% confidence limits are also shown. A clear peak in tremor is evident at 
approximately 3Hz, which is reduced following LEV (Fig. 4-3B: left) and returned to 
baseline level with placebo (Fig. 4-3B: right). In this patient there appears to be a 
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Figure 4-3: A, Postural tremor scores for all 10 patients plotted against the sum tremor 
power over the selected frequency range. Dotted line indicates the cut-off point below 
which patients were not deemed to have significant postural tremor. B, Postural tremor 
power spectra from patient 5. C: Efficacy histogram from Monte Carlo analysis. Study 
population efficacy is denoted by the red line and dotted lines represent the median and 
upper and lower quartile values. 
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measurable improvement in tremor following treatment with LEV, however this did not 
reach statistical significance (Z=-1.53). Taken individually, none of the six patients with 
postural tremor showed a significantly greater reduction in tremor with LEV than placebo 
(Z< -1.96). Population analysis focussed on the 6/10 patients with postural tremor. On 
average there was a significant reduction in postural tremor in these patients following 
LEV (Monte Carlo test, P=0.0251; Fig. 4-3 C). 
Example reaching movements re-constructed from Polhemus motion data (wrist sensor) are 
shown in Fig. 4-4B along with simultaneously recorded raw EMG and accelerometry data 
(Fig. 4-4 A). It is easy to see the complexity of these aberrant movements which comprise 
not only a rhythmic tremor, but also a profound ataxia. The high amplitude oscillations 
close to the targets result in a movement path which is significantly larger than the actual 
distance between targets. Consequently our analysis probed the length of the path travelled 
during each trial; depending on filter properties, this correlates to either a measure of 
tremor or dysmetria alone. Across the patient cohort, this method revealed no significant 
change in either dysmetria or cerebellar tremor (Fig 4-4 C); this was confirmed by a Monte 
Carlo analysis in each case (Fig 4-4D; Dysmetria: P=0.524; Tremor: P=0.580).  
Figure 4-5 shows the change in tremor scores as self-reported by patients (Fig. 4-5 A, B) 
and an independent clinician (Fig. 4-5 C, D). Neither shows any significant trend though it 
is perhaps worth noting that patients generally scored tremor as being more severe than an 
experienced clinician. In addition, the change in time taken to complete the 9-hole peg test 
(Fig. 4-5 E: large pegboard; Fig. 4-5 F: small pegboard) did not show any significant 
change over the course of the study.   
 
Discussion 
LEV is a good candidate for anti-tremor medication as it has a good safety profile, few side 
effects and does not interact with other commonly prescribed drugs. In general, LEV was 
well tolerated during our study, though where adverse effects were reported, they tended to 
involve exacerbation of MS symptoms.  
Postural tremor did not appear to be a significant problem in our patient cohort. Only 6
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Figure 4-4: A, Raw EMG and accelerometer data. Arrows denote LED illumination which 
cues movement; this occurred every 3 seconds. B, 3-D plot of one reaching movement; 
each colour denotes a different reaching direction. C, Boxplots of population data for 
treatment efficacy on tremor and dysmetria. D, Histograms of efficacy probability from 
Monte Carlo analysis carried out on both filtered datasets. Study population efficacy is 
denoted by the red line and dotted lines represent the median and upper and lower quartile 
values.  
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Figure 4-5: Change in patient self-reported scores for postural tremor (A) and intention 
tremor (B) of the limb under observation, averaged across all 10 patients. Tremor 
assessment taken from Bain et al., 1993; 0: no tremor, 1-3: mild, 4-6: moderate, 7-9: 
severe, 10: extremely severe. Clinician reported scores for postural (C) and intention (D) 
tremor. Pegboard completion times are shown in E (large pegboard) and F (small 
pegboard). Error bars represent standard error of the mean. 
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patients with postural tremor were identified and five of these were considered to be very 
mild. In this small group, Z-scores revealed no significant effect within individual patients 
however the effect of LEV on postural tremor was significant with the increased statistical 
power of averaging across the population. The clinical relevance of this is unclear however 
since there was no corresponding improvement in the tremor scores reported by either 
patients or the independent clinician. 
In contrast, this study was not able to demonstrate any significant effect on MS cerebellar 
intention tremor or dysmetria when averaged across the population. This is echoed in the 
subjective measures, judged by both patients and a clinical assessment, suggesting that this 
drug has, on average, no clinically significant effect on intention tremor or dysmetria 
across the whole patient cohort.  
One advantage of the use of quantitative measures such as accelerometry is that significant 
changes can be detected in tremor amplitude in a single patient, since power spectral 
estimates can be computed with their own confidence limits (e.g. Fig. 4-3B). In this study 
however, we did not find any significant benefit from LEV treatment within any individual 
which was surprising given positive findings from other reports in the literature (Mandler, 
2003; Striano et al., 2006). 
It may be that the effect of LEV is only very weak or perhaps only a subset of patients with 
MS tremor are likely to benefit from LEV. By its very nature, multiple sclerosis is a highly 
variable disease; in many cases, the complicated underlying pathology may confound any 
potentially beneficial effects of the drug.  
Previous studies have universally focussed on the population effect of LEV on MS tremor. 
Results have been conflicting; Striano et al (2006) found a positive effect in contrast to 
Solaro et al (2008) and Feys et al (2009). There are a number of potential reasons for these 
differences. Firstly, a wide variety of LEV doses were administered (between 1000-
4000mg/day). Low doses of the drug might explain the negative results found in two of the 
reports. In addition, there were differences in study design; a placebo control was not 
employed by Striano et al (2006) therefore a placebo effect cannot be ruled out in their 
case. Furthermore, the intrinsic variability of MS means that we cannot ever have a
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uniform population of patients; as such it is difficult to compare results between studies. 
In addition to the variability between studies, there are also many within-trial problems. 
During this experiment, there was a high dropout rate, in part due to adverse effects known 
to have an increased incidence in patients with MS (Solaro et al., 2005). There was also an 
issue of compliance; some patients failed to take the medication correctly or at all. It was 
also noted that factors other than tremor could affect patient performance, such as fatigue 
and depression. In my experience, patient self-reported scores were an unreliable measure 
of disability. Disease burden and in particular cognitive impairment often precludes the 
ability to attribute realistic, comparable scores on self-assessment. Anecdotally, scores 
were found to be sometimes a reflection of mood; often reflecting the severity of the MS in 
general, not specifically the tremor. Pegboard times could be similarly affected; in some 
cases, patients experiencing low mood were found to be perceptibly less motivated. 
Where subjective measures have obvious limitations, quantitative measures of movement 
should allow us to gauge precisely any changes in tremor over the course of a trial. 
However, during the course of this study some potential confounds were identified which 
could affect the sensitivity of this technique. One of the major problems is the natural 
variation of MS tremor. This fluctuated on a daily basis and could be affected by factors 
such as temperature, emotional states, fatigue and stress. Although acceleromtery is the 
conventional technique used for tremor measurement, these piezoelectric units are 
extremely sensitive and probably therefore inappropriate for this type of fluctuating tremor 
unless incorporated into a wearable device which could be used to monitor tremor over 
much longer periods of time. 
Similarly, the laboratory environment can initially be intimidating to many patients; the 
anxiety associated with this could easily result in transiently increased tremor on the 
baseline visit. It is difficult to control for this variation during an extended study and 
therefore important to consider that it may cause a false positive result. The recent 
introduction of an intravenous preparation of LEV might help reduce the variability in this 
type of study. However, any positive effect of LEV might be due to a cumulative effect 
which would only be visible in an extended trial.  
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Despite the difficulties experienced during this trial, 3/10 patients reported a subjective
improvement in their tremor and requested to continue taking LEV once the trial was 
completed. The results presented here suggest that LEV may have a weak beneficial effect 
for the alleviation of MS tremor however there are many caveats to be taken into 
consideration. Further extended studies with tremor quantification are necessary to 
elucidate the full therapeutic profile of LEV in relation to MS tremor.  
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CHAPTER V: TRANSCRANIAL MAGNETIC STIMULATION 
ACTIVATES NEURONS IN THE RETICULAR FORMATION AT 
SURPRISINGLY LONG LATENCIES. 
 
Transcranial magnetic stimulation (TMS) is a powerful tool for the non-invasive 
investigation of brain function. This technique has been popular in the neuroscience 
community since it’s advent in 1985, superceding transcranial electrical stimulation (TES) 
as a painless method of stimulating brain tissue. It was originally designed with the motor 
system in mind, but has since been applied to countless cortical areas for a variety of 
purposes. 
Over recent years, in vivo studies in macaques (Edgley et al., 1990; Edgley et al., 1997) and 
humans (Di Lazzaro et al., 1998; Houlden et al., 1999) have given us insight into the 
physiological mechanisms underlying the responses we see to TMS. Stimulation over the 
motor cortex gives rise to a series of repetitive discharges which can be observed from 
single cells within the corticospinal tract; these are considered either direct (D) or indirect 
(I) in nature. D-waves are characterized by their large amplitude and short, fixed latency. 
They arise from direct stimulation of corticospinal axons close to the cell body where 
action potentials are initiated. The same neurons are also excited trans-synaptically, 
generating much later I-waves. These tend to be smaller in amplitude and are typically 
much more variable temporally.  
In addition to the responses observed centrally, stimulation over the motor cortex also gives 
rise to peripheral motor evoked potentials (MEPs) which can be measured in the muscles. 
A rectified MEP is characterized by a bifid peak occurring at a fixed latency relative to the 
distance from the CNS.  
TMS is used extensively in basic science research, but it also has a role to play as an aid to 
clinical diagnosis and is implicated as a therapy in a range of neurological conditions (Chen 
et al., 2008). Twenty five years after its introduction, TMS equipment is now a common
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finding in neuroscience laboratories worldwide. As a consequence, there are now multiple 
companies competing in the market and pushing the limits of the technique. 
Despite the widespread use of TMS, its underlying effects on the brain are poorly 
understood. Most of our knowledge results from modelling studies and indirect measures in 
human subjects. Very few studies have directly examined neuronal responses to TMS and 
so the fundamental mechanism of how TMS works at a cellular level remains to be 
elucidated. 
The mechanism of TMS is based on Faraday’s principle of electromagnetic induction 
whereby a rapidly changing magnetic field induces an electrical current in a conductor. In 
this case, the brain acts as the conductor and current flow in cortical cells can cause local 
depolarisation. Optimal activation occurs when neurones are oriented parallel to the 
direction of the current. This makes pyramidal neurones originating in the primary motor 
cortex particularly susceptible to activation by TMS. 
The induced magnetic field falls off rapidly with distance from the coil (Pascual-Leone et 
al., 2002); this has traditionally restricted the technique to investigation of very superficial 
cortical structures. Conventional TMS coils are only able to induce an electric field up to 
an estimated 1.5cm beneath the skull surface (Bohning et al., 1997; Roth et al., 2007). 
However, deeper structures can be activated through a transynaptic pathway.  
 
Neuronal recordings during TMS 
Effects occurring local to the site of stimulation have historically been very difficult to 
record for technical reasons. In fact, there are very few reports at all which show either 
single-unit or LFP recordings from neurones anywhere in the brain during TMS. One series 
of studies has looked at the effects of TMS on single unit activity and LFPs in visual cortex 
in anaesthetised cats (Aydin-Abidin et al., 2006; Moliadze et al., 2003; Moliadze et al., 
2005). However, they were unable to look at the first 10ms following each stimulus 
because of the blanking effect of the artefact. Another group recently performed TMS in 
patients undergoing surgery to implant DBS electrodes for the treatment of severe 
Parkinson’s disease (Strafella et al., 2004). Again, this was not ideal because the tissue 
undergoing investigation could not be considered healthy. 
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A recent paper by Tischler and colleagues (2011) unveiled a new mini TMS coil (outside 
diameter: 26.5mm). The authors demonstrated in monkeys that this coil could provide focal 
stimulation with the same characteristics as the conventional ‘human’ TMS coils whilst 
also permitting simultaneous recording of underlying neural activity. This is an exciting 
development in the field which will open up the opportunity for directly investigating the 
underlying mechanism of TMS at a cellular level in healthy brains.  
 
TMS and the motor system 
TMS is frequently used to investigate the motor system both in healthy subjects and for 
diagnostic and therapeutic purposes in patients. The superficial location of the motor cortex 
on the anterior bank of the central sulcus lends itself to the technique. In general, the 
application is to investigate the function of the corticospinal tract (CST). TMS over the 
primary motor cortex (M1) elicits multiple volleys in the descending pyramidal tract (Di 
Lazzaro et al., 1998; Edgley et al., 1990; Edgley et al., 1997). Direct activation of 
corticospinal axons close to the cell bodies and indirect activation on the same neurons give 
rise to D and I-waves respectively. The D-wave is very precisely timed since the cell is 
excited by current directly, but I-waves are temporally dispersed and have a variable onset 
latency which depends largely on the location of activation. 
In the periphery the summation of these responses can be recorded as biphasic muscle 
potentials called motor evoked potentials (MEPs). These are usually recorded in the 
contralateral musculature since the corticospinal tract is predominantly a crossed pathway. 
Although MEPs are an indirect measure of CST function, they are largely consistent 
amongst individuals; this has helped establish their use for a variety of experimental and 
diagnostic purposes.  
The last decade has seen an explosion of interest in the field of repetitive TMS (rTMS). 
This involves rapid, repetitive discharge of the coil in place of the conventional single 
pulse stimulation. rTMS is proposed to either increase or decrease the excitability of 
cortical areas depending on the frequency of stimulation. Particular focus has been on using 
rTMS as a therapeutic intervention for patients with neurological disease. In general, 
results have been mixed but beneficial effects have been reported in stroke (Khedr et al., 
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2005), tinnitus (Rossi et al., 2007), depression (Berman et al., 2000) and Parkinson’s 
disease (Hamada et al., 2008). 
 
Ipsilateral motor evoked potentials (iMEPs)  
Ipsilateral EMG responses (iMEPs) to M1 stimulation have also been reported. These are 
easiest to observe in proximal and trunk muscles but some reports also show the presence 
of distal iMEPs (Wassermann et al., 1994; Ziemann et al., 1999). For most people, iMEPs 
tend to be small and highly variable; they also have a higher threshold than those for 
contralateral MEPs. Amplitude depends roughly linearly on size of contraction; indeed  
iMEPs are rarely seen at rest. Responses occur at a long latency; this can be 5-13 ms longer 
than for contralateral MEPs for distal muscles (Ziemann et al., 1999).  
The presence of iMEPs is not entirely surprising considering that anatomical studies have 
demonstrated that approximately 10% of CST neurons are uncrossed (Armand and 
Kuypers, 1980). However, the long response latency means iMEPs are unlikely to be due 
to stimulation of the slow uncrossed corticospinal tract fibres. This is also too long for 
simple spread of current to the opposite hemisphere. The prevailing view is that iMEPs 
arise via a corticobulbar projection. This notion is supported by evidence suggesting that 
finger & wrist extensors and also elbow flexors receive greater input from the 
reticulospinal tract (Peterson et al., 1979); these particular muscle groups have better, more 
consistent iMEPs. In addition, head rotation towards the side of stimulation is known to 
facilitate iMEPs. This is proposed to occur via neck muscle afferents which project to 
reticulospinal neurons in the brainstem (Ziemann et al., 1999).  
The proposed pathway underlying iMEPs is largely supported by patient data. Subjects 
who acquire brain damage such as stroke or MND commonly display iMEPs with a similar 
prolonged latency relative to contralateral MEPs (Benecke et al., 1991; Krampfl et al., 
2004; Netz et al., 1997; Turton et al., 1996). Ipsilateral MEPs are also more common in 
children under the age of 10 years (Muller et al., 1997) which corresponds with maturation 
of the CST as assessed by TMS (Koh and Eyre, 1988).  
Interestingly, there may also be a reticulospinal component to contralateral MEPs. A recent 
study has shown that two distinct responses to TMS can be observed in single unit 
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recordings from pectoralis muscles (Unpublished results; personal communication with 
Prof. J. Rothwell). An early response occurs contralateral to the stimulus at a latency of 
approximately 9ms. This is followed by a bilateral response around 10ms later, a delay 
which could correspond to corticoreticular activation of the reticulospinal tract.  
 
The Reticulospinal tract 
The reticulospinal tract (RST) is one of the major descending pathways through which the 
brain influences the spinal cord. It is present in all vertebrates yet it has largely been 
overlooked in primates in favour of the phylogenetically younger corticospinal tract (CST). 
Here, strong monosynaptic connections with spinal motoneurones control complicated, 
dextrous movements.  
Diffuse and widespread connections in the RST led to the thinking that it was responsible 
for co-ordination of gross proximal movements and posture and was not capable of 
selective movement of individual limbs or muscles. Experiments in lamprey (Deliagina et 
al., 2000), and cats (Drew et al., 1986; Perreault et al., 1993; Stapley and Drew, 2009) have 
demonstrated a role for RST in locomotion, postural control and gait adjustments; all can 
be considered global processes involving action across many muscles.  
More recently, Drew and Rossignol (Drew and Rossignol, 1990a; Drew and Rossignol, 
1990b)  demonstrated that a wide range of movements, often bilateral, could be elicited by 
PMRF microstimulation including reciprocal movements of the forelimbs. This suggested 
that the RST was capable of more selective movements and was not limited to global 
changes in muscle activity. 
In primates RST function is poorly understood. However, the importance of the brainstem 
motor pathways was highlighted in detail in the seminal work of Lawrence and Kuypers. 
Following complete bilateral lesion to the CST at the level of the medullary pyramids, 
monkeys recovered most motor function quickly with the exception of fractionated finger 
movements (Lawrence and Kuypers, 1965). This demonstrated that there was substantial 
redundancy in the motor system but suggested that brainstem pathways may not have the 
specificity and selectivity of connections to allow very fine, distal movements.  
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Recent work has challenged the dogmatic theory that the RST is solely responsible for the 
co-ordination of global movements for posture and locomotion. Modulation of 
reticulospinal activity during reaching movements has been demonstrated in cats (Schepens 
and Drew, 2004; Schepens and Drew, 2006) and primates (Buford and Davidson, 2004; 
Davidson and Buford, 2006; Davidson et al., 2007) although the cells encoded movement 
direction poorly.  
Riddle et al (2009) carried out intracellular recordings from motoneurones in macaque 
monkeys and found both monosynaptic and disynaptic connections from the medial 
longitudinal fasciculus (MLF) projecting to hand muscles. In their yield of cells, they 
observed just as many projections to distal muscles as to proximal. Moreover in a second 
paper, Riddle et al (2010) showed that there was convergence of CST and RST axons onto 
the same spinal interneurones. Monosynaptic RST projections to distal muscles were 
certainly weaker than those from the CST but nevertheless are present. This lends weight to 
the argument that the RST forms a parallel system of descending control alongside the 
CST. 
A further study from our laboratory has demonstrated that there are functional changes in 
the RST following unilateral lesion of the pyramidal tract (Zaaimi et al., Submitted). 
Stimulation of the MLF during intracellular recording of cervical motoneurones revealed 
strengthening of both monosynaptic and disynaptic RST connections, specifically to 
neurons supplying the forearm flexors and intrinsic hand muscles. This finding 
demonstrates that the connections are in place so that plasticity in the parallel system is 
capable of restoring motor function.  
 
Anatomy of the RST 
The origin of the reticulospinal tract is the pontomedullary reticular formation (PMRF) 
which constitutes the medial brainstem region. Anatomical and electrophysiological 
evidence has shown that there are two distinct arms to the RST which originate in the 
PMRF. The lateral portion arises mostly from the gigantocellular reticular nucleus (Gi) 
(Peterson et al., 1975) and projects bilaterally in the ventrolateral funiculus. Although 
projections extend the length of the spinal cord, terminations are predominantly in cervical 
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regions within laminae V-IX.   
The medial RST arises mainly in the caudal pontine reticular nucleus (PnC) or oral pontine 
reticular nucleus (PnO; and to a lesser extent from the dorsal region of Gi). This descends 
ipsilaterally in the medial longitudinal fasciculus (MLF) in the caudal brainstem, 
continuing through the ventromedial funiculus in the spinal cord. Termination of medial 
RST fibres occurs in laminae VI-IX at all levels of the spinal cord (Nyberg-Hansen, 1965).  
 
Pontomedullary reticular formation (PMRF) 
At first glance, the PMRF is a relatively diffuse and unorganised collection of neurons in 
the medial brainstem. On the basis of this, the RST was long thought to be incapable of 
control of individual muscles or limbs; instead the anatomy suggested it could only 
subserve global control of relatively gross movements. However anatomical and 
electrophysiological evidence across species has subsequently shown the PMRF to consist 
of a number of interconnected yet highly distinct nuclei (Newman, 1985; Paxinos and 
Huang, 2000; Sakai et al., 2009; Valverde, 1962). 
A parasagittal cross-section through PMRF is shown in Fig. 5-1B; this illustrates the 
elaborately complex network of nuclei present within primate PMRF. Distinct boundaries 
between nuclei can be difficult to identify both on the basis of cytoarchitecture and 
electrophysiology and it is clear that the areas overlap to some extent. There is also a high 
level of interconnectivity between nuclei; reticular neurons are highly collateralised and 
project to neighbouring areas (Ito and McCarley, 1987; Matsuyama et al., 1993; McCarley 
et al., 1987; Shammah-Lagnado et al., 1987). 
There is a wide distribution of cell types across PMRF but most distinct are the giant cells 
which are primarily localised within Gi. This is the largest nucleus in the medial brainstem 
region occupying two thirds of the space. Aside from the giant cells, there are also a range 
of smaller cell types, both multipolar and fusiform in shape which become increasingly 
common in rostral areas. Rostral to Gi are two other major nuclei: PnC and PnO. Small and 
medium sized cells dominate these regions although a sparse population of giant cells are 
also found. Reticulospinal cells have been shown to be widely distributed throughout Gi,
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Figure 5-1: A: Schematic representation of the the corticospinal and reticulospinal 
descending motor pathways in primates. Note the direct, bilateral input from primary motor 
areas to the PMRF. Adapted from Brinkman and Kuypers (1973). B: Parasagittal section 
through PMRF in the macaque showing the major nuclei. From Sakai and Buford (2009).    
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PnC and PnO although there is a caudo-rostral hierarchy of frequency in primates; Sakai 
and Buford (2009) found there to be a ten-fold decrease in labelling of cells projecting to 
the RST from Gi to PnC.  
The PMRF is a phylogenetically old part of the brain which is crucial for many lower 
species. As a consequence the reticular formation has a myriad of functions, only one of 
which is sensorimotor control. In fact, most useful information about the body is relayed 
via the PMRF. This coupled with the high interconnectivity both within the brainstem and 
with cortex and spinal cord means that the PMRF has a role in many basic and high level 
physiological functions including control of autonomic functions, consciousness and gating 
of sensory information.  
 
Inputs to PMRF 
PMRF receives an assortment of input from many cortical and subcortical areas as well as 
the spinal cord; in fact on the basis of its high interconnectivity, the PMRF is ideally placed 
simultaneously to filter ascending sensory information and review descending motor 
information.  
Sensory inputs arrive from both central and peripheral sources. Ascending information 
carried in the spinal cord is relayed to PMRF via spinoreticular afferents (Rossi and Brodal, 
1957) along with collaterals from other ascending sensory pathways. In addition, PMRF 
also receives input from central relays concerning all of our senses; considerable input 
comes from areas including the frontal eye fields (Stanton et al., 1988), superior colliculus 
(May, 2006), the cochlea (Irvine and Jackson, 1983; Lingenhohl and Friauf, 1992) and the 
vestibular system (Carleton and Carpenter, 1983; Matesz et al., 2002; Peterson and Abzug, 
1975). 
Corticoreticular fibres arising from pericruciate cortex relay descending motor programs to 
the brainstem. These fibres largely originate in areas 4 and 6, and traverse the internal 
capsule to reach the brainstem (Jinnai, 1984; Kably and Drew, 1998a; Matsuyama and 
Drew, 1997; Pilyavsky and Gokin, 1978; Rho et al., 1997). Corticoreticular neurons 
terminate bilaterally in PMRF (Berrevoets and Kuypers, 1975; Matsuyama et al., 2004; 
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Rossi and Brodal, 1956). Some are collaterals of CST neurons and have been proposed to 
modify posture during movement (Kably and Drew, 1998b). 
In addition to the sensorimotor inputs to PMRF, afferent connections also include the 
cerebellum, inferior olive, frontal cortex and the limbic system. 
 
Projections from PMRF 
Ascending fibres from the PMRF project to multiple areas including the thalamus, 
hypothalamus, the preoptic area, basal ganglia and cortex. These projections usually arise 
from the most caudal regions of Gi, overlapping with the origin of reticulospinal neurones. 
The most recognised efferent projection comprises the reticular activating system which is 
critical for the maintenance and regulation of consciousness and attention. 
Descending fibres from the PMRF form the reticulospinal tract. In broad terms, the RST 
projects bilaterally, sending axons out from the PMRF to motoneurones innervating both 
ipsilateral and contralateral musculature. RST axons are highly collateralised (Matsuyama 
et al., 1993; Matsuyama et al., 1999), much more so than those seen in the CST. Individual 
neurons therefore have the ability to activate motoneurones at multiple levels of the spinal 
cord. This widespread recruitment of motoneurones allows the RST a greater range of 
muscles over which it has influence at one time. 
Both ascending and descending fibres are highly collateralised and there are widespread 
reticulo-reticular connections between neighbouring PMRF nuclei allowing for intra-
reticular communication (Kably and Drew, 1998).  
 
Aims/outline 
In light of the recent surge of interest in the role of the reticulospinal tract in the control of 
hand movements in humans, it is pertinent to determine whether the reticular formation can 
be activated using a non-invasive method. Therefore during this series of experiments, the 
aim is to understand the effects of TMS over M1 on the PMRF and elucidate the pathways 
involved.  
It is well known that TMS has transynaptic effects that are distant to the site of stimulation; 
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an MEP for example is a potential recorded in muscle which arises from activation of 
motor cortical cells. It is also known that primary motor cortex has very strong connections 
with the pontomedullary reticular formation and so it is reasonable to expect to see 
responses to TMS at a short latency because of the fast conduction speeds of these fibres. 
 
Methods 
All animal procedures were carried out in accordance with UK Home Office regulations 
(Animals in Scientific Procedures Act, 1986) and approved by the local research ethics 
committee of Newcastle University.   
Experiments were performed in 3 adult female terminally anaesthetised rhesus macaques: P 
(14years, 9.47kg), U (15 years, 10.52kg), V (15 years, 8.43kg).  
 
Surgical preparation 
Initial surgical procedures were performed under deep general anaesthesia using 
sevoflurane (3-5% in 100% O2) and alfentanil (7-23µg/kg/hr). Methylprednisolone 
(5.4mg/kg/hr) was also infused throughout to reduce intracranial swelling. All animals 
underwent a laminectomy which exposed spinal segments C5-T1. A craniotomy window 
was also created extending 5-8mm bilaterally from midline over the occiput. The dura was 
removed and a pool was created around the recording site and filled with paraffin oil to 
prevent drying of the exposed tissue. A tracheotomy was performed to allow artificial 
ventilation. Body temperature was maintained with an underbody heating blanket and an 
intraoperative heating blanket. Urinary catheterisation allowed drainage of fluids. 
Following surgery, the anaesthesia schedule was switched to a Propofol (5-14mg/ kg/ hr) 
and alfentanil (7-23µg/kg/hr) infusion. The vertebral column was clamped at the high 
thoracic and midlumbar levels and the head was fixed in a stereotaxic frame, angled to give 
a 71 degree flexion of the neck. To prevent the metal ear and eye bars interfering with the 
TMS, we substituted them with plastic rods anchored to the head with dental acrylic; this 
was done once all measurements had been made just prior to recording. Neuromuscular 
blockade was achieved with atracuronium (0.7mg/kg/hr). Bilateral pneumothorax 
minimized respiratory movements. Continuous monitoring of physiological measures was 
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Figure 5-2: A: Schematic of the experimental set-up showing the position of the monkey 
in the spinal and stereotaxic frames as well as the drive penetration angle. B: Relative size 
of the TMS coils to monkey and human heads.  
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performed throughout the experiment to facilitate the maintenance of a deep, stable 
anaesthesia (arterial and venous blood pressure, oxygen saturation, heart rate, end-tidal 
CO2 as well as core and peripheral temperature). 
TMS target sites were marked on the scalp using stereotaxic measurements (before removal 
of ear bars). The main targets were left and right primary motor cortex (M1) which are 
located at A13, L/R 18. 
  
Reticular formation recordings 
Recordings were made using a 16 channel Eckhorn microdrive (Thomas Recording GmbH) 
(Eckhorn and Thomas, 1993) which was mounted on an arch angled between 30-40° (Fig. 
5-2A). Guide tubes were organised in a 4x4 array with 500µm spacing. The total span of 
the array was therefore 1.5mm square. Electrodes within the array could be moved 
independently. Recording from neurons in the PMRF utilised tetrodes in 2 of the 3 
monkeys in order to optimise the recording area and signal to noise ratio. 
A double small 25mm TMS coil was mounted on a cross-bar of the stereotaxic frame using 
a Kopf manipulator for accurate positioning (see Fig. 5-2B: relative size of coil to monkey 
and human head). Due to the length of the experiment, the coil was prone to overheating 
and so was cooled using ice packs. 
Stimulating electrodes were placed in the medial and lateral spinal cord between the C4/C5 
vertebrae to target the reticulospinal tract. Stimulation was performed pair-wise between 
spinal electrodes and was triggered at specific intervals following a spontaneous spike in 
the PMRF. Cells were classified simply as either ‘reticulospinal’ (those that responded 
antidromically to spinal stimulation) or ‘unidentified’ (those that either were not 
spontaneously active or did not respond to spinal stimulation). In addition, there was also a 
silver ball electrode placed on the cord dorsum to record surface volleys of the spinal cord.  
Spikes were continuously sampled at 25k via a National Instruments data acquisition card. 
Filters were 300Hz-10kHz. Gains were set at 10k for most recordings but were reduced 
where appropriate to avoid signal clipping. Stimulus markers were captured along with the 
data. 
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Protocol 
A target site within PMRF was identified and the guide tubes were inserted a few 
millimetres into the tissue overlying this region. Electrodes were then individually driven 
into the brain.  A 1Hz spinal cord stimulus was applied during this stage to check for 
antidromic field potentials which would indicate a region projecting to the reticulospinal 
tract. Once in the right area, the stimulus was changed to TMS in order to find cells which 
responded. 
Following identification of a set of cells, TMS was delivered at 0.2Hz over primary motor 
cortex at a range of intensities. If the cells were stable, the coil was carefully moved to the 
opposite hemisphere since we know that reticular formation receives bilateral 
corticoreticular projections. The coil was positioned tangentially to the scalp with an 
orientation 45 degrees to the midsagittal axis. Current therefore flowed in an anteromedial 
direction in the brain; this is the conventional orientation used in human studies since it is 
optimal to elicit contralateral MEPs.   
To investigate the origin of responses to TMS, a series of control experiments were 
performed. In all cases, an initial intensity series dataset of responses to TMS over M1 
were collected. Then, the coil was gradually and precisely lifted off the head a millimetre at 
a time using the manipulator; responses to TMS were recorded throughout. When the 
response disappeared, a 6.35mm thick plastic disc was placed between the coil and the 
head to allow the click elicited when the stimulator discharged to be more effectively 
transmitted to the skull. Finally, a bone vibrator was used (B71, Radioear) over the M1 site 
as well as each mastoid process. The stimulus consisted of a 0.1ms square wave click with 
variable gain. Intensity was determined via a power amplifier (TPA 50, HH Electronics) 
which generated pulses of up to 50V.  
Following successful penetrations, marker lesions were made by passing current at 100µA 
for 20 seconds (electrode negative) through relevant electrodes in the Eckhorn drive.  
At the end of the experiment, anaesthesia was increased to a lethal level and the animals 
were perfused through the heart with a phosphate buffered saline solution followed by 4% 
paraformaldehyde. Relevant brain and spinal cord areas were removed and placed in a 
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series of ascending concentrations of sucrose (10% ,20%, 30%) solution for cryoprotection. 
The brainstem and spinal cord were subsequently sectioned at 50 µm using a freezing 
microtome. Sections were then mounted and stained with cresyl violet to enable 
reconstruction of penetrations. 
 
Analysis 
Spike discrimination was performed using custom written clustering software (GetSpike; 
Prof. SN Baker). Prior to this, the stimulus artefact was removed by fitting response sweeps 
to a double exponential function and subtracting this from the recording; this allowed 
visualisation of the first 2ms post-stimulus. Any mains noise on the recordings was also 
removed at this stage using an algorithm which removed phase-locked 50Hz. Only single 
units which had consistent waveforms and no interspike intervals <1ms were used. 
Matlab programs provided the detailed analysis. Spikes were first aligned to stimulus onset 
and raster plots and peri stimulus time histograms (PSTH) were generated. 
A population response probability plot was generated to allow us to determine the different 
responses to TMS. Time windows were identified for 3 different responses: 1-3ms, 3-7ms 
and 7-25ms. To confirm that the correct response groups had been selected, response jitter 
in each window was calculated. This was done by collating the time to first spike for all 
responding cells tested with 100% TMS intensity. Jitter was then calculated as the standard 
deviation of these values.  
The cell population was classified according to whether significant responses were present 
in each time window. Significance was calculated by comparing the number of spikes 
occurring in the response window to an estimation of the count expected to occur in that 
window. This was done based on a Poisson process by calculating the mean number of 
spikes occurring at baseline to find the probability distribution of spikes occurring in each 
time window. 
We chose to apply a Bonferroni correction to the statistical analysis to give a conservative 
measure of significance. This was performed to correct for 8 comparisons, since usually 
~10 stimulus intensities were tested. Reduction of the significance level to P<0.005 was
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Figure 5-3: Epidural responses to ascending intensities of TMS are shown from monkey P. 
These were recorded using a ball electrode on the surface of the spinal cord between the C4 
and C5 vertebrae. Stimulus onset is marked with a dashed black line whilst the direct and 
indirect responses are shown within the dashed red lines. Green circles denote probable 
white matter activation. 
  
 116 
 
required to minimise the chance occurrence of false positives.  
Unpaired t-tests were used for comparison of threshold values between the different 
response groups.  
 
Results 
Epidural spinal volleys were recorded through two ball electrodes placed between the 
C4/C5 vertebrae. An intensity series revealed the threshold for a spinal volley in each 
animal (Fig. 5-3; P=30%, U=35%, V=30%). D-waves were observed at ~1.5ms and small 
I1 waves at ~4ms could be seen at high intensities. There was also an early deflection at the 
highest intensities which probably reflects white matter activation; this was reported by 
Edgely et al. (1990) following high intensity electrical stimulation.  
Recordings were made from 210 cells in the macaque PMRF; all cells were within the 
gigantocellular reticular nucleus (Gi). An anatomical reconstruction is shown for the total 
cell population across all animals in figure 5-6. Previous studies have shown multiple 
subdivisions within Gi but we were not able to achieve this level of detail.   
Example raster plots showing individual cell responses to TMS are shown in figure 5-4. 
Most of these comprise an increase in firing rate but there was also a group of cells that 
responded to TMS with suppression (example raster shown in Fig. 5-4D). Here, responses 
can be seen occurring very late (after 25ms); this may represent the rebound of activity 
following cessation of firing. Given the difficulty in accurately measuring suppression 
(Aertsen and Gerstein, 1985), this particular group have not been included in the analysis. 
Powerful responses to TMS over M1 were observed in many cells within PMRF; these are 
summarised in figure 5-5. Responses fell into 3 main categories according to latency (Fig. 
5-8); these were either early (1-3ms or 3-7ms onset) or late (7-25ms). Sometimes these 
responses were observed exclusively but often they could be seen in combination.  
The number of cells showing a significant increase in firing (P<0.005) during these 
windows was 51 (24%), 58 (28%) and 84 (40%) respectively. Cells ipsilateral and 
contralateral to the stimulation site were initially pooled as there were no differences in 
response characteristics; moreover we know that PMRF receives bilateral input from motor 
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Figure 5-4: Example raster plots of cells responding early (A), late (B), both early and late 
(C) and a cell that shows suppression of firing following TMS (D). Red line denotes 
stimulus onset.   
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Figure 5-5: A: Plot of response probability for all cells across the population which 
respond to TMS. Each horizontal bar represents a stimulus intensity at which there is a 
response. The dotted red line denotes stimulus onset and the calibration bar indicates the 
probability per 1ms bin. The corresponding latency histogram is also shown. Individual 
response probability plots and latency histograms are also shown for each animal (B: 
monkey P, C: monkey V, D: monkey U). 
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Figure 5-6: Parasagittal sections through the brainstem showing the recording sites and the 
cells responding between 1-3ms (A), 3-7ms (B) and 7-26ms (C). Red triangles are cells that 
showed a late response to TMS; those outlined in green indicate identified RST cells. Black 
circles indicate cells that did not show a late response to TMS at the intensities tested; those 
outlined in green are RST identified cells. Some cells were moved to enable all recording 
sites to be seen; movement was always less than 0.5mm. Gi=gigantocellular reticular 
nucleus, Cu=cuneate, IO=inferior olive, PnC=caudal pontine reticular nucleus, 
6N=abducens nucleus.  
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cortex. Collision of spontaneous spikes with antidromic spikes elicited by spinal cord 
stimulation (pair-wise stimulation through electrodes in the medial and lateral spinal cord) 
revealed that 8 cells out of the total population could be identified as reticulospinal 
(example collision shown in figure 5-7). Of these, 2 cells showed an early response and 3 
showed responses within the later window (one cell responded with both).  
Response jitter versus mean onset latency is shown in figure 5-8. There is a very strong 
correlation between these two variables. Jitter increased markedly with later responses; 
there were 3 clear groups within the data which confirms the classification of responses.  
Mean thresholds were 71%MSO for the earliest response, 68%MSO for the second 
response and 55%MSO for the late response (Fig. 5-9). In each case there was no 
significant difference between contralateral and ipsilateral TMS.  The two earliest 
responses show no significant difference between their thresholds but the late response was 
significantly different from both  (P<10
-4
). 
The mean number of late spikes evoked per stimulus is plotted for all responding cells 
versus TMS intensity in figure 5-10. For the majority of cells, the response to TMS was by 
nature all or nothing; the number of spikes did not change with increasing stimulus 
intensity. However, in some cases, more spikes were recruited with increasing stimulus 
intensity which leads to strong bursts of spikes at the highest levels.  
Sound appears to be important in the generation of the late response to TMS since it often 
persisted when the coil was lifted off the head (Fig. 5-11B). Since the magnetic field is 
known to fall off very rapidly with distance (Pascual-Leone et al., 2002), such a strong 
response to TMS would not be expected at low output intensities. Moreover, there were 
sometimes late responses in PMRF at intensities below the threshold for a spinal volley 
(Fig 5-9).  
Where the response disappeared as the coil was lifted from the head, a piece of plastic 
(thickness=6.35mm) was sometimes inserted underneath the coil. This renewed contact 
between the head and coil; as a result the response often returned with the same features 
(Fig. 5-12). In this instance, simple activation of cutaneous receptors could be sufficient to 
activate the PMRF which is known to receive substantial sensory input. However, the
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Figure 5-7: A: Schematic showing the principle of antidromic identification of a 
reticulospinal neuron. A spontaneous spike (a) generated within the PMRF triggers 
stimulation of the spinal cord (b) within a given interval. This antidromic spike travels up 
the axon and will collide out the spontaneous orthodromic spike when appropriately timed 
so that no response is observed at the recording site. Failure to collide would lead to the 
presence of a spike within the PMRF. B: Successful collision of a spontaneous spike from a 
neuron within PMRF with an antidromic volley from the spinal cord at an interval of 1.3ms 
(bottom) but not at 1.4ms (top). 
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Figure 5-8: Scatter plot of response jitter against latency. Each circle describes the 
response observed in one cell. The response windows are separated according to colour: 
green=early (n=25); blue=second response (n=42); red=late response (n=64). 
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Figure 5-9: Histograms of response thresholds of cells with a response onset between 1-
3ms (A), 3-7ms (B) and 7-25ms (C). Responses in each latency window are divided into 
cells contralateral (D, E, F) and ipsilateral (G, H, I) to the stimulus. In each plot, ‘n’ 
indicates the number of cells responding. Arrows indicate the threshold for a spinal volley 
in each of the 3 animals (P=30%, V=30%, U=35%). 
 124 
 
responses observed did not appear to arise from activation of sensory pathways since 
electrical stimulation of the scalp in a small number of cells (n=3) did not have the same 
effect.  
PMRF responses to TMS often persisted when the coil was not in contact with the head and 
in many cases could be enhanced when contact was renewed with a piece of plastic. This 
does not appear to simply be a result of sensory input and therefore it is likely that sound 
plays an important role. Similar responses to air and bone conducted sound have been 
shown in the vestibular system (Colebatch et al., 1994; Curthoys and Vulovic, 2010; 
McCue and Guinan, 1997) which is known to project strongly to the PMRF (Peterson and 
Abzug, 1975). A common non-invasive method to probe the integrity of this system in 
humans is to use a click stimulus. Brief pulses of sound delivered through headphones or 
via bone tappers are capable of activating the vestibular nerve and nucleus and 
consequently the vestibulospinal tract. This results in myogenic potentials which can be 
recorded in neck muscles. 
Twelve cells responding late to TMS were therefore tested with a click stimulus as 
described by Colebatch et al (1994). Seven of these cells responded to the stimulus within 
the same latency range as they did to TMS. An example cell which responded to both TMS 
and bone vibration is shown in figure 5-13. The response latency and number of spikes 
elicited per stimulus were strikingly similar. Moreover, the cell was extremely sensitive to 
bone vibration, responding down to the minimum intensity tested. It is clear that both 
stimuli are capable of strongly activating cells within the PMRF. Moreover, the similar 
response latency suggests that there may be an overlap in the underlying pathway.  
 
Discussion 
The observation of strong responses to TMS in the PMRF is a novel one. It is clear that the 
early and late responses are mediated by different pathways. Not only is there a clear divide 
in the onset latency, response thresholds were also significantly different; thresholds were 
71%, 68% and 55% for the three responses respectively (P<0.005; see Fig. 5-9). In 
addition, whereas early responses tended to be a tightly time-locked single spike, later 
responses were more variable. Often these consisted of bursts of spikes and sometimes the 
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Figure 5-10: Scatter plots showing the number of spikes per stimulus for each cell that 
responds at a given intensity. Each plot represents a different response group: A: 1-3ms; B: 
3-7ms; C: 7-25ms. Red lines show the mean values. 
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Figure 5-11: A: Raster plot showing responses from a cell in the right PMRF during TMS 
over contralateral motor cortex. Note that the responses persist even at the lowest 
intensities. B: Raster plot showing responses from a different cell (left RF; TMS to 
contralateral M1) during a sham stimulation protocol during which the coil was positioned 
1cm above the head. 
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Figure 5-12: Raster plot showing spikes occurring in response to TMS over right motor 
cortex from a cell recorded within the contralateral PMRF. The coil was raised off the head 
by the designated amounts to test whether sound was important for the generation of the 
response. At the end, a plastic disc (6.35mm thickness) was placed between the coil and the 
head.  
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Figure 5-13: Data are shown from a single cell which was tested with both TMS and bone 
vibration. A: Spike responses to individual TMS stimuli over right motor cortex at 
60%MSO. B: Raster plot showing the full intensity profile of responses to TMS. C: Spike 
responses from the same cell to bone vibration stimuli under the coil. D: Raster plot 
showing response profile to bone vibration stimuli over the intensity series.  
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onset latency changed with increasing intensity (see Fig. 5-4C). In line with this, jitter 
increased with response latency. 
During this experiment, only a small number of reticulospinal cells were identified due to 
the lack of spontaneous firing under anaesthesia (and the intraspinal electrodes were not 
available for technical reasons during monkey V’s experiment). However, the anatomical 
reconstructions suggest that recordings were from a broad area of the medial brainstem 
region, mostly in the gigantocellular reticular nucleus. Anatomical tracer and 
electrophysiological studies in cats and monkeys have shown that the majority of 
descending fibres to both the medial and lateral RSTs originate here (Holstege and 
Kuypers, 1982; Peterson et al., 1975; Sakai et al., 2009; Torvik and Brodal, 1957).  
 
Early response 1: a corticoreticular projection 
The earliest response observed within PMRF was always a single spike response which 
was very tightly time locked to the stimulus. There was almost no jitter (0.32ms) indicating 
a fast conducting, direct pathway. The most likely candidate for this pathway is the 
corticoreticular projection. This system is very well understood in the cat where there are 
two separate groups of pericruciate neurons which project to the medial brainstem and are 
classified by conduction velocity. The fastest fibres relay M1 activity to cat reticulospinal 
neurones between 1.2-2.7ms. For slower corticoreticular neurones, this drops to 2.9-6.8ms 
(Pilyavsky and Gokin, 1978). During the experiment reported here, the earliest response 
onset latencies were 1.2-3.24ms with a mean of 2.49ms for the population; this is therefore 
consistent with a fast corticoreticular pathway. 
Corticoreticular fibres terminate widely throughout the PMRF (Kably and Drew, 1998a; 
Matsuyama and Drew, 1997). Although there is a weak ipsilateral preference, these 
projections are frequently bilateral (Kably and Drew, 1998a). Responses to TMS were 
found throughout the gigantocellular reticular nucleus both ipsilateral and contralateral to 
the site of stimulation. Although there was a contralateral bias, this was only because many 
more contralateral cells were tested. 
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Early response 2 
The second response which occurred at short latency typically comprised 1-2 spikes and 
showed much more variability than the earliest response (Fig 5-8, 5-10). This suggests an 
indirect pathway which occurs via more than one synapse. There are a number of different 
possibilities for the pathway mediating this response. 
The mean onset latency for the second response was 4.65ms, roughly 2ms after the early 
corticoreticular response. It is entirely possible therefore that this response could also be 
mediated by input from pericruciate fibres since the latencies fall within the range shown 
by slow corticoreticular neurones. Perhaps therefore this second response could just be a 
slower, second corticoreticular response. This certainly could be the case in cells which 
have very low jitter in terms of the response spike distribution. The observation of higher 
jitter for this response could also simply result from dispersion in the slow corticoreticular 
pathway.  
Another obvious candidate would be local reticulo-reticular activation of PMRF cells. 
Electrophysiological studies have repeatedly demonstrated that nuclei within the PMRF are 
highly interconnected both within hemisphere and between hemispheres (Ito and 
McCarley, 1987; Matsuyama et al., 1993; McCarley et al., 1987; Shammah-Lagnado et al., 
1987). This observation of high interconnectivity and heavily collateralised neurones has 
been ascribed to facilitate a role for PMRF in the control of co-ordinated movements. 
Monosynaptic postsynaptic potentials were found in almost all cells recorded in PMRF 
during one study of microstimulation within cat brainstem (Ito and McCarley, 1987; 
McCarley et al., 1987). Moreover, the response latencies were 0.6-2ms which is consistent 
with the second response occurring just a few milliseconds after the first. The addition of 
an extra synapse with a reticulo-reticular projection would account for the small variability 
in onset latency and jitter.  
An alternative and attractive hypothesis would be collateral input relaying late CST 
activation to the brainstem. Epidural recordings in both animals and humans have 
demonstrated clearly that TMS elicits multiple descending volleys in the spinal cord (Di 
Lazzaro et al., 1998; Edgley et al., 1997). Indirect activation of CST neurons in particular 
causes a dispersed succession of late volleys or I-waves. In primates, the first I-wave 
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occurs approximately 2.5ms after the D-wave (Edgley et al., 1997). It is reasonable to 
believe therefore that collaterals of descending CST axons could relay this information to 
PMRF within the time window of the second response.  
 
Pathway for long latency response to TMS  
The origin of the late response is much more difficult to determine. The mean onset latency 
was 15ms although a very broad range were observed (minimum: 5.9ms; maximum: 
30.7ms). PMRF receives projections from a broad range of cortical and subcortical areas 
and the timing is such that multiple synapses could be involved.  
Given the strong sensory input to the reticular formation via cutaneous afferents, simple 
contact of the coil with the scalp could be sufficient to activate cells in the PMRF. The 
observation of strong responses which persisted when the coil was lifted above the head 
would not support this notion (Fig. 5-11, 5-12). Moreover, electrical stimulation of the 
scalp did not generate any responses in a subset of cells tested (n=3). 
Many different pathways were considered on the basis of all the different inputs to PMRF. 
Firstly, the possibility of a relay via dentate nucleus was investigated since we know there 
is a strong projection from here to the PMRF (Bantli and Bloedel, 1975). However, 
substantial mapping of the deep cerebellar nuclei in one monkey revealed no responses to 
TMS in this region.   
Secondly, the role of sound in the generation of the late response was investigated. This 
appears to be important and it would therefore be careless to discount the auditory system 
as a candidate pathway. Indeed this would seem to be the simplest and most obvious 
choice. Interestingly, PMRF responses to acoustic stimuli have previously been shown to 
occur at latencies between 10-30ms (Irvine and Jackson, 1983). Moreover, sound has also 
been shown to be very important in the PMRF which is a critical relay in the acoustic 
startle circuit (Davis et al., 1982a; Leitner et al., 1980). Damage to the caudal pontine 
reticular nucleus (PnC) has been shown to abolish the acoustic startle reflex (Davis et al., 
1982a) and Kuhn et al., (2004) showed that contralateral biceps MEPs were inhibited when
TMS was delivered 30-60ms after a startling stimulus. The inhibitory pathway is unclear 
but these findings demonstrate a strong influence of PMRF on motor output.   
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The sound generated by discharge of the TMS coil could influence PMRF cells in one of 
two main ways; it could either be transmitted to the brainstem via the cochlea or via the 
vestibular system. If the cochlea was implicated in the pathway, obstructing the ear canal 
should prevent or reduce the sound waves being transmitted to the inner ear. This was 
attempted by recording from a small number of responding cells whilst ear bars were 
inserted or the pinna were covered, however there was not sufficient data to make any 
inferences as to whether transmission of sound via the cochlea is of primary importance. It 
is worth noting however that the acoustic startle reflex mediated via the cochlea habituates 
very rapidly (Brown et al., 1991; Davis et al., 1982b) whereas we were able to record 
PMRF responses to TMS consistently for the duration of our recordings (up to 30 minutes). 
The vestibular system is also capable of transmitting information to the brainstem about 
sound. Both air and bone conducted sounds are known to activate vestibular afferents 
(Curthoys and Vulovic, 2010; McCue and Guinan, 1997). Activation of the vestibulospinal 
system in this way produces a short latency myogenic response which can be measured in 
neck muscles – the vestibular evoked myogenic potential (VEMP). VEMPs can be 
observed even in the presence of complete sensorineural deafness confirming that the 
response pathway is completely independent of the cochlea (Colebatch et al., 1994). The 
stimulus conventionally used to elicit VEMPs is a short duration click which is highly 
reminiscent of that generated by discharge of the TMS coil. Given this striking similarity, 
the vestibular system is an interesting candidate in the pathway underlying PMRF 
responses to TMS. 
VEMPs arise from activation of the otoliths of the inner ear (in particular the saccule) and 
subsequent activity in the vestibular nerve and nuclei. The PMRF is known to receive 
strong input from the vestibular apparatus (Carleton and Carpenter, 1984; Peterson and 
Abzug, 1975). Moreover, electrophysiological evidence in cats shows that the connection, 
although direct is slow and variable at between 0.6-3ms (Peterson and Abzug, 1975). 
Combined with the sound conduction time and a synapse in the vestibular nuclei, the 
latency would be appropriate for the late response. 
A recent report suggests that the 0.1ms click might not be the optimal stimulus to elicit 
VEMPs; Rosengren et al., (2009) showed that a 500Hz 2ms sine wave was optimal in 
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healthy control subjects. Moreover, the best stimulation site was found to be mastoid; 
midline skull was shown to be the least effective (Stenfelt and Goode, 2005). A further 
consideration is that the presence of VEMPs has been shown to decrease with age 
(Brantberg et al., 2007; Su et al., 2004; Welgampola and Colebatch, 2001). The monkeys 
used for this particular experiment were all 14-15 years of age; average lifespans for 
macaques in the wild is 15 years and in captivity 15-20 years. This may account for the 
cells observed that did not respond to bone conducted clicks.  
In this experiment, a number of pieces of evidence have been presented which support a 
role for the vestibular system in the generation of the late PMRF response to TMS. A clear 
limitation of the study is the small population of cells which were tested with the bone 
vibration stimulus. However, the finding of responses to bone vibration coupled with the 
observation of low threshold responses to TMS and air and plastic-conducted responses to 
TMS strongly support this claim.  
 
Implications for future use of TMS 
This experiment has revealed a strong indirect pathway projecting to the brainstem which 
can be accessed by TMS over primary motor cortex. This demonstrates that TMS can have 
potent effects downstream of the stimulation site. It has long been known that this could be 
the case but in the investigation of descending motor pathways, motor cortex stimulation is 
generally considered to specifically and exclusively activate the CST (for contralateral 
MEPs). However, given recent findings regarding the largely parallel reticulospinal system, 
it should no longer be assumed that this is the case.    
Similar modulation of brainstem activity by TMS has been demonstrated by another group 
who reported disruption of saccades following appropriately timed stimuli (Xu-Wilson et 
al., 2011). Interestingly, this was shown to be the case regardless of stimulation site. If this 
effect is a result of the click stimulus, there are serious implications for future placebo 
controlled TMS studies. Placebo coils have become the accepted form of sham stimulation 
in the field. These coils elicit the same click sound as the regular TMS coils (along with 
some sensory stimulation) but without the magnetic field. Since the transmission of the 
click is important in the generation of late PMRF responses to TMS and is independent of 
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stimulation site, we may be forced to readdress the use of placebo coils in research. The 
observations here might also go some way to explain some of the beneficial ‘placebo’ 
effects shown in several clinical trials. 
 
Implications for future use of click stimuli 
The most exciting finding of this study is that a simple click stimulus could allow a non-
invasive window to access the reticulospinal system. This area of the brain is very deep and 
normally inaccessible to direct stimulation by conventional electrophysiological 
techniques. There are already a number of other paradigms which can indirectly access the 
PMRF for example the acoustic startle (Davis et al., 1982a), startReact paradigm 
(Valldeoriola et al., 1998) and prepulse inhibition of the blink reflex (Valls-Sole et al., 
1999). However, the observation of powerful, bilateral and widespread activation of PMRF 
to the click would suggest this could also be an interesting and straightforward way to 
study the reticulospinal tract in healthy subjects.  
The most useful application for the click however would be in rehabilitation of patients 
following injury to the CST. Damage to this pathway occurs in many conditions but stroke 
is by far the most common; in the UK alone, this is the leading cause of disability in adults 
affecting ~150,000 people every year. For chronic patients, damage to the CST is critical to 
this disability. Animal studies demonstrate a plastic reorganisation of medial brainstem 
motor pathways following CST insult which contributes to functional recovery (Lawrence 
and Kuypers, 1965; Lawrence and Kuypers, 1968a; Zaaimi et al., Submitted).  
Rehabilitative interventions seek to expedite and enhance this process but are 
fundamentally indirect by nature. 
Recent work from our laboratory (Zaaimi et al., Submitted) has shown 
electrophysiologically that there are functional changes in the RST following pyramidal 
lesions. There is a strengthening of RST projections to motoneurones, particularly to those 
controlling flexor and intrinsic hand muscles. This mirrors the pattern of recovery of stroke 
patients whereby overactive flexor muscles can often result in spasticity. An exciting 
prospect would be the pairing of appropriately timed click stimuli with muscle activation to 
induce plasticity. This could involve either facilitation of weak extensor muscles or
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suppression of the counterproductive flexor activity.     
 
Future directions 
This experiment has revealed a strong late response to TMS in the brainstem reticular 
formation. Although a role for the vestibular system has been suggested in the generation 
of this response, this is speculation and the underlying pathway is far from determined. To 
confirm whether the vestibular system is critical to the response, other stimulus frequencies 
and intensities which are known to elicit VEMPs would have to be tested. In particular, 
frequency tuning has been described for both air and bone conducted sound; although this 
varies with stimulus intensity, it typically occurs at rates of around 500-1000Hz (McCue 
and Guinan, 1995; Rauch et al., 2004; Rosengren et al., 2009). Investigation of the tuning 
profile of PMRF responses to bone vibration and TMS should enable us to determine 
whether the vestibular apparatus is critical for their generation. 
Anaesthesia is also an important consideration when interpreting the results described here.  
The PMRF is particularly susceptible to anaesthetic drugs and as a consequence it may be 
that such strong responses are observed as a side effect of the anaesthesia. Many cells are 
quiescent during this time when the animal is still and there are few external stimuli. In this 
situation therefore, perhaps only a very small input to cells in the PMRF would be 
sufficient to produce a strong and widespread response. Conversely, in the awake animal 
the PMRF is under constant bombardment with information from ascending sensory tracts 
and a whole host of cortical and subcortical areas in which case the input may have less 
importance and therefore not produce the same modulation in activity. Alternatively, 
perhaps the suppressive effect of anaesthesia would reduce the occurrence of late responses 
since it is relatively difficult to activate cells. In favour of this argument is the recent 
observation of reticulospinally mediated contralateral MEPs in healthy human subjects 
(Prof J. Rothwell; personal communication); this would suggest that the reticular formation 
is powerfully activated by TMS in the awake state.  
Investigation in the awake animal would further enable us to test whether the response 
could be enhanced or modified with muscle contraction. VEMPs in human subjects are 
only elicited when the target muscle is active. This is also the case for ipsilateral MEPs. 
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Again, this would help us to deduce whether there is a vestibular-reticular pathway in the 
generation of these responses. 
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CHAPTER VI: GENERAL DISCUSSION 
 
There is no doubt that non-invasive methods of investigating brain function are of huge 
value. The benefit for diagnostic purposes is clear to see; the introduction of MRI for 
example revolutionised brain imaging and substantially improved the identification and 
localisation of brain tumours and stroke lesions. Moreover, the ability specifically to access 
particular brain regions or pathways has proved invaluable in learning about human motor 
function. There are numerous such techniques which have each pushed back the boundaries 
and enabled us to progress our knowledge or improve our diagnostic capabilities.  
From the results described in this thesis, intermuscular coherence is suggested to be a 
promising new non-invasive biomarker of upper motor neuron dysfunction which could be 
applied in neurological conditions such as MND. This technique remains to be proven in 
larger and more heterogeneous patient populations, however, the initial results are 
promising. If the clinical utility is confirmed, this technique could offer clinicians a 
window into an otherwise inaccessible part of the motor system; an area which is affected 
in many conditions but which is currently extremely difficult to assess.  
Despite the benefits associated with non-invasive techniques like intermuscular coherence, 
it must be understood that they cannot answer all questions about the brain; animal studies 
still have a critical role to play in many ways. Indeed, we need these basic studies to 
validate the non-invasive methods in the first place. Basic physiological investigations 
underpin all of the methods we use whether invasive or non-invasive. They help us to 
understand the mechanisms of action as well as to define safety parameters. Without this 
fundamental and invaluable knowledge, non-invasive methods would be useless since there 
would be no context within which to assess any differences.   
This thesis confirms the importance of non-invasive methods but also provides a number of 
cautionary tales for those using these techniques. The first lesson learned is that careful 
experimental design is paramount. Retrospectively, it is easy to see that the trial design for 
the LEV study was not optimal and there were too many factors beyond our control. In 
particular, the nature of the disease means that tremor, the parameter we were measuring, 
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was highly variable. Conventionally tremor is measured using accelerometers but perhaps 
this highly quantitative technique was not appropriate to account for the day-to-day 
variability in MS tremor. It is easy to see how false positives could arise when 
measurements were made within a very small time window. This problem may have been 
difficult to avoid, however different experimental approaches could have perhaps provided 
a better platform to address the problem. The recent introduction of an IV drug preparation 
could be more suited to this kind of clinical trial, permitting all data to be collected under 
the same conditions. Alternatively, a wearable device could have been used to measure 
tremor over longer periods of time; this would have had the added benefit of use within the 
‘safe’ environment of the patient’s home.  
A second warning concerns the assumptions made when using non-invasive methods. Non-
invasive stimulation techniques by nature can be very non-specific due to current spread or 
indirect downstream effects. When using techniques such as TMS it is often very difficult 
therefore to isolate a causal pathway for a specific phenomenon. However, often this fact 
can be overlooked if there is an obvious or attractive pathway to explain the observation. 
Care must always be taken to exclude all other possibilities before we ascribe a particular 
effect on one brain area. This is certainly the case for ‘cerebellar’ TMS; this study has 
demonstrated that the technique is not selective since there is concomitant activation of 
other structures at the intensities routinely used. 
The key message throughout this thesis is the importance of understanding the basic 
physiology underpinning the methods being utilised. There is a rather frustrating tendency 
for new techniques to become fashionable long before this basic physiology is understood. 
rTMS is a classic example of a technique that has fallen foul of this trend. Over the last 20 
years rTMS has been applied to a whole host of neurological conditions for therapeutic 
purposes. Yet, the underlying processes are still completely unknown.  We can often see 
the effects, for example the induction of speech arrest with stimulation over Broca’s area. 
However, we have no comprehension of the complex processes taking place or even how 
many different pathways contribute to these effects. In addition, we must be concerned 
about safety aspects of the technique since there are at least 16 documented cases of seizure 
following application of this method. Safety recommendations are now in place but these 
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were only implemented following multiple incidents (Rossi et al., 2009a; Wassermann, 
1998) .  
We should also be careful to thoroughly evaluate the techniques which are already in 
common use. Within this thesis, I have demonstrated that even commonplace methods such 
as TMS require careful evaluation. Everything known to date about this technique has 
resulted from a combination of indirect measurements and modelling studies. There is no 
direct evidence showing specificity or selectivity which is critical. The studies described 
here have shown that there is potentially confounding activation of brainstem pathways not 
only whilst stimulating locally over the base of the skull but also whilst stimulating primary 
motor cortex; a method which is conventionally thought to selectively measure 
corticospinal tract function.  
The results of the TMS studies demonstrate that non-invasive methods must be 
appropriately validated before they are accepted into mainstream use. We must understand 
the basic physiology. It is often assumed that techniques are appropriate and fit for purpose 
just because they are considered to be ‘standard’. For example it is generally accepted that 
accelerometry is the best way to measure tremor when it may not always be optimal. In 
addition, questions about the precise timing of certain processes are often addressed using 
functional MRI which has a very poor temporal resolution. 
Current research trends mean that this is an appropriate time to review non-invasive 
methods to investigate brain function. The interest in non-invasive brain-machine 
interfaces and neuroprosthetics is continuing to grow and technology is progressing at a 
rapid rate. With this constant stream of new developments and the race to develop the first 
commercially viable and effective non-invasive device, the basics can often be overlooked. 
However, in order to make a useful contribution with our research we need to be sure we 
understand at a fundamental level what is happening in the brain. Only then can the 
knowledge be applied in the wider neuroscience community 
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